Skip to main content
Erschienen in: Clinical Reviews in Allergy & Immunology 2/2015

01.10.2015

Fibromyalgia: A Critical and Comprehensive Review

verfasst von: Andrea T. Borchers, M. Eric Gershwin

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Fibromyalgia is a disorder that is part of a spectrum of syndromes that lack precise classification. It is often considered as part of the global overview of functional somatic syndromes that are otherwise medically unexplained or part of a somatization disorder. Patients with fibromyalgia share symptoms with other functional somatic problems, including issues of myalgias, arthralgias, fatigue and sleep disturbances. Indeed, there is often diagnostic and classification overlap for the case definitions of a variety of somatization disorders. Fibromyalgia, however, is a critically important syndrome for physicians and scientists to be aware of. Patients should be taken very seriously and provided optimal care. Although inflammatory, infectious, and autoimmune disorders have all been ascribed to be etiological events in the development of fibromyalgia, there is very little data to support such a thesis. Many of these disorders are associated with depression and anxiety and may even be part of what has been sometimes called affected spectrum disorders. There is no evidence that physical trauma, i.e., automobile accidents, is associated with the development or exacerbation of fibromyalgia. Treatment should be placed on education, patient support, physical therapy, nutrition, and exercise, including the use of drugs that are approved for the treatment of fibromyalgia. Treatment should not include opiates and patients should not become poly pharmacies in which the treatment itself can lead to significant morbidities. Patients with fibromyalgia are living and not dying of this disorder and positive outlooks and family support are key elements in the management of patients.
Literatur
1.
Zurück zum Zitat Smythe HA (1972) Non-articular rheumatism and the fibrositis syndrome. In: Hollander JL, McCarty DJ Jr (eds) Arthritis and allied conditions, 8th edn. Lea & Febiger, Philadelphia, PA, pp 874–84 Smythe HA (1972) Non-articular rheumatism and the fibrositis syndrome. In: Hollander JL, McCarty DJ Jr (eds) Arthritis and allied conditions, 8th edn. Lea & Febiger, Philadelphia, PA, pp 874–84
2.
Zurück zum Zitat Smythe HA, Moldofsky H (1977) Two contributions to understanding of the “fibrositis” syndrome. Bull Rheum Dis 28(1):928–31PubMed Smythe HA, Moldofsky H (1977) Two contributions to understanding of the “fibrositis” syndrome. Bull Rheum Dis 28(1):928–31PubMed
3.
Zurück zum Zitat McBeth J, Mulvey MR (2012) Fibromyalgia: mechanisms and potential impact of the ACR 2010 classification criteria. Nat Rev Rheumatol 8(2):108–16PubMed McBeth J, Mulvey MR (2012) Fibromyalgia: mechanisms and potential impact of the ACR 2010 classification criteria. Nat Rev Rheumatol 8(2):108–16PubMed
4.
Zurück zum Zitat Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The American college of rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33(2):160–72PubMedCrossRef Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The American college of rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33(2):160–72PubMedCrossRef
5.
Zurück zum Zitat Pfau DB, Rolke R, Nickel R, Treede RD, Daublaender M (2009) Somatosensory profiles in subgroups of patients with myogenic temporomandibular disorders and fibromyalgia syndrome. Pain 147(1–3):72–83PubMedCrossRef Pfau DB, Rolke R, Nickel R, Treede RD, Daublaender M (2009) Somatosensory profiles in subgroups of patients with myogenic temporomandibular disorders and fibromyalgia syndrome. Pain 147(1–3):72–83PubMedCrossRef
6.
Zurück zum Zitat Jensen KB, Kosek E, Petzke F, Carville S, Fransson P, Marcus H et al (2009) Evidence of dysfunctional pain inhibition in fibromyalgia reflected in rACC during provoked pain. Pain 144(1–2):95–100PubMedCrossRef Jensen KB, Kosek E, Petzke F, Carville S, Fransson P, Marcus H et al (2009) Evidence of dysfunctional pain inhibition in fibromyalgia reflected in rACC during provoked pain. Pain 144(1–2):95–100PubMedCrossRef
7.
Zurück zum Zitat Amris K, Jespersen A, Bliddal H (2010) Self-reported somatosensory symptoms of neuropathic pain in fibromyalgia and chronic widespread pain correlate with tender point count and pressure-pain thresholds. Pain 151(3):664–9PubMedCrossRef Amris K, Jespersen A, Bliddal H (2010) Self-reported somatosensory symptoms of neuropathic pain in fibromyalgia and chronic widespread pain correlate with tender point count and pressure-pain thresholds. Pain 151(3):664–9PubMedCrossRef
8.
Zurück zum Zitat Menzies V, Lyon DE (2010) Integrated review of the association of cytokines with fibromyalgia and fibromyalgia core symptoms. Biol Res Nurs 11(4):387–94PubMedCentralPubMedCrossRef Menzies V, Lyon DE (2010) Integrated review of the association of cytokines with fibromyalgia and fibromyalgia core symptoms. Biol Res Nurs 11(4):387–94PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat McLoughlin MJ, Colbert LH, Stegner AJ, Cook DB (2011) Are women with fibromyalgia less physically active than healthy women? Med Sci Sports Exerc 43(5):905–12PubMedCentralPubMedCrossRef McLoughlin MJ, Colbert LH, Stegner AJ, Cook DB (2011) Are women with fibromyalgia less physically active than healthy women? Med Sci Sports Exerc 43(5):905–12PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Yuen KC, Bennett RM, Hryciw CA, Cook MB, Rhoads SA, Cook DM (2007) Is further evaluation for growth hormone (GH) deficiency necessary in fibromyalgia patients with low serum insulin-like growth factor (IGF)-I levels? Growth Horm IGF Res 17(1):82–8PubMedCrossRef Yuen KC, Bennett RM, Hryciw CA, Cook MB, Rhoads SA, Cook DM (2007) Is further evaluation for growth hormone (GH) deficiency necessary in fibromyalgia patients with low serum insulin-like growth factor (IGF)-I levels? Growth Horm IGF Res 17(1):82–8PubMedCrossRef
11.
Zurück zum Zitat Jones KD, Deodhar P, Lorentzen A, Bennett RM, Deodhar AA (2007) Growth hormone perturbations in fibromyalgia: a review. Semin Arthritis Rheum 36(6):357–79PubMedCrossRef Jones KD, Deodhar P, Lorentzen A, Bennett RM, Deodhar AA (2007) Growth hormone perturbations in fibromyalgia: a review. Semin Arthritis Rheum 36(6):357–79PubMedCrossRef
12.
Zurück zum Zitat Okifuji A, Turk DC, Sinclair JD, Starz TW, Marcus DA (1997) A standardized manual tender point survey. I. Development and determination of a threshold point for the identification of positive tender points in fibromyalgia syndrome. J Rheumatol 24(2):377–83PubMed Okifuji A, Turk DC, Sinclair JD, Starz TW, Marcus DA (1997) A standardized manual tender point survey. I. Development and determination of a threshold point for the identification of positive tender points in fibromyalgia syndrome. J Rheumatol 24(2):377–83PubMed
13.
Zurück zum Zitat Tastekin N, Birtane M, Uzunca K (2007) Which of the three different tender points assessment methods is more useful for predicting the severity of fibromyalgia syndrome? Rheumatol Int 27(5):447–51PubMedCrossRef Tastekin N, Birtane M, Uzunca K (2007) Which of the three different tender points assessment methods is more useful for predicting the severity of fibromyalgia syndrome? Rheumatol Int 27(5):447–51PubMedCrossRef
14.
Zurück zum Zitat Fallon N, Chiu YH, Li X, Nurmikko TJ, Stancak A (2013) Ipsilateral cortical activation in fibromyalgia patients during brushing correlates with symptom severity. Clin Neurophysiol 124(1):154–63PubMedCrossRef Fallon N, Chiu YH, Li X, Nurmikko TJ, Stancak A (2013) Ipsilateral cortical activation in fibromyalgia patients during brushing correlates with symptom severity. Clin Neurophysiol 124(1):154–63PubMedCrossRef
15.
Zurück zum Zitat Neumann L, Lerner E, Glazer Y, Bolotin A, Shefer A, Buskila D (2008) A cross-sectional study of the relationship between body mass index and clinical characteristics, tenderness measures, quality of life, and physical functioning in fibromyalgia patients. Clin Rheumatol 27(12):1543–7PubMedCrossRef Neumann L, Lerner E, Glazer Y, Bolotin A, Shefer A, Buskila D (2008) A cross-sectional study of the relationship between body mass index and clinical characteristics, tenderness measures, quality of life, and physical functioning in fibromyalgia patients. Clin Rheumatol 27(12):1543–7PubMedCrossRef
16.
Zurück zum Zitat Jacobs JW, Geenen R, van der Heide A, Rasker JJ, Bijlsma JW (1995) Are tender point scores assessed by manual palpation in fibromyalgia reliable? an investigation into the variance of tender point scores. Scand J Rheumatol 24(4):243–7PubMedCrossRef Jacobs JW, Geenen R, van der Heide A, Rasker JJ, Bijlsma JW (1995) Are tender point scores assessed by manual palpation in fibromyalgia reliable? an investigation into the variance of tender point scores. Scand J Rheumatol 24(4):243–7PubMedCrossRef
17.
Zurück zum Zitat Cott A, Parkinson W, Bell MJ, Adachi J, Bedard M, Cividino A et al (1992) Interrater reliability of the tender point criterion for fibromyalgia. J Rheumatol 19(12):1955–9PubMed Cott A, Parkinson W, Bell MJ, Adachi J, Bedard M, Cividino A et al (1992) Interrater reliability of the tender point criterion for fibromyalgia. J Rheumatol 19(12):1955–9PubMed
18.
Zurück zum Zitat Clark P, Franco-Marina F, Goldsmith C, Burgos-Vargas R (1997) Reliability of tender point examination in fibromyalgia. J Clin Epidemiol 50(Suppl 1):S4CrossRef Clark P, Franco-Marina F, Goldsmith C, Burgos-Vargas R (1997) Reliability of tender point examination in fibromyalgia. J Clin Epidemiol 50(Suppl 1):S4CrossRef
19.
Zurück zum Zitat Wolfe F, Cathey MA (1985) The epidemiology of tender points: a prospective study of 1520 patients. J Rheumatol 12(6):1164–8PubMed Wolfe F, Cathey MA (1985) The epidemiology of tender points: a prospective study of 1520 patients. J Rheumatol 12(6):1164–8PubMed
20.
21.
Zurück zum Zitat Petzke F, Gracely RH, Park KM, Ambrose K, Clauw DJ (2003) What do tender points measure? Influence of distress on 4 measures of tenderness. J Rheumatol 30(3):567–74PubMed Petzke F, Gracely RH, Park KM, Ambrose K, Clauw DJ (2003) What do tender points measure? Influence of distress on 4 measures of tenderness. J Rheumatol 30(3):567–74PubMed
22.
Zurück zum Zitat Wolfe F (1997) The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis 56(4):268–71PubMedCentralPubMedCrossRef Wolfe F (1997) The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis 56(4):268–71PubMedCentralPubMedCrossRef
23.
Zurück zum Zitat Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P et al (2010) The American college of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 62(5):600–10CrossRef Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P et al (2010) The American college of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 62(5):600–10CrossRef
24.
Zurück zum Zitat Thompson EN (2010) Diagnostic criteria for fibromyalgia: comment on the article by Wolfe et al. Arthritis Care Res 62(11):1674–5, author reply 6–8 CrossRef Thompson EN (2010) Diagnostic criteria for fibromyalgia: comment on the article by Wolfe et al. Arthritis Care Res 62(11):1674–5, author reply 6–8 CrossRef
25.
Zurück zum Zitat Vanderschueren S, Van Wambeke P, Morlion B (2010) Fibromyalgia: do not give up the tender point count too easily: comment on the article by Wolfe et al. Arthritis Care Res 62(11):1675, author reply 6–8 CrossRef Vanderschueren S, Van Wambeke P, Morlion B (2010) Fibromyalgia: do not give up the tender point count too easily: comment on the article by Wolfe et al. Arthritis Care Res 62(11):1675, author reply 6–8 CrossRef
26.
Zurück zum Zitat Staud R, Price DD, Robinson ME (2010) The provisional diagnostic criteria for fibromyalgia: one step forward, two steps back: comment on the article by Wolfe et al. Arthritis Care Res 62(11):1675–6, author reply 6–8 CrossRef Staud R, Price DD, Robinson ME (2010) The provisional diagnostic criteria for fibromyalgia: one step forward, two steps back: comment on the article by Wolfe et al. Arthritis Care Res 62(11):1675–6, author reply 6–8 CrossRef
27.
Zurück zum Zitat Toda K (2011) The modification of the American college of rheumatology preliminary diagnostic criteria for fibromyalgia should be supplemented and revised. J Rheumatol 38(9):2075, author reply 6 PubMedCrossRef Toda K (2011) The modification of the American college of rheumatology preliminary diagnostic criteria for fibromyalgia should be supplemented and revised. J Rheumatol 38(9):2075, author reply 6 PubMedCrossRef
28.
Zurück zum Zitat Smythe HA (2011) Unhelpful criteria sets for “diagnosis” and “assessment of severity” of fibromyalgia. J Rheumatol 38(6):975–8PubMedCrossRef Smythe HA (2011) Unhelpful criteria sets for “diagnosis” and “assessment of severity” of fibromyalgia. J Rheumatol 38(6):975–8PubMedCrossRef
29.
Zurück zum Zitat Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RS et al (2011) Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol 38(6):1113–22PubMedCrossRef Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RS et al (2011) Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol 38(6):1113–22PubMedCrossRef
30.
Zurück zum Zitat Wolfe F, Brähler E, Hinz A, Häuser W (2013) Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res 65(5):777–85CrossRef Wolfe F, Brähler E, Hinz A, Häuser W (2013) Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res 65(5):777–85CrossRef
31.
Zurück zum Zitat Fitzcharles MA, Boulos P (2003) Inaccuracy in the diagnosis of fibromyalgia syndrome: analysis of referrals. Rheumatology (Oxford) 42(2):263–7CrossRef Fitzcharles MA, Boulos P (2003) Inaccuracy in the diagnosis of fibromyalgia syndrome: analysis of referrals. Rheumatology (Oxford) 42(2):263–7CrossRef
32.
Zurück zum Zitat Usui C, Hatta K, Aratani S, Yagishita N, Nishioka K, Kanazawa T et al (2012) The Japanese version of the 2010 American college of rheumatology preliminary diagnostic criteria for fibromyalgia and the fibromyalgia symptom scale: reliability and validity. Mod Rheumatol 22(1):40–4PubMedCrossRef Usui C, Hatta K, Aratani S, Yagishita N, Nishioka K, Kanazawa T et al (2012) The Japanese version of the 2010 American college of rheumatology preliminary diagnostic criteria for fibromyalgia and the fibromyalgia symptom scale: reliability and validity. Mod Rheumatol 22(1):40–4PubMedCrossRef
33.
Zurück zum Zitat Kim SM, Lee SH, Kim HR (2012) Applying the ACR preliminary diagnostic criteria in the diagnosis and assessment of fibromyalgia. Korean J Pain 25(3):173–82PubMedCentralPubMedCrossRef Kim SM, Lee SH, Kim HR (2012) Applying the ACR preliminary diagnostic criteria in the diagnosis and assessment of fibromyalgia. Korean J Pain 25(3):173–82PubMedCentralPubMedCrossRef
34.
Zurück zum Zitat Bidari A, Hassanzadeh M, Ghavidel Parsa B, Kianmehr N, Kabir A, Pirhadi S et al (2013) Validation of the 2010 American college of rheumatology preliminary diagnostic criteria for fibromyalgia in an Iranian population. Rheumatol Int 33(12):2999–3007PubMedCrossRef Bidari A, Hassanzadeh M, Ghavidel Parsa B, Kianmehr N, Kabir A, Pirhadi S et al (2013) Validation of the 2010 American college of rheumatology preliminary diagnostic criteria for fibromyalgia in an Iranian population. Rheumatol Int 33(12):2999–3007PubMedCrossRef
35.
Zurück zum Zitat Jones GT, Atzeni F, Beasley M, Fluss E, Sarzi-Puttini P, Macfarlane GJ (2014) The prevalence of fibromyalgia in the general population - a comparison of the American college of rheumatology 1990, 2010 and modified 2010 classification criteria. Arthritis Rheumatol 67(2):568–75CrossRef Jones GT, Atzeni F, Beasley M, Fluss E, Sarzi-Puttini P, Macfarlane GJ (2014) The prevalence of fibromyalgia in the general population - a comparison of the American college of rheumatology 1990, 2010 and modified 2010 classification criteria. Arthritis Rheumatol 67(2):568–75CrossRef
36.
Zurück zum Zitat Bennett RM, Friend R, Marcus D, Bernstein C, Han BK, Yachoui R et al (2014) Criteria for the diagnosis of fibromyalgia: validation of the modified 2010 preliminary American college of rheumatology criteria and the development of alternative criteria. Arthritis Care Res 66(9):1364–73CrossRef Bennett RM, Friend R, Marcus D, Bernstein C, Han BK, Yachoui R et al (2014) Criteria for the diagnosis of fibromyalgia: validation of the modified 2010 preliminary American college of rheumatology criteria and the development of alternative criteria. Arthritis Care Res 66(9):1364–73CrossRef
37.
Zurück zum Zitat Ferrari R, Russell AS (2013) A questionnaire using the modified 2010 American college of rheumatology criteria for fibromyalgia: specificity and sensitivity in clinical practice. J Rheumatol 40(9):1590–5PubMedCrossRef Ferrari R, Russell AS (2013) A questionnaire using the modified 2010 American college of rheumatology criteria for fibromyalgia: specificity and sensitivity in clinical practice. J Rheumatol 40(9):1590–5PubMedCrossRef
38.
Zurück zum Zitat Usui C, Hatta K, Aratani S, Yagishita N, Nishioka K, Kanazawa T et al (2013) The Japanese version of the modified ACR preliminary diagnostic criteria for fibromyalgia and the fibromyalgia symptom scale: reliability and validity. Mod Rheumatol 23(5):846–50PubMedCrossRef Usui C, Hatta K, Aratani S, Yagishita N, Nishioka K, Kanazawa T et al (2013) The Japanese version of the modified ACR preliminary diagnostic criteria for fibromyalgia and the fibromyalgia symptom scale: reliability and validity. Mod Rheumatol 23(5):846–50PubMedCrossRef
39.
Zurück zum Zitat Segura-Jiménez V, Aparicio VA, Álvarez-Gallardo IC, Soriano-Maldonado A, Estévez-López F, Delgado-Fernández M et al (2014) Validation of the modified 2010 American college of rheumatology diagnostic criteria for fibromyalgia in a Spanish population. Rheumatology (Oxford) 53(10):1803–11CrossRef Segura-Jiménez V, Aparicio VA, Álvarez-Gallardo IC, Soriano-Maldonado A, Estévez-López F, Delgado-Fernández M et al (2014) Validation of the modified 2010 American college of rheumatology diagnostic criteria for fibromyalgia in a Spanish population. Rheumatology (Oxford) 53(10):1803–11CrossRef
40.
Zurück zum Zitat Häuser W, Jung E, Erbslöh-Möller B, Gesmann M, Kühn-Becker H, Petermann F et al (2012) Validation of the fibromyalgia survey questionnaire within a cross-sectional survey. PLoS One 7(5):e37504PubMedCentralPubMedCrossRef Häuser W, Jung E, Erbslöh-Möller B, Gesmann M, Kühn-Becker H, Petermann F et al (2012) Validation of the fibromyalgia survey questionnaire within a cross-sectional survey. PLoS One 7(5):e37504PubMedCentralPubMedCrossRef
41.
Zurück zum Zitat Katz RS, Wolfe F, Michaud K (2006) Fibromyalgia diagnosis: a comparison of clinical, survey, and American college of rheumatology criteria. Arthritis Rheum 54(1):169–76PubMedCrossRef Katz RS, Wolfe F, Michaud K (2006) Fibromyalgia diagnosis: a comparison of clinical, survey, and American college of rheumatology criteria. Arthritis Rheum 54(1):169–76PubMedCrossRef
42.
43.
Zurück zum Zitat Vincent A, Lahr BD, Wolfe F, Clauw DJ, Whipple MO, Oh TH et al (2013) Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester epidemiology project. Arthritis Care Res 65(5):786–92CrossRef Vincent A, Lahr BD, Wolfe F, Clauw DJ, Whipple MO, Oh TH et al (2013) Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester epidemiology project. Arthritis Care Res 65(5):786–92CrossRef
44.
Zurück zum Zitat Forseth KO, Gran JT, Husby G (1997) A population study of the incidence of fibromyalgia among women aged 26–55 year. Br J Rheumatol 36(12):1318–23PubMedCrossRef Forseth KO, Gran JT, Husby G (1997) A population study of the incidence of fibromyalgia among women aged 26–55 year. Br J Rheumatol 36(12):1318–23PubMedCrossRef
45.
Zurück zum Zitat Weir PT, Harlan GA, Nkoy FL, Jones SS, Hegmann KT, Gren LH et al (2006) The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on international classification of diseases, 9th revision codes. J Clin Rheumatol 12(3):124–8PubMedCrossRef Weir PT, Harlan GA, Nkoy FL, Jones SS, Hegmann KT, Gren LH et al (2006) The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on international classification of diseases, 9th revision codes. J Clin Rheumatol 12(3):124–8PubMedCrossRef
46.
Zurück zum Zitat Raphael KG, Janal MN, Nayak S, Schwartz JE, Gallagher RM (2006) Psychiatric comorbidities in a community sample of women with fibromyalgia. Pain 124(1–2):117–25PubMedCrossRef Raphael KG, Janal MN, Nayak S, Schwartz JE, Gallagher RM (2006) Psychiatric comorbidities in a community sample of women with fibromyalgia. Pain 124(1–2):117–25PubMedCrossRef
47.
Zurück zum Zitat White KP, Nielson WR, Harth M, Ostbye T, Speechley M (2002) Does the label “fibromyalgia” alter health status, function, and health service utilization? a prospective, within-group comparison in a community cohort of adults with chronic widespread pain. Arthritis Rheum 47(3):260–5PubMedCrossRef White KP, Nielson WR, Harth M, Ostbye T, Speechley M (2002) Does the label “fibromyalgia” alter health status, function, and health service utilization? a prospective, within-group comparison in a community cohort of adults with chronic widespread pain. Arthritis Rheum 47(3):260–5PubMedCrossRef
48.
Zurück zum Zitat Yunus MB, Inanici F, Aldag JC, Mangold RF (2000) Fibromyalgia in men: comparison of clinical features with women. J Rheumatol 27(2):485–90PubMed Yunus MB, Inanici F, Aldag JC, Mangold RF (2000) Fibromyalgia in men: comparison of clinical features with women. J Rheumatol 27(2):485–90PubMed
49.
Zurück zum Zitat Yunus MB, Celiker R, Aldag JC (2004) Fibromyalgia in men: comparison of psychological features with women. J Rheumatol 31(12):2464–7PubMed Yunus MB, Celiker R, Aldag JC (2004) Fibromyalgia in men: comparison of psychological features with women. J Rheumatol 31(12):2464–7PubMed
50.
Zurück zum Zitat White KP, Speechley M, Harth M, Ostbye T (1999) The London fibromyalgia epidemiology study: comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls. J Rheumatol 26(7):1577–85PubMed White KP, Speechley M, Harth M, Ostbye T (1999) The London fibromyalgia epidemiology study: comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls. J Rheumatol 26(7):1577–85PubMed
51.
Zurück zum Zitat Ruiz Perez I, Ubago Linares MC, Bermejo Perez MJ, Plazaola Castano J, Olry de Labry-Lima A, Hernandez-Torres E (2007) Diferencias en características sociodemográficas, clinicas y psicológicas entre hombres y mujeres diagnosticados de fibromialgia [differences in sociodemographic, clinical, psychosocial and health care characteristics between men and women diagnosed with fibromyalgia]. Rev Clin Esp 207(9):433–9PubMedCrossRef Ruiz Perez I, Ubago Linares MC, Bermejo Perez MJ, Plazaola Castano J, Olry de Labry-Lima A, Hernandez-Torres E (2007) Diferencias en características sociodemográficas, clinicas y psicológicas entre hombres y mujeres diagnosticados de fibromialgia [differences in sociodemographic, clinical, psychosocial and health care characteristics between men and women diagnosed with fibromyalgia]. Rev Clin Esp 207(9):433–9PubMedCrossRef
52.
Zurück zum Zitat Lange M, Karpinski N, Krohn-Grimberghe B, Petermann F (2010) Geschlechtsunterschiede beim fibromyalgiesyndrom [patients with fibromyalgia: gender differences]. Schmerz 24(3):262–6PubMedCrossRef Lange M, Karpinski N, Krohn-Grimberghe B, Petermann F (2010) Geschlechtsunterschiede beim fibromyalgiesyndrom [patients with fibromyalgia: gender differences]. Schmerz 24(3):262–6PubMedCrossRef
54.
Zurück zum Zitat White KP, Speechley M, Harth M, Ostbye T (1999) The London fibromyalgia epidemiology study: the prevalence of fibromyalgia syndrome in London Ontario. J Rheumatol 26(7):1570–6PubMed White KP, Speechley M, Harth M, Ostbye T (1999) The London fibromyalgia epidemiology study: the prevalence of fibromyalgia syndrome in London Ontario. J Rheumatol 26(7):1570–6PubMed
55.
Zurück zum Zitat Bergman S (2005) Psychosocial aspects of chronic widespread pain and fibromyalgia. Disabil Rehabil 27(12):675–83PubMedCrossRef Bergman S (2005) Psychosocial aspects of chronic widespread pain and fibromyalgia. Disabil Rehabil 27(12):675–83PubMedCrossRef
56.
Zurück zum Zitat Macfarlane GJ, Norrie G, Atherton K, Power C, Jones GT (2009) The influence of socioeconomic status on the reporting of regional and widespread musculoskeletal pain: results from the 1958 British birth cohort study. Ann Rheum Dis 68(10):1591–5PubMedCrossRef Macfarlane GJ, Norrie G, Atherton K, Power C, Jones GT (2009) The influence of socioeconomic status on the reporting of regional and widespread musculoskeletal pain: results from the 1958 British birth cohort study. Ann Rheum Dis 68(10):1591–5PubMedCrossRef
57.
Zurück zum Zitat Bannwarth B, Blotman F, Roue-Le Lay K, Caubere JP, Andre E, Taieb C (2009) Fibromyalgia syndrome in the general population of France: a prevalence study. Joint Bone Spine 76(2):184–7PubMedCrossRef Bannwarth B, Blotman F, Roue-Le Lay K, Caubere JP, Andre E, Taieb C (2009) Fibromyalgia syndrome in the general population of France: a prevalence study. Joint Bone Spine 76(2):184–7PubMedCrossRef
58.
Zurück zum Zitat Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M et al (2010) Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum 39(6):448–53PubMedCrossRef Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M et al (2010) Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum 39(6):448–53PubMedCrossRef
59.
Zurück zum Zitat Wolfe F, Ross K, Anderson J, Russell IJ (1995) Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol 22(1):151–6PubMed Wolfe F, Ross K, Anderson J, Russell IJ (1995) Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol 22(1):151–6PubMed
60.
Zurück zum Zitat Häuser W, Schmutzer G, Brähler E, Glaesmer H (2009) A cluster within the continuum of biopsychosocial distress can be labeled “fibromyalgia syndrome”—evidence from a representative German population survey. J Rheumatol 36(12):2806–12PubMedCrossRef Häuser W, Schmutzer G, Brähler E, Glaesmer H (2009) A cluster within the continuum of biopsychosocial distress can be labeled “fibromyalgia syndrome”—evidence from a representative German population survey. J Rheumatol 36(12):2806–12PubMedCrossRef
61.
Zurück zum Zitat Aaron LA, Buchwald D (2001) A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med 134(9 Pt 2):868–81PubMedCrossRef Aaron LA, Buchwald D (2001) A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med 134(9 Pt 2):868–81PubMedCrossRef
62.
Zurück zum Zitat Jason LA, Taylor RR, Kennedy CL (2000) Chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities in a community-based sample of persons with chronic fatigue syndrome-like symptoms. Psychosom Med 62(5):655–63PubMedCrossRef Jason LA, Taylor RR, Kennedy CL (2000) Chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities in a community-based sample of persons with chronic fatigue syndrome-like symptoms. Psychosom Med 62(5):655–63PubMedCrossRef
63.
Zurück zum Zitat White KP, Speechley M, Harth M, Ostbye T (2000) Co-existence of chronic fatigue syndrome with fibromyalgia syndrome in the general population. A controlled study. Scand J Rheumatol 29(1):44–51PubMedCrossRef White KP, Speechley M, Harth M, Ostbye T (2000) Co-existence of chronic fatigue syndrome with fibromyalgia syndrome in the general population. A controlled study. Scand J Rheumatol 29(1):44–51PubMedCrossRef
64.
Zurück zum Zitat Kato K, Sullivan PF, Evengard B, Pedersen NL (2006) Chronic widespread pain and its comorbidities: a population-based study. Arch Intern Med 166(15):1649–54PubMedCrossRef Kato K, Sullivan PF, Evengard B, Pedersen NL (2006) Chronic widespread pain and its comorbidities: a population-based study. Arch Intern Med 166(15):1649–54PubMedCrossRef
65.
Zurück zum Zitat Arnold LM, Crofford LJ, Mease PJ, Burgess SM, Palmer SC, Abetz L et al (2008) Patient perspectives on the impact of fibromyalgia. Patient Educ Couns 73(1):114–20PubMedCentralPubMedCrossRef Arnold LM, Crofford LJ, Mease PJ, Burgess SM, Palmer SC, Abetz L et al (2008) Patient perspectives on the impact of fibromyalgia. Patient Educ Couns 73(1):114–20PubMedCentralPubMedCrossRef
66.
Zurück zum Zitat Hudson JI, Goldenberg DL, Pope HG Jr, Keck PE Jr, Schlesinger L (1992) Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 92(4):363–7PubMedCrossRef Hudson JI, Goldenberg DL, Pope HG Jr, Keck PE Jr, Schlesinger L (1992) Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 92(4):363–7PubMedCrossRef
67.
Zurück zum Zitat Ciccone DS, Natelson BH (2003) Comorbid illness in women with chronic fatigue syndrome: a test of the single syndrome hypothesis. Psychosom Med 65(2):268–75PubMedCrossRef Ciccone DS, Natelson BH (2003) Comorbid illness in women with chronic fatigue syndrome: a test of the single syndrome hypothesis. Psychosom Med 65(2):268–75PubMedCrossRef
68.
Zurück zum Zitat Ciccone DS, Weissman L, Natelson BH (2008) Chronic fatigue syndrome in male Gulf War veterans and civilians: a further test of the single syndrome hypothesis. J Health Psychol 13(4):529–36PubMedCrossRef Ciccone DS, Weissman L, Natelson BH (2008) Chronic fatigue syndrome in male Gulf War veterans and civilians: a further test of the single syndrome hypothesis. J Health Psychol 13(4):529–36PubMedCrossRef
69.
Zurück zum Zitat Kurland JE, Coyle WJ, Winkler A, Zable E (2006) Prevalence of irritable bowel syndrome and depression in fibromyalgia. Dig Dis Sci 51(3):454–60PubMedCrossRef Kurland JE, Coyle WJ, Winkler A, Zable E (2006) Prevalence of irritable bowel syndrome and depression in fibromyalgia. Dig Dis Sci 51(3):454–60PubMedCrossRef
70.
Zurück zum Zitat Riedl A, Schmidtmann M, Stengel A, Goebel M, Wisser AS, Klapp BF et al (2008) Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J Psychosom Res 64(6):573–82PubMedCrossRef Riedl A, Schmidtmann M, Stengel A, Goebel M, Wisser AS, Klapp BF et al (2008) Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J Psychosom Res 64(6):573–82PubMedCrossRef
71.
Zurück zum Zitat Mengshoel AM, Forre O (1993) Pain and fatigue in patients with rheumatic disorders. Clin Rheumatol 12(4):515–21PubMedCrossRef Mengshoel AM, Forre O (1993) Pain and fatigue in patients with rheumatic disorders. Clin Rheumatol 12(4):515–21PubMedCrossRef
72.
73.
Zurück zum Zitat Staud R, Vierck CJ, Robinson ME, Price DD (2006) Overall fibromyalgia pain is predicted by ratings of local pain and pain-related negative affect—possible role of peripheral tissues. Rheumatology (Oxford) 45(11):1409–15CrossRef Staud R, Vierck CJ, Robinson ME, Price DD (2006) Overall fibromyalgia pain is predicted by ratings of local pain and pain-related negative affect—possible role of peripheral tissues. Rheumatology (Oxford) 45(11):1409–15CrossRef
74.
Zurück zum Zitat Ge HY, Wang Y, Fernandez-de-las-Penas C, Graven-Nielsen T, Danneskiold-Samsoe B, Arendt-Nielsen L (2011) Reproduction of overall spontaneous pain pattern by manual stimulation of active myofascial trigger points in fibromyalgia patients. Arthritis Res Ther 13(2):R48PubMedCentralPubMedCrossRef Ge HY, Wang Y, Fernandez-de-las-Penas C, Graven-Nielsen T, Danneskiold-Samsoe B, Arendt-Nielsen L (2011) Reproduction of overall spontaneous pain pattern by manual stimulation of active myofascial trigger points in fibromyalgia patients. Arthritis Res Ther 13(2):R48PubMedCentralPubMedCrossRef
75.
Zurück zum Zitat Leavitt F, Katz RS, Golden HE, Glickman PB, Layfer LF (1986) Comparison of pain properties in fibromyalgia patients and rheumatoid arthritis patients. Arthritis Rheum 29(6):775–81PubMedCrossRef Leavitt F, Katz RS, Golden HE, Glickman PB, Layfer LF (1986) Comparison of pain properties in fibromyalgia patients and rheumatoid arthritis patients. Arthritis Rheum 29(6):775–81PubMedCrossRef
76.
Zurück zum Zitat Lautenbacher S, Rollman GB, McCain GA (1994) Multi-method assessment of experimental and clinical pain in patients with fibromyalgia. Pain 59(1):45–53PubMedCrossRef Lautenbacher S, Rollman GB, McCain GA (1994) Multi-method assessment of experimental and clinical pain in patients with fibromyalgia. Pain 59(1):45–53PubMedCrossRef
77.
Zurück zum Zitat Hughes L (2006) Physical and psychological variables that influence pain in patients with fibromyalgia. Orthop Nurs 25(2):112–9, quiz 20–1 PubMedCrossRef Hughes L (2006) Physical and psychological variables that influence pain in patients with fibromyalgia. Orthop Nurs 25(2):112–9, quiz 20–1 PubMedCrossRef
78.
Zurück zum Zitat Campbell SM, Clark S, Tindall EA, Forehand ME, Bennett RM (1983) Clinical characteristics of fibrositis. I. A “blinded,” controlled study of symptoms and tender points. Arthritis Rheum 26(7):817–24PubMedCrossRef Campbell SM, Clark S, Tindall EA, Forehand ME, Bennett RM (1983) Clinical characteristics of fibrositis. I. A “blinded,” controlled study of symptoms and tender points. Arthritis Rheum 26(7):817–24PubMedCrossRef
79.
Zurück zum Zitat Affaitati G, Costantini R, Fabrizio A, Lapenna D, Tafuri E, Giamberardino MA (2011) Effects of treatment of peripheral pain generators in fibromyalgia patients. Eur J Pain 15(1):61–9PubMedCrossRef Affaitati G, Costantini R, Fabrizio A, Lapenna D, Tafuri E, Giamberardino MA (2011) Effects of treatment of peripheral pain generators in fibromyalgia patients. Eur J Pain 15(1):61–9PubMedCrossRef
80.
Zurück zum Zitat Bellamy N, Sothern RB, Campbell J (2004) Aspects of diurnal rhythmicity in pain, stiffness, and fatigue in patients with fibromyalgia. J Rheumatol 31(2):379–89PubMed Bellamy N, Sothern RB, Campbell J (2004) Aspects of diurnal rhythmicity in pain, stiffness, and fatigue in patients with fibromyalgia. J Rheumatol 31(2):379–89PubMed
81.
Zurück zum Zitat Klerman EB, Goldenberg DL, Brown EN, Maliszewski AM, Adler GK (2001) Circadian rhythms of women with fibromyalgia. J Clin Endocrinol Metab 86(3):1034–9PubMed Klerman EB, Goldenberg DL, Brown EN, Maliszewski AM, Adler GK (2001) Circadian rhythms of women with fibromyalgia. J Clin Endocrinol Metab 86(3):1034–9PubMed
82.
Zurück zum Zitat Okifuji A, Turk DC (2002) Stress and psychophysiological dysregulation in patients with fibromyalgia syndrome. Appl Psychophysiol Biofeedback 27(2):129–41PubMedCrossRef Okifuji A, Turk DC (2002) Stress and psychophysiological dysregulation in patients with fibromyalgia syndrome. Appl Psychophysiol Biofeedback 27(2):129–41PubMedCrossRef
83.
Zurück zum Zitat Toussaint L, Vincent A, McAllister SJ, Whipple M (2014) Intra- and inter-patient symptom variability in fibromyalgia: results of a 90 days assessment. Musculoskelet Care. doi:10.1002/msc.1090, [doi]:accessed 3/2/15 Toussaint L, Vincent A, McAllister SJ, Whipple M (2014) Intra- and inter-patient symptom variability in fibromyalgia: results of a 90 days assessment. Musculoskelet Care. doi:10.​1002/​msc.​1090, [doi]:accessed 3/2/15
84.
Zurück zum Zitat Okifuji A, Bradshaw DH, Donaldson GW, Turk DC (2011) Sequential analyses of daily symptoms in women with fibromyalgia syndrome. J Pain 12(1):84–93PubMedCentralPubMedCrossRef Okifuji A, Bradshaw DH, Donaldson GW, Turk DC (2011) Sequential analyses of daily symptoms in women with fibromyalgia syndrome. J Pain 12(1):84–93PubMedCentralPubMedCrossRef
85.
Zurück zum Zitat Zautra AJ, Fasman R, Parish BP, Davis MC (2007) Daily fatigue in women with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Pain 128(1–2):128–35PubMedCrossRef Zautra AJ, Fasman R, Parish BP, Davis MC (2007) Daily fatigue in women with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Pain 128(1–2):128–35PubMedCrossRef
86.
Zurück zum Zitat Bossema ER, van Middendorp H, Jacobs JW, Bijlsma JW, Geenen R (2013) Influence of weather on daily symptoms of pain and fatigue in female patients with fibromyalgia: a multilevel regression analysis. Arthritis Care Res 65(7):1019–25CrossRef Bossema ER, van Middendorp H, Jacobs JW, Bijlsma JW, Geenen R (2013) Influence of weather on daily symptoms of pain and fatigue in female patients with fibromyalgia: a multilevel regression analysis. Arthritis Care Res 65(7):1019–25CrossRef
87.
Zurück zum Zitat Burckhardt CS, Clark SR, O’Reilly CA, Bennett RA (1997) Pain-coping strategies of women with fibromyalgia: relationship to pain, fatigue, and quality of life. J Muscoskel Pain 5(3):5–21CrossRef Burckhardt CS, Clark SR, O’Reilly CA, Bennett RA (1997) Pain-coping strategies of women with fibromyalgia: relationship to pain, fatigue, and quality of life. J Muscoskel Pain 5(3):5–21CrossRef
88.
Zurück zum Zitat Hassett AL, Cone JD, Patella SJ, Sigal LH (2000) The role of catastrophizing in the pain and depression of women with fibromyalgia syndrome. Arthritis Rheum 43(11):2493–500PubMedCrossRef Hassett AL, Cone JD, Patella SJ, Sigal LH (2000) The role of catastrophizing in the pain and depression of women with fibromyalgia syndrome. Arthritis Rheum 43(11):2493–500PubMedCrossRef
89.
Zurück zum Zitat Sánchez AI, Martínez MP, Miró E, Medina A (2011) Predictors of the pain perception and self-efficacy for pain control in patients with fibromyalgia. Span J Psychol 14(1):366–73PubMedCrossRef Sánchez AI, Martínez MP, Miró E, Medina A (2011) Predictors of the pain perception and self-efficacy for pain control in patients with fibromyalgia. Span J Psychol 14(1):366–73PubMedCrossRef
90.
Zurück zum Zitat Van Liew C, Brown KC, Cronan TA, Bigatti SM, Kothari DJ (2013) Predictors of pain and functioning over time in fibromyalgia syndrome: an autoregressive path analysis. Arthritis Care Res 65(2):251–6CrossRef Van Liew C, Brown KC, Cronan TA, Bigatti SM, Kothari DJ (2013) Predictors of pain and functioning over time in fibromyalgia syndrome: an autoregressive path analysis. Arthritis Care Res 65(2):251–6CrossRef
91.
92.
Zurück zum Zitat Desmeules JA, Cedraschi C, Rapiti E, Baumgartner E, Finckh A, Cohen P et al (2003) Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum 48(5):1420–9PubMedCrossRef Desmeules JA, Cedraschi C, Rapiti E, Baumgartner E, Finckh A, Cohen P et al (2003) Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum 48(5):1420–9PubMedCrossRef
93.
Zurück zum Zitat Banic B, Petersen-Felix S, Andersen OK, Radanov BP, Villiger PM, Arendt-Nielsen L et al (2004) Evidence for spinal cord hypersensitivity in chronic pain after whiplash injury and in fibromyalgia. Pain 107(1–2):7–15PubMedCrossRef Banic B, Petersen-Felix S, Andersen OK, Radanov BP, Villiger PM, Arendt-Nielsen L et al (2004) Evidence for spinal cord hypersensitivity in chronic pain after whiplash injury and in fibromyalgia. Pain 107(1–2):7–15PubMedCrossRef
94.
Zurück zum Zitat Staud R, Vierck CJ, Cannon RL, Mauderli AP, Price DD (2001) Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 91(1–2):165–75PubMedCrossRef Staud R, Vierck CJ, Cannon RL, Mauderli AP, Price DD (2001) Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 91(1–2):165–75PubMedCrossRef
95.
Zurück zum Zitat Staud R, Cannon RC, Mauderli AP, Robinson ME, Price DD, Vierck CJ Jr (2003) Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome. Pain 102(1–2):87–95PubMedCrossRef Staud R, Cannon RC, Mauderli AP, Robinson ME, Price DD, Vierck CJ Jr (2003) Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome. Pain 102(1–2):87–95PubMedCrossRef
96.
Zurück zum Zitat Staud R, Vierck CJ, Robinson ME, Price DD (2004) Spatial summation of heat pain within and across dermatomes in fibromyalgia patients and pain-free subjects. Pain 111(3):342–50PubMedCrossRef Staud R, Vierck CJ, Robinson ME, Price DD (2004) Spatial summation of heat pain within and across dermatomes in fibromyalgia patients and pain-free subjects. Pain 111(3):342–50PubMedCrossRef
97.
Zurück zum Zitat Sörensen J, Graven-Nielsen T, Henriksson KG, Bengtsson M, Arendt-Nielsen L (1998) Hyperexcitability in fibromyalgia. J Rheumatol 25(1):152–5PubMed Sörensen J, Graven-Nielsen T, Henriksson KG, Bengtsson M, Arendt-Nielsen L (1998) Hyperexcitability in fibromyalgia. J Rheumatol 25(1):152–5PubMed
98.
Zurück zum Zitat Graven-Nielsen T, Aspegren Kendall S, Henriksson KG, Bengtsson M, Sorensen J, Johnson A et al (2000) Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain 85(3):483–91PubMedCrossRef Graven-Nielsen T, Aspegren Kendall S, Henriksson KG, Bengtsson M, Sorensen J, Johnson A et al (2000) Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain 85(3):483–91PubMedCrossRef
99.
Zurück zum Zitat Staud R, Koo E, Robinson ME, Price DD (2007) Spatial summation of mechanically evoked muscle pain and painful after sensations in normal subjects and fibromyalgia patients. Pain 130(1–2):177–87PubMedCentralPubMedCrossRef Staud R, Koo E, Robinson ME, Price DD (2007) Spatial summation of mechanically evoked muscle pain and painful after sensations in normal subjects and fibromyalgia patients. Pain 130(1–2):177–87PubMedCentralPubMedCrossRef
100.
Zurück zum Zitat Staud R, Robinson ME, Price DD (2007) Temporal summation of second pain and its maintenance are useful for characterizing widespread central sensitization of fibromyalgia patients. J Pain 8(11):893–901PubMedCentralPubMedCrossRef Staud R, Robinson ME, Price DD (2007) Temporal summation of second pain and its maintenance are useful for characterizing widespread central sensitization of fibromyalgia patients. J Pain 8(11):893–901PubMedCentralPubMedCrossRef
101.
Zurück zum Zitat Julien N, Goffaux P, Arsenault P, Marchand S (2005) Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 114(1–2):295–302PubMedCrossRef Julien N, Goffaux P, Arsenault P, Marchand S (2005) Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 114(1–2):295–302PubMedCrossRef
102.
Zurück zum Zitat Blumenstiel K, Gerhardt A, Rolke R, Bieber C, Tesarz J, Friederich HC et al (2011) Quantitative sensory testing profiles in chronic back pain are distinct from those in fibromyalgia. Clin J Pain 27(8):682–90PubMedCrossRef Blumenstiel K, Gerhardt A, Rolke R, Bieber C, Tesarz J, Friederich HC et al (2011) Quantitative sensory testing profiles in chronic back pain are distinct from those in fibromyalgia. Clin J Pain 27(8):682–90PubMedCrossRef
103.
Zurück zum Zitat Tampin B, Briffa NK, Slater H (2013) Self-reported sensory descriptors are associated with quantitative sensory testing parameters in patients with cervical radiculopathy, but not in patients with fibromyalgia. Eur J Pain 17(4):621–33PubMedCrossRef Tampin B, Briffa NK, Slater H (2013) Self-reported sensory descriptors are associated with quantitative sensory testing parameters in patients with cervical radiculopathy, but not in patients with fibromyalgia. Eur J Pain 17(4):621–33PubMedCrossRef
104.
Zurück zum Zitat Lautenbacher S, Rollman GB (1997) Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain 13(3):189–96PubMedCrossRef Lautenbacher S, Rollman GB (1997) Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain 13(3):189–96PubMedCrossRef
105.
Zurück zum Zitat Potvin S, Larouche A, Normand E, de Souza JB, Gaumond I, Grignon S et al (2009) DRD3 Ser9Gly polymorphism is related to thermal pain perception and modulation in chronic widespread pain patients and healthy controls. J Pain 10(9):969–75PubMedCrossRef Potvin S, Larouche A, Normand E, de Souza JB, Gaumond I, Grignon S et al (2009) DRD3 Ser9Gly polymorphism is related to thermal pain perception and modulation in chronic widespread pain patients and healthy controls. J Pain 10(9):969–75PubMedCrossRef
106.
Zurück zum Zitat Kosek E, Ekholm J, Hansson P (1996) Sensory dysfunction in fibromyalgia patients with implications for pathogenic mechanisms. Pain 68(2–3):375–83PubMedCrossRef Kosek E, Ekholm J, Hansson P (1996) Sensory dysfunction in fibromyalgia patients with implications for pathogenic mechanisms. Pain 68(2–3):375–83PubMedCrossRef
107.
Zurück zum Zitat Staud R, Nagel S, Robinson ME, Price DD (2009) Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled study. Pain 145(1–2):96–104PubMedCentralPubMedCrossRef Staud R, Nagel S, Robinson ME, Price DD (2009) Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled study. Pain 145(1–2):96–104PubMedCentralPubMedCrossRef
108.
Zurück zum Zitat Geisser ME, Casey KL, Brucksch CB, Ribbens CM, Appleton BB, Crofford LJ (2003) Perception of noxious and innocuous heat stimulation among healthy women and women with fibromyalgia: association with mood, somatic focus, and catastrophizing. Pain 102(3):243–50PubMedCrossRef Geisser ME, Casey KL, Brucksch CB, Ribbens CM, Appleton BB, Crofford LJ (2003) Perception of noxious and innocuous heat stimulation among healthy women and women with fibromyalgia: association with mood, somatic focus, and catastrophizing. Pain 102(3):243–50PubMedCrossRef
109.
Zurück zum Zitat Gibson SJ, Littlejohn GO, Gorman MM, Helme RD, Granges G (1994) Altered heat pain thresholds and cerebral event-related potentials following painful CO2 laser stimulation in subjects with fibromyalgia syndrome. Pain 58(2):185–93PubMedCrossRef Gibson SJ, Littlejohn GO, Gorman MM, Helme RD, Granges G (1994) Altered heat pain thresholds and cerebral event-related potentials following painful CO2 laser stimulation in subjects with fibromyalgia syndrome. Pain 58(2):185–93PubMedCrossRef
110.
Zurück zum Zitat Berglund B, Harju EL, Kosek E, Lindblom U (2002) Quantitative and qualitative perceptual analysis of cold dysesthesia and hyperalgesia in fibromyalgia. Pain 96(1–2):177–87PubMedCrossRef Berglund B, Harju EL, Kosek E, Lindblom U (2002) Quantitative and qualitative perceptual analysis of cold dysesthesia and hyperalgesia in fibromyalgia. Pain 96(1–2):177–87PubMedCrossRef
111.
Zurück zum Zitat Hurtig IM, Raak RI, Kendall SA, Gerdle B, Wahren LK (2001) Quantitative sensory testing in fibromyalgia patients and in healthy subjects: identification of subgroups. Clin J Pain 17(4):316–22PubMedCrossRef Hurtig IM, Raak RI, Kendall SA, Gerdle B, Wahren LK (2001) Quantitative sensory testing in fibromyalgia patients and in healthy subjects: identification of subgroups. Clin J Pain 17(4):316–22PubMedCrossRef
112.
Zurück zum Zitat McDermid AJ, Rollman GB, McCain GA (1996) Generalized hypervigilance in fibromyalgia: evidence of perceptual amplification. Pain 66(2–3):133–44PubMedCrossRef McDermid AJ, Rollman GB, McCain GA (1996) Generalized hypervigilance in fibromyalgia: evidence of perceptual amplification. Pain 66(2–3):133–44PubMedCrossRef
113.
Zurück zum Zitat Geisser ME, Glass JM, Rajcevska LD, Clauw DJ, Williams DA, Kileny PR et al (2008) A psychophysical study of auditory and pressure sensitivity in patients with fibromyalgia and healthy controls. J Pain 9(5):417–22PubMedCrossRef Geisser ME, Glass JM, Rajcevska LD, Clauw DJ, Williams DA, Kileny PR et al (2008) A psychophysical study of auditory and pressure sensitivity in patients with fibromyalgia and healthy controls. J Pain 9(5):417–22PubMedCrossRef
114.
Zurück zum Zitat Carrillo-de-la-Peña MT, Vallet M, Pérez MI, Gómez-Perretta C (2006) Intensity dependence of auditory-evoked cortical potentials in fibromyalgia patients: a test of the generalized hypervigilance hypothesis. J Pain 7(7):480–7PubMedCrossRef Carrillo-de-la-Peña MT, Vallet M, Pérez MI, Gómez-Perretta C (2006) Intensity dependence of auditory-evoked cortical potentials in fibromyalgia patients: a test of the generalized hypervigilance hypothesis. J Pain 7(7):480–7PubMedCrossRef
116.
Zurück zum Zitat Van Damme S, Crombez G, Wiech K, Legrain V, Peters ML, Eccleston C (2009) Why become more general when we can be more specific? comment on Hollins et al. “perceived intensity and unpleasantness of cutaneous and auditory stimuli: an evaluation of the generalized hypervigilance hypothesis” [pain 2009;141:215–221], and on Rollman “perspectives on hypervigilance” [pain 2009;141:183–184]. Pain 144(3):342–3, author reply 3–4 PubMedCrossRef Van Damme S, Crombez G, Wiech K, Legrain V, Peters ML, Eccleston C (2009) Why become more general when we can be more specific? comment on Hollins et al. “perceived intensity and unpleasantness of cutaneous and auditory stimuli: an evaluation of the generalized hypervigilance hypothesis” [pain 2009;141:215–221], and on Rollman “perspectives on hypervigilance” [pain 2009;141:183–184]. Pain 144(3):342–3, author reply 3–4 PubMedCrossRef
117.
Zurück zum Zitat Van Damme S, Crombez G, Eccleston C, Roelofs J (2004) The role of hypervigilance in the experience of pain. In: Asmundson GJG, Vlaeyen JW, Crombez G (eds) Understanding and treating fear of pain. Oxford University Press, Oxford, pp 71–90 Van Damme S, Crombez G, Eccleston C, Roelofs J (2004) The role of hypervigilance in the experience of pain. In: Asmundson GJG, Vlaeyen JW, Crombez G (eds) Understanding and treating fear of pain. Oxford University Press, Oxford, pp 71–90
119.
Zurück zum Zitat Staud R, Robinson ME, Vierck CJ Jr, Price DD (2003) Diffuse noxious inhibitory controls (DNIC) attenuate temporal summation of second pain in normal males but not in normal females or fibromyalgia patients. Pain 101(1–2):167–74PubMedCrossRef Staud R, Robinson ME, Vierck CJ Jr, Price DD (2003) Diffuse noxious inhibitory controls (DNIC) attenuate temporal summation of second pain in normal males but not in normal females or fibromyalgia patients. Pain 101(1–2):167–74PubMedCrossRef
120.
Zurück zum Zitat Kosek E, Hansson P (1997) Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects. Pain 70(1):41–51PubMedCrossRef Kosek E, Hansson P (1997) Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects. Pain 70(1):41–51PubMedCrossRef
121.
Zurück zum Zitat Paul-Savoie E, Marchand S, Morin M, Bourgault P, Brissette N, Rattanavong V et al (2012) Is the deficit in pain inhibition in fibromyalgia influenced by sleep impairments? Open Rheumatol J 6:296–302PubMedCentralPubMedCrossRef Paul-Savoie E, Marchand S, Morin M, Bourgault P, Brissette N, Rattanavong V et al (2012) Is the deficit in pain inhibition in fibromyalgia influenced by sleep impairments? Open Rheumatol J 6:296–302PubMedCentralPubMedCrossRef
122.
Zurück zum Zitat Chalaye P, Goffaux P, Bourgault P, Lafrenaye S, Devroede G, Watier A et al (2012) Comparing pain modulation and autonomic responses in fibromyalgia and irritable bowel syndrome patients. Clin J Pain 28(6):519–26PubMedCrossRef Chalaye P, Goffaux P, Bourgault P, Lafrenaye S, Devroede G, Watier A et al (2012) Comparing pain modulation and autonomic responses in fibromyalgia and irritable bowel syndrome patients. Clin J Pain 28(6):519–26PubMedCrossRef
123.
Zurück zum Zitat de Souza JB, Potvin S, Goffaux P, Charest J, Marchand S (2009) The deficit of pain inhibition in fibromyalgia is more pronounced in patients with comorbid depressive symptoms. Clin J Pain 25(2):123–7PubMedCrossRef de Souza JB, Potvin S, Goffaux P, Charest J, Marchand S (2009) The deficit of pain inhibition in fibromyalgia is more pronounced in patients with comorbid depressive symptoms. Clin J Pain 25(2):123–7PubMedCrossRef
124.
Zurück zum Zitat Chalaye P, Lafrenaye S, Goffaux P, Marchand S (2014) The role of cardiovascular activity in fibromyalgia and conditioned pain modulation. Pain 155(6):1064–9PubMedCrossRef Chalaye P, Lafrenaye S, Goffaux P, Marchand S (2014) The role of cardiovascular activity in fibromyalgia and conditioned pain modulation. Pain 155(6):1064–9PubMedCrossRef
125.
Zurück zum Zitat Martinsen S, Flodin P, Berrebi J, Lofgren M, Bileviciute-Ljungar I, Ingvar M et al (2014) Fibromyalgia patients had normal distraction related pain inhibition but cognitive impairment reflected in caudate nucleus and hippocampus during the stroop color word test. PLoS One 9(9):e108637PubMedCentralPubMedCrossRef Martinsen S, Flodin P, Berrebi J, Lofgren M, Bileviciute-Ljungar I, Ingvar M et al (2014) Fibromyalgia patients had normal distraction related pain inhibition but cognitive impairment reflected in caudate nucleus and hippocampus during the stroop color word test. PLoS One 9(9):e108637PubMedCentralPubMedCrossRef
126.
Zurück zum Zitat Goffaux P, de Souza JB, Potvin S, Marchand S (2009) Pain relief through expectation supersedes descending inhibitory deficits in fibromyalgia patients. Pain 145(1–2):18–23PubMedCrossRef Goffaux P, de Souza JB, Potvin S, Marchand S (2009) Pain relief through expectation supersedes descending inhibitory deficits in fibromyalgia patients. Pain 145(1–2):18–23PubMedCrossRef
127.
Zurück zum Zitat Goffaux P, Redmond WJ, Rainville P, Marchand S (2007) Descending analgesia—when the spine echoes what the brain expects. Pain 130(1–2):137–43PubMedCrossRef Goffaux P, Redmond WJ, Rainville P, Marchand S (2007) Descending analgesia—when the spine echoes what the brain expects. Pain 130(1–2):137–43PubMedCrossRef
128.
Zurück zum Zitat Reyes del Paso GA, Garrido S, Pulgar A, Duschek S (2011) Autonomic cardiovascular control and responses to experimental pain stimulation in fibromyalgia syndrome. J Psychosom Res 70(2):125–34PubMedCrossRef Reyes del Paso GA, Garrido S, Pulgar A, Duschek S (2011) Autonomic cardiovascular control and responses to experimental pain stimulation in fibromyalgia syndrome. J Psychosom Res 70(2):125–34PubMedCrossRef
129.
Zurück zum Zitat Vierck CJ Jr, Staud R, Price DD, Cannon RL, Mauderli AP, Martin AD (2001) The effect of maximal exercise on temporal summation of second pain (windup) in patients with fibromyalgia syndrome. J Pain 2(6):334–44PubMedCrossRef Vierck CJ Jr, Staud R, Price DD, Cannon RL, Mauderli AP, Martin AD (2001) The effect of maximal exercise on temporal summation of second pain (windup) in patients with fibromyalgia syndrome. J Pain 2(6):334–44PubMedCrossRef
130.
Zurück zum Zitat Lannersten L, Kosek E (2010) Dysfunction of endogenous pain inhibition during exercise with painful muscles in patients with shoulder myalgia and fibromyalgia. Pain 151(1):77–86PubMedCrossRef Lannersten L, Kosek E (2010) Dysfunction of endogenous pain inhibition during exercise with painful muscles in patients with shoulder myalgia and fibromyalgia. Pain 151(1):77–86PubMedCrossRef
131.
Zurück zum Zitat Ge HY, Nie H, Graven-Nielsen T, Danneskiold-Samsoe B, Arendt-Nielsen L (2012) Descending pain modulation and its interaction with peripheral sensitization following sustained isometric muscle contraction in fibromyalgia. Eur J Pain 16(2):196–203PubMedCrossRef Ge HY, Nie H, Graven-Nielsen T, Danneskiold-Samsoe B, Arendt-Nielsen L (2012) Descending pain modulation and its interaction with peripheral sensitization following sustained isometric muscle contraction in fibromyalgia. Eur J Pain 16(2):196–203PubMedCrossRef
132.
Zurück zum Zitat Kosek E, Ekholm J, Hansson P (1996) Modulation of pressure pain thresholds during and following isometric contraction in patients with fibromyalgia and in healthy controls. Pain 64(3):415–23PubMedCrossRef Kosek E, Ekholm J, Hansson P (1996) Modulation of pressure pain thresholds during and following isometric contraction in patients with fibromyalgia and in healthy controls. Pain 64(3):415–23PubMedCrossRef
133.
Zurück zum Zitat Staud R, Robinson ME, Price DD (2005) Isometric exercise has opposite effects on central pain mechanisms in fibromyalgia patients compared to normal controls. Pain 118(1–2):176–84PubMedCrossRef Staud R, Robinson ME, Price DD (2005) Isometric exercise has opposite effects on central pain mechanisms in fibromyalgia patients compared to normal controls. Pain 118(1–2):176–84PubMedCrossRef
134.
Zurück zum Zitat Hoeger Bement MK, Weyer AD, Yoon T, Hunter SK (2014) Corticomotor excitability during a noxious stimulus before and after exercise in women with fibromyalgia. J Clin Neurophysiol 31(1):94–8PubMedCrossRef Hoeger Bement MK, Weyer AD, Yoon T, Hunter SK (2014) Corticomotor excitability during a noxious stimulus before and after exercise in women with fibromyalgia. J Clin Neurophysiol 31(1):94–8PubMedCrossRef
135.
Zurück zum Zitat Salerno A, Thomas E, Olive P, Blotman F, Picot MC, Georgesco M (2000) Motor cortical dysfunction disclosed by single and double magnetic stimulation in patients with fibromyalgia. Clin Neurophysiol 111(6):994–1001PubMedCrossRef Salerno A, Thomas E, Olive P, Blotman F, Picot MC, Georgesco M (2000) Motor cortical dysfunction disclosed by single and double magnetic stimulation in patients with fibromyalgia. Clin Neurophysiol 111(6):994–1001PubMedCrossRef
136.
Zurück zum Zitat Mhalla A, de Andrade DC, Baudic S, Perrot S, Bouhassira D (2010) Alteration of cortical excitability in patients with fibromyalgia. Pain 149(3):495–500PubMedCrossRef Mhalla A, de Andrade DC, Baudic S, Perrot S, Bouhassira D (2010) Alteration of cortical excitability in patients with fibromyalgia. Pain 149(3):495–500PubMedCrossRef
137.
Zurück zum Zitat Schwenkreis P, Voigt M, Hasenbring M, Tegenthoff M, Vorgerd M, Kley RA (2011) Central mechanisms during fatiguing muscle exercise in muscular dystrophy and fibromyalgia syndrome: a study with transcranial magnetic stimulation. Muscle Nerve 43(4):479–84PubMedCrossRef Schwenkreis P, Voigt M, Hasenbring M, Tegenthoff M, Vorgerd M, Kley RA (2011) Central mechanisms during fatiguing muscle exercise in muscular dystrophy and fibromyalgia syndrome: a study with transcranial magnetic stimulation. Muscle Nerve 43(4):479–84PubMedCrossRef
138.
Zurück zum Zitat Roizenblatt S, Moldofsky H, Benedito-Silva AA, Tufik S (2001) Alpha sleep characteristics in fibromyalgia. Arthritis Rheum 44(1):222–30PubMedCrossRef Roizenblatt S, Moldofsky H, Benedito-Silva AA, Tufik S (2001) Alpha sleep characteristics in fibromyalgia. Arthritis Rheum 44(1):222–30PubMedCrossRef
139.
Zurück zum Zitat Bigatti SM, Hernandez AM, Cronan TA, Rand KL (2008) Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression. Arthritis Rheum 59(7):961–7PubMedCentralPubMedCrossRef Bigatti SM, Hernandez AM, Cronan TA, Rand KL (2008) Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression. Arthritis Rheum 59(7):961–7PubMedCentralPubMedCrossRef
140.
Zurück zum Zitat Cobankara V, Unal UO, Kaya A, Bozkurt AI, Ozturk MA (2011) The prevalence of fibromyalgia among textile workers in the city of Denizli in Turkey. Int J Rheum Dis 14(4):390–4PubMedCrossRef Cobankara V, Unal UO, Kaya A, Bozkurt AI, Ozturk MA (2011) The prevalence of fibromyalgia among textile workers in the city of Denizli in Turkey. Int J Rheum Dis 14(4):390–4PubMedCrossRef
141.
Zurück zum Zitat Miró E, Martínez MP, Sánchez AI, Prados G, Medina A (2011) When is pain related to emotional distress and daily functioning in fibromyalgia syndrome? The mediating roles of self-efficacy and sleep quality. Br J Health Psychol 16(4):799–814PubMedCrossRef Miró E, Martínez MP, Sánchez AI, Prados G, Medina A (2011) When is pain related to emotional distress and daily functioning in fibromyalgia syndrome? The mediating roles of self-efficacy and sleep quality. Br J Health Psychol 16(4):799–814PubMedCrossRef
142.
Zurück zum Zitat Diaz-Piedra C, Di Stasi LL, Baldwin CM, Buela-Casal G, Catena A (2014) Sleep disturbances of adult women suffering from fibromyalgia: a systematic review of observational studies. Sleep Med Rev. doi:10.1016/j.smrv.2014.09.001, [doi], accessed 2/24/15 PubMed Diaz-Piedra C, Di Stasi LL, Baldwin CM, Buela-Casal G, Catena A (2014) Sleep disturbances of adult women suffering from fibromyalgia: a systematic review of observational studies. Sleep Med Rev. doi:10.​1016/​j.​smrv.​2014.​09.​001, [doi], accessed 2/24/15 PubMed
143.
Zurück zum Zitat Cöster L, Kendall S, Gerdle B, Henriksson C, Henriksson KG, Bengtsson A (2008) Chronic widespread musculoskeletal pain—a comparison of those who meet criteria for fibromyalgia and those who do not. Eur J Pain 12(5):600–10PubMedCrossRef Cöster L, Kendall S, Gerdle B, Henriksson C, Henriksson KG, Bengtsson A (2008) Chronic widespread musculoskeletal pain—a comparison of those who meet criteria for fibromyalgia and those who do not. Eur J Pain 12(5):600–10PubMedCrossRef
144.
Zurück zum Zitat Rizzi M, Sarzi-Puttini P, Atzeni F, Capsoni F, Andreoli A, Pecis M et al (2004) Cyclic alternating pattern: a new marker of sleep alteration in patients with fibromyalgia? J Rheumatol 31(6):1193–9PubMed Rizzi M, Sarzi-Puttini P, Atzeni F, Capsoni F, Andreoli A, Pecis M et al (2004) Cyclic alternating pattern: a new marker of sleep alteration in patients with fibromyalgia? J Rheumatol 31(6):1193–9PubMed
145.
Zurück zum Zitat Landis CA, Lentz MJ, Tsuji J, Buchwald D, Shaver JL (2004) Pain, psychological variables, sleep quality, and natural killer cell activity in midlife women with and without fibromyalgia. Brain Behav Immun 18(4):304–13PubMedCrossRef Landis CA, Lentz MJ, Tsuji J, Buchwald D, Shaver JL (2004) Pain, psychological variables, sleep quality, and natural killer cell activity in midlife women with and without fibromyalgia. Brain Behav Immun 18(4):304–13PubMedCrossRef
146.
Zurück zum Zitat Chervin RD, Teodorescu M, Kushwaha R, Deline AM, Brucksch CB, Ribbens-Grimm C et al (2009) Objective measures of disordered sleep in fibromyalgia. J Rheumatol 36(9):2009–16PubMedCentralPubMedCrossRef Chervin RD, Teodorescu M, Kushwaha R, Deline AM, Brucksch CB, Ribbens-Grimm C et al (2009) Objective measures of disordered sleep in fibromyalgia. J Rheumatol 36(9):2009–16PubMedCentralPubMedCrossRef
147.
Zurück zum Zitat Besteiro González JL, Suárez Fernández TV, Arboleya Rodríguez L, Muñiz J, Lemos Giráldez S, Álvarez FA (2011) Sleep architecture in patients with fibromyalgia. Psicothema 23(3):368–73PubMed Besteiro González JL, Suárez Fernández TV, Arboleya Rodríguez L, Muñiz J, Lemos Giráldez S, Álvarez FA (2011) Sleep architecture in patients with fibromyalgia. Psicothema 23(3):368–73PubMed
148.
Zurück zum Zitat Moldofsky H, Scarisbrick P, England R, Smythe H (1975) Musculosketal symptoms and non-REM sleep disturbance in patients with “fibrositis syndrome” and healthy subjects. Psychosom Med 37(4):341–51PubMedCrossRef Moldofsky H, Scarisbrick P, England R, Smythe H (1975) Musculosketal symptoms and non-REM sleep disturbance in patients with “fibrositis syndrome” and healthy subjects. Psychosom Med 37(4):341–51PubMedCrossRef
149.
Zurück zum Zitat Mahowald ML, Mahowald MW (2000) Nighttime sleep and daytime functioning (sleepiness and fatigue) in less well-defined chronic rheumatic diseases with particular reference to the ‘alpha-delta NREM sleep anomaly’. Sleep Med 1(3):195–207PubMedCrossRef Mahowald ML, Mahowald MW (2000) Nighttime sleep and daytime functioning (sleepiness and fatigue) in less well-defined chronic rheumatic diseases with particular reference to the ‘alpha-delta NREM sleep anomaly’. Sleep Med 1(3):195–207PubMedCrossRef
150.
Zurück zum Zitat Olsen MN, Sherry DD, Boyne K, McCue R, Gallagher PR, Brooks LJ (2013) Relationship between sleep and pain in adolescents with juvenile primary fibromyalgia syndrome. Sleep 36(4):509–16PubMedCentralPubMed Olsen MN, Sherry DD, Boyne K, McCue R, Gallagher PR, Brooks LJ (2013) Relationship between sleep and pain in adolescents with juvenile primary fibromyalgia syndrome. Sleep 36(4):509–16PubMedCentralPubMed
151.
Zurück zum Zitat Roizenblatt S, Neto NS, Tufik S (2011) Sleep disorders and fibromyalgia. Curr Pain Headache Rep 15(5):347–57PubMedCrossRef Roizenblatt S, Neto NS, Tufik S (2011) Sleep disorders and fibromyalgia. Curr Pain Headache Rep 15(5):347–57PubMedCrossRef
152.
Zurück zum Zitat Spaeth M, Rizzi M, Sarzi-Puttini P (2011) Fibromyalgia and sleep. Best Pract Res Clin Rheumatol 25(2):227–39PubMedCrossRef Spaeth M, Rizzi M, Sarzi-Puttini P (2011) Fibromyalgia and sleep. Best Pract Res Clin Rheumatol 25(2):227–39PubMedCrossRef
153.
Zurück zum Zitat Civelek GM, Ciftkaya PO, Karatas M (2014) Evaluation of restless legs syndrome in fibromyalgia syndrome: an analysis of quality of sleep and life. J Back Musculoskelet Rehabil 27(4):537–44PubMed Civelek GM, Ciftkaya PO, Karatas M (2014) Evaluation of restless legs syndrome in fibromyalgia syndrome: an analysis of quality of sleep and life. J Back Musculoskelet Rehabil 27(4):537–44PubMed
154.
Zurück zum Zitat Viola-Saltzman M, Watson NF, Bogart A, Goldberg J, Buchwald D (2010) High prevalence of restless legs syndrome among patients with fibromyalgia: a controlled cross-sectional study. J Clin Sleep Med 6(5):423–7PubMedCentralPubMed Viola-Saltzman M, Watson NF, Bogart A, Goldberg J, Buchwald D (2010) High prevalence of restless legs syndrome among patients with fibromyalgia: a controlled cross-sectional study. J Clin Sleep Med 6(5):423–7PubMedCentralPubMed
155.
Zurück zum Zitat Stehlik R, Arvidsson L, Ulfberg J (2009) Restless legs syndrome is common among female patients with fibromyalgia. Eur Neurol 61(2):107–11PubMedCrossRef Stehlik R, Arvidsson L, Ulfberg J (2009) Restless legs syndrome is common among female patients with fibromyalgia. Eur Neurol 61(2):107–11PubMedCrossRef
156.
Zurück zum Zitat Prados G, Miro E, Martinez MP, Sanchez AI, Lopez S, Saez G (2013) Fibromyalgia: gender differences and sleep-disordered breathing. Clin Exp Rheumatol 31(6 Suppl 79):S102–10PubMed Prados G, Miro E, Martinez MP, Sanchez AI, Lopez S, Saez G (2013) Fibromyalgia: gender differences and sleep-disordered breathing. Clin Exp Rheumatol 31(6 Suppl 79):S102–10PubMed
157.
Zurück zum Zitat Germanowicz D, Lumertz MS, Martinez D, Margarites AF (2006) Sleep disordered breathing concomitant with fibromyalgia syndrome. J Bras Pneumol 32(4):333–8PubMed Germanowicz D, Lumertz MS, Martinez D, Margarites AF (2006) Sleep disordered breathing concomitant with fibromyalgia syndrome. J Bras Pneumol 32(4):333–8PubMed
158.
Zurück zum Zitat Korszun A, Young EA, Engleberg NC, Brucksch CB, Greden JF, Crofford LA (2002) Use of actigraphy for monitoring sleep and activity levels in patients with fibromyalgia and depression. J Psychosom Res 52(6):439–43PubMedCrossRef Korszun A, Young EA, Engleberg NC, Brucksch CB, Greden JF, Crofford LA (2002) Use of actigraphy for monitoring sleep and activity levels in patients with fibromyalgia and depression. J Psychosom Res 52(6):439–43PubMedCrossRef
159.
Zurück zum Zitat Munguia-Izquierdo D, Legaz-Arrese A (2012) Determinants of sleep quality in middle-aged women with fibromyalgia syndrome. J Sleep Res 21(1):73–9PubMedCrossRef Munguia-Izquierdo D, Legaz-Arrese A (2012) Determinants of sleep quality in middle-aged women with fibromyalgia syndrome. J Sleep Res 21(1):73–9PubMedCrossRef
160.
Zurück zum Zitat Theadom A, Cropley M (2008) Dysfunctional beliefs, stress and sleep disturbance in fibromyalgia. Sleep Med 9(4):376–81PubMedCrossRef Theadom A, Cropley M (2008) Dysfunctional beliefs, stress and sleep disturbance in fibromyalgia. Sleep Med 9(4):376–81PubMedCrossRef
161.
Zurück zum Zitat Diaz-Piedra C, Catena A, Miro E, Martinez MP, Sanchez AI, Buela-Casal G (2014) The impact of pain on anxiety and depression is mediated by objective and subjective sleep characteristics in fibromyalgia patients. Clin J Pain 30(10):852–9PubMedCrossRef Diaz-Piedra C, Catena A, Miro E, Martinez MP, Sanchez AI, Buela-Casal G (2014) The impact of pain on anxiety and depression is mediated by objective and subjective sleep characteristics in fibromyalgia patients. Clin J Pain 30(10):852–9PubMedCrossRef
162.
Zurück zum Zitat Belt NK, Kronholm E, Kauppi MJ (2009) Sleep problems in fibromyalgia and rheumatoid arthritis compared with the general population. Clin Exp Rheumatol 27(1):35–41PubMed Belt NK, Kronholm E, Kauppi MJ (2009) Sleep problems in fibromyalgia and rheumatoid arthritis compared with the general population. Clin Exp Rheumatol 27(1):35–41PubMed
163.
Zurück zum Zitat Affleck G, Urrows S, Tennen H, Higgins P, Abeles M (1996) Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia. Pain 68(2–3):363–8PubMedCrossRef Affleck G, Urrows S, Tennen H, Higgins P, Abeles M (1996) Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia. Pain 68(2–3):363–8PubMedCrossRef
164.
Zurück zum Zitat Hamilton NA, Catley D, Karlson C (2007) Sleep and the affective response to stress and pain. Health Psychol 26(3):288–95PubMedCrossRef Hamilton NA, Catley D, Karlson C (2007) Sleep and the affective response to stress and pain. Health Psychol 26(3):288–95PubMedCrossRef
165.
Zurück zum Zitat Hamilton NA, Affleck G, Tennen H, Karlson C, Luxton D, Preacher KJ et al (2008) Fibromyalgia: the role of sleep in affect and in negative event reactivity and recovery. Health Psychol 27(4):490–7PubMedCrossRef Hamilton NA, Affleck G, Tennen H, Karlson C, Luxton D, Preacher KJ et al (2008) Fibromyalgia: the role of sleep in affect and in negative event reactivity and recovery. Health Psychol 27(4):490–7PubMedCrossRef
166.
Zurück zum Zitat Hamilton NA, Pressman M, Lillis T, Atchley R, Karlson C, Stevens N (2012) Evaluating evidence for the role of sleep in fibromyalgia: a test of the Sleep and Pain Diathesis Model. Cogn Ther Res 36(6):806–14CrossRef Hamilton NA, Pressman M, Lillis T, Atchley R, Karlson C, Stevens N (2012) Evaluating evidence for the role of sleep in fibromyalgia: a test of the Sleep and Pain Diathesis Model. Cogn Ther Res 36(6):806–14CrossRef
167.
Zurück zum Zitat Nakamura I, Nishioka K, Usui C, Osada K, Ichibayashi H, Ishida M et al (2014) An epidemiologic internet survey of fibromyalgia and chronic pain in Japan. Arthritis Care Res 66(7):1093–101CrossRef Nakamura I, Nishioka K, Usui C, Osada K, Ichibayashi H, Ishida M et al (2014) An epidemiologic internet survey of fibromyalgia and chronic pain in Japan. Arthritis Care Res 66(7):1093–101CrossRef
168.
Zurück zum Zitat Yunus M, Masi AT, Calabro JJ, Miller KA, Feigenbaum SL (1981) Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 11(1):151–71PubMedCrossRef Yunus M, Masi AT, Calabro JJ, Miller KA, Feigenbaum SL (1981) Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 11(1):151–71PubMedCrossRef
169.
Zurück zum Zitat Roehrs T, Diederichs C, Gillis M, Burger AJ, Stout RA, Lumley MA et al (2013) Nocturnal sleep, daytime sleepiness and fatigue in fibromyalgia patients compared to rheumatoid arthritis patients and healthy controls: a preliminary study. Sleep Med 14(1):109–15PubMedCrossRef Roehrs T, Diederichs C, Gillis M, Burger AJ, Stout RA, Lumley MA et al (2013) Nocturnal sleep, daytime sleepiness and fatigue in fibromyalgia patients compared to rheumatoid arthritis patients and healthy controls: a preliminary study. Sleep Med 14(1):109–15PubMedCrossRef
170.
Zurück zum Zitat Malin K, Littlejohn GO (2012) Psychological control is a key modulator of fibromyalgia symptoms and comorbidities. J Pain Res 5:463–71PubMedCentralPubMed Malin K, Littlejohn GO (2012) Psychological control is a key modulator of fibromyalgia symptoms and comorbidities. J Pain Res 5:463–71PubMedCentralPubMed
171.
Zurück zum Zitat Mease PJ, Arnold LM, Crofford LJ, Williams DA, Russell IJ, Humphrey L et al (2008) Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises. Arthritis Rheum 59(7):952–60PubMedCrossRef Mease PJ, Arnold LM, Crofford LJ, Williams DA, Russell IJ, Humphrey L et al (2008) Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises. Arthritis Rheum 59(7):952–60PubMedCrossRef
172.
Zurück zum Zitat Mease PJ, Clauw DJ, Christensen R, Crofford LJ, Gendreau RM, Martin SA et al (2011) Toward development of a fibromyalgia responder index and disease activity score: OMERACT module update. J Rheumatol 38(7):1487–95PubMedCentralPubMedCrossRef Mease PJ, Clauw DJ, Christensen R, Crofford LJ, Gendreau RM, Martin SA et al (2011) Toward development of a fibromyalgia responder index and disease activity score: OMERACT module update. J Rheumatol 38(7):1487–95PubMedCentralPubMedCrossRef
173.
Zurück zum Zitat Cella D, Yount S, Rothrock N, Gershon R, Cook K, Reeve B et al (2007) The patient-reported outcomes measurement information system (PROMIS): progress of an NIH roadmap cooperative group during its first two years. Med Care 45(5 Suppl 1):S3–S11PubMedCentralPubMedCrossRef Cella D, Yount S, Rothrock N, Gershon R, Cook K, Reeve B et al (2007) The patient-reported outcomes measurement information system (PROMIS): progress of an NIH roadmap cooperative group during its first two years. Med Care 45(5 Suppl 1):S3–S11PubMedCentralPubMedCrossRef
174.
Zurück zum Zitat Humphrey L, Arbuckle R, Mease P, Williams DA, Samsoe BD, Gilbert C (2010) Fatigue in fibromyalgia: a conceptual model informed by patient interviews. BMC Musculoskelet Disord 11:216PubMedCentralPubMedCrossRef Humphrey L, Arbuckle R, Mease P, Williams DA, Samsoe BD, Gilbert C (2010) Fatigue in fibromyalgia: a conceptual model informed by patient interviews. BMC Musculoskelet Disord 11:216PubMedCentralPubMedCrossRef
175.
Zurück zum Zitat Vincent A, Benzo RP, Whipple MO, McAllister SJ, Erwin PJ, Saligan LN (2013) Beyond pain in fibromyalgia: insights into the symptom of fatigue. Arthritis Res Ther 15(6):221PubMedCentralPubMedCrossRef Vincent A, Benzo RP, Whipple MO, McAllister SJ, Erwin PJ, Saligan LN (2013) Beyond pain in fibromyalgia: insights into the symptom of fatigue. Arthritis Res Ther 15(6):221PubMedCentralPubMedCrossRef
176.
Zurück zum Zitat Parrish BP, Zautra AJ, Davis MC (2008) The role of positive and negative interpersonal events on daily fatigue in women with fibromyalgia, rheumatoid arthritis, and osteoarthritis. Health Psychol 27(6):694–702PubMedCentralPubMedCrossRef Parrish BP, Zautra AJ, Davis MC (2008) The role of positive and negative interpersonal events on daily fatigue in women with fibromyalgia, rheumatoid arthritis, and osteoarthritis. Health Psychol 27(6):694–702PubMedCentralPubMedCrossRef
177.
Zurück zum Zitat Zachrisson O, Regland B, Jahreskog M, Kron M, Gottfries CG (2002) A rating scale for fibromyalgia and chronic fatigue syndrome (the fibro fatigue scale). J Psychosom Res 52(6):501–9PubMedCrossRef Zachrisson O, Regland B, Jahreskog M, Kron M, Gottfries CG (2002) A rating scale for fibromyalgia and chronic fatigue syndrome (the fibro fatigue scale). J Psychosom Res 52(6):501–9PubMedCrossRef
178.
Zurück zum Zitat Leavitt F, Katz RS, Mills M, Heard AR (2002) Cognitive and dissociative manifestations in fibromyalgia. J Clin Rheumatol 8(2):77–84PubMedCrossRef Leavitt F, Katz RS, Mills M, Heard AR (2002) Cognitive and dissociative manifestations in fibromyalgia. J Clin Rheumatol 8(2):77–84PubMedCrossRef
179.
Zurück zum Zitat Katz RS, Heard AR, Mills M, Leavitt F (2004) The prevalence and clinical impact of reported cognitive difficulties (fibrofog) in patients with rheumatic disease with and without fibromyalgia. J Clin Rheumatol 10(2):53–8PubMedCrossRef Katz RS, Heard AR, Mills M, Leavitt F (2004) The prevalence and clinical impact of reported cognitive difficulties (fibrofog) in patients with rheumatic disease with and without fibromyalgia. J Clin Rheumatol 10(2):53–8PubMedCrossRef
180.
Zurück zum Zitat Schaefer C, Chandran A, Hufstader M, Baik R, McNett M, Goldenberg D et al (2011) The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States. Health Qual Life Outcomes 9:71PubMedCentralPubMedCrossRef Schaefer C, Chandran A, Hufstader M, Baik R, McNett M, Goldenberg D et al (2011) The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States. Health Qual Life Outcomes 9:71PubMedCentralPubMedCrossRef
181.
Zurück zum Zitat Rutledge DN, Mouttapa M, Wood PB (2009) Symptom clusters in fibromyalgia: potential utility in patient assessment and treatment evaluation. Nurs Res 58(5):359–67PubMedCrossRef Rutledge DN, Mouttapa M, Wood PB (2009) Symptom clusters in fibromyalgia: potential utility in patient assessment and treatment evaluation. Nurs Res 58(5):359–67PubMedCrossRef
182.
Zurück zum Zitat Grace GM, Nielson WR, Hopkins M, Berg MA (1999) Concentration and memory deficits in patients with fibromyalgia syndrome. J Clin Exp Neuropsychol 21(4):477–87PubMedCrossRef Grace GM, Nielson WR, Hopkins M, Berg MA (1999) Concentration and memory deficits in patients with fibromyalgia syndrome. J Clin Exp Neuropsychol 21(4):477–87PubMedCrossRef
183.
Zurück zum Zitat Suhr JA (2003) Neuropsychological impairment in fibromyalgia: relation to depression, fatigue, and pain. J Psychosom Res 55(4):321–9PubMedCrossRef Suhr JA (2003) Neuropsychological impairment in fibromyalgia: relation to depression, fatigue, and pain. J Psychosom Res 55(4):321–9PubMedCrossRef
184.
Zurück zum Zitat Glass JM, Park DC, Minear M, Crofford LJ (2005) Memory beliefs and function in fibromyalgia patients. J Psychosom Res 58(3):263–9PubMedCrossRef Glass JM, Park DC, Minear M, Crofford LJ (2005) Memory beliefs and function in fibromyalgia patients. J Psychosom Res 58(3):263–9PubMedCrossRef
185.
Zurück zum Zitat Landrø NI, Fors EA, Våpenstad LL, Holthe O, Stiles TC, Borchgrevink PC (2013) The extent of neurocognitive dysfunction in a multidisciplinary pain centre population. Is there a relation between reported and tested neuropsychological functioning? Pain 154(7):972–7PubMedCrossRef Landrø NI, Fors EA, Våpenstad LL, Holthe O, Stiles TC, Borchgrevink PC (2013) The extent of neurocognitive dysfunction in a multidisciplinary pain centre population. Is there a relation between reported and tested neuropsychological functioning? Pain 154(7):972–7PubMedCrossRef
186.
Zurück zum Zitat Tesio V, Torta DM, Colonna F, Leombruni P, Ghiggia A, Fusaro E et al (2015) Are fibromyalgia patients cognitively impaired? Objective and subjective neuropsychological evidence. Arthritis Care Res 67(1):143–50CrossRef Tesio V, Torta DM, Colonna F, Leombruni P, Ghiggia A, Fusaro E et al (2015) Are fibromyalgia patients cognitively impaired? Objective and subjective neuropsychological evidence. Arthritis Care Res 67(1):143–50CrossRef
187.
Zurück zum Zitat Glass JM (2009) Review of cognitive dysfunction in fibromyalgia: a convergence on working memory and attentional control impairments. Rheum Dis Clin North Am 35(2):299–311PubMedCrossRef Glass JM (2009) Review of cognitive dysfunction in fibromyalgia: a convergence on working memory and attentional control impairments. Rheum Dis Clin North Am 35(2):299–311PubMedCrossRef
188.
Zurück zum Zitat Dick B, Eccleston C, Crombez G (2002) Attentional functioning in fibromyalgia, rheumatoid arthritis, and musculoskeletal pain patients. Arthritis Rheum 47(6):639–44PubMedCrossRef Dick B, Eccleston C, Crombez G (2002) Attentional functioning in fibromyalgia, rheumatoid arthritis, and musculoskeletal pain patients. Arthritis Rheum 47(6):639–44PubMedCrossRef
189.
Zurück zum Zitat Miró E, Lupiáñez J, Hita E, Martínez MP, Sánchez AI, Buela-Casal G (2011) Attentional deficits in fibromyalgia and its relationships with pain, emotional distress and sleep dysfunction complaints. Psychol Health 26(6):765–80PubMedCrossRef Miró E, Lupiáñez J, Hita E, Martínez MP, Sánchez AI, Buela-Casal G (2011) Attentional deficits in fibromyalgia and its relationships with pain, emotional distress and sleep dysfunction complaints. Psychol Health 26(6):765–80PubMedCrossRef
190.
Zurück zum Zitat Correa A, Miro E, Martinez MP, Sanchez AI, Lupianez J (2011) Temporal preparation and inhibitory deficit in fibromyalgia syndrome. Brain Cogn 75(3):211–6PubMedCrossRef Correa A, Miro E, Martinez MP, Sanchez AI, Lupianez J (2011) Temporal preparation and inhibitory deficit in fibromyalgia syndrome. Brain Cogn 75(3):211–6PubMedCrossRef
191.
Zurück zum Zitat Glass JM, Williams DA, Fernandez-Sanchez ML, Kairys A, Barjola P, Heitzeg MM et al (2011) Executive function in chronic pain patients and healthy controls: different cortical activation during response inhibition in fibromyalgia. J Pain 12(12):1219–29PubMedCentralPubMedCrossRef Glass JM, Williams DA, Fernandez-Sanchez ML, Kairys A, Barjola P, Heitzeg MM et al (2011) Executive function in chronic pain patients and healthy controls: different cortical activation during response inhibition in fibromyalgia. J Pain 12(12):1219–29PubMedCentralPubMedCrossRef
192.
Zurück zum Zitat Reyes Del Paso GA, Pulgar A, Duschek S, Garrido S (2012) Cognitive impairment in fibromyalgia syndrome: the impact of cardiovascular regulation, pain, emotional disorders and medication. Eur J Pain 16(3):421–9PubMedCrossRef Reyes Del Paso GA, Pulgar A, Duschek S, Garrido S (2012) Cognitive impairment in fibromyalgia syndrome: the impact of cardiovascular regulation, pain, emotional disorders and medication. Eur J Pain 16(3):421–9PubMedCrossRef
193.
Zurück zum Zitat Leavitt F, Katz RS (2006) Distraction as a key determinant of impaired memory in patients with fibromyalgia. J Rheumatol 33(1):127–32PubMed Leavitt F, Katz RS (2006) Distraction as a key determinant of impaired memory in patients with fibromyalgia. J Rheumatol 33(1):127–32PubMed
194.
Zurück zum Zitat Dick BD, Verrier MJ, Harker KT, Rashiq S (2008) Disruption of cognitive function in fibromyalgia syndrome. Pain 139(3):610–6PubMedCrossRef Dick BD, Verrier MJ, Harker KT, Rashiq S (2008) Disruption of cognitive function in fibromyalgia syndrome. Pain 139(3):610–6PubMedCrossRef
195.
Zurück zum Zitat Ambrose KR, Gracely RH, Glass JM (2012) Fibromyalgia dyscognition: concepts and issues. Reumatismo 64(4):206–15PubMedCrossRef Ambrose KR, Gracely RH, Glass JM (2012) Fibromyalgia dyscognition: concepts and issues. Reumatismo 64(4):206–15PubMedCrossRef
196.
Zurück zum Zitat Seo J, Kim SH, Kim YT, Song HJ, Lee JJ, Han SW et al (2012) Working memory impairment in fibromyalgia patients associated with altered frontoparietal memory network. PLoS One 7(6):e37808PubMedCentralPubMedCrossRef Seo J, Kim SH, Kim YT, Song HJ, Lee JJ, Han SW et al (2012) Working memory impairment in fibromyalgia patients associated with altered frontoparietal memory network. PLoS One 7(6):e37808PubMedCentralPubMedCrossRef
197.
Zurück zum Zitat de Melo LF, Da-Silva SL (2012) Neuropsychological assessment of cognitive disorders in patients with fibromyalgia, rheumatoid arthritis, and systemic lupus erythematosus. Rev Bras Reumatol 52(2):181–8PubMedCrossRef de Melo LF, Da-Silva SL (2012) Neuropsychological assessment of cognitive disorders in patients with fibromyalgia, rheumatoid arthritis, and systemic lupus erythematosus. Rev Bras Reumatol 52(2):181–8PubMedCrossRef
198.
Zurück zum Zitat Kim SH, Kim SK, Nam EJ, Han SW, Lee SJ (2012) Spatial versus verbal memory impairments in patients with fibromyalgia. Rheumatol Int 32(5):1135–42PubMedCrossRef Kim SH, Kim SK, Nam EJ, Han SW, Lee SJ (2012) Spatial versus verbal memory impairments in patients with fibromyalgia. Rheumatol Int 32(5):1135–42PubMedCrossRef
199.
Zurück zum Zitat Cánovas R, León I, Roldán MD, Astur R, Cimadevilla JM (2009) Virtual reality tasks disclose spatial memory alterations in fibromyalgia. Rheumatology (Oxford) 48(10):1273–8CrossRef Cánovas R, León I, Roldán MD, Astur R, Cimadevilla JM (2009) Virtual reality tasks disclose spatial memory alterations in fibromyalgia. Rheumatology (Oxford) 48(10):1273–8CrossRef
200.
Zurück zum Zitat Duschek S, Werner NS, Winkelmann A, Wankner S (2013) Implicit memory function in fibromyalgia syndrome. Behav Med 39(1):11–6PubMedCrossRef Duschek S, Werner NS, Winkelmann A, Wankner S (2013) Implicit memory function in fibromyalgia syndrome. Behav Med 39(1):11–6PubMedCrossRef
201.
Zurück zum Zitat Grisart J, Van der Linden M, Masquelier E (2002) Controlled processes and automaticity in memory functioning in fibromyalgia patients: relation with emotional distress and hypervigilance. J Clin Exp Neuropsychol 24(8):994–1009PubMedCrossRef Grisart J, Van der Linden M, Masquelier E (2002) Controlled processes and automaticity in memory functioning in fibromyalgia patients: relation with emotional distress and hypervigilance. J Clin Exp Neuropsychol 24(8):994–1009PubMedCrossRef
202.
Zurück zum Zitat Leavitt F, Katz RS (2008) Speed of mental operations in fibromyalgia: a selective naming speed deficit. J Clin Rheumatol 14(4):214–8PubMed Leavitt F, Katz RS (2008) Speed of mental operations in fibromyalgia: a selective naming speed deficit. J Clin Rheumatol 14(4):214–8PubMed
203.
Zurück zum Zitat Montoro CI, Duschek S, de Guevara Munoz-Ladron C, Fernandez-Serrano MJ, Reyes Del Paso GA (2014) Aberrant cerebral blood flow responses during cognition: implications for the understanding of cognitive deficits in fibromyalgia. Neuropsychology 29(2):173–82PubMedCrossRef Montoro CI, Duschek S, de Guevara Munoz-Ladron C, Fernandez-Serrano MJ, Reyes Del Paso GA (2014) Aberrant cerebral blood flow responses during cognition: implications for the understanding of cognitive deficits in fibromyalgia. Neuropsychology 29(2):173–82PubMedCrossRef
204.
Zurück zum Zitat Park DC, Glass JM, Minear M, Crofford LJ (2001) Cognitive function in fibromyalgia patients. Arthritis Rheum 44(9):2125–33PubMedCrossRef Park DC, Glass JM, Minear M, Crofford LJ (2001) Cognitive function in fibromyalgia patients. Arthritis Rheum 44(9):2125–33PubMedCrossRef
205.
Zurück zum Zitat Walitt B, Roebuck-Spencer T, Bleiberg J, Foster G, Weinstein A (2008) Automated neuropsychiatric measurements of information processing in fibromyalgia. Rheumatol Int 28(6):561–6PubMedCrossRef Walitt B, Roebuck-Spencer T, Bleiberg J, Foster G, Weinstein A (2008) Automated neuropsychiatric measurements of information processing in fibromyalgia. Rheumatol Int 28(6):561–6PubMedCrossRef
206.
Zurück zum Zitat Veldhuijzen DS, Sondaal SF, Oosterman JM (2012) Intact cognitive inhibition in patients with fibromyalgia but evidence of declined processing speed. J Pain 13(5):507–15PubMedCrossRef Veldhuijzen DS, Sondaal SF, Oosterman JM (2012) Intact cognitive inhibition in patients with fibromyalgia but evidence of declined processing speed. J Pain 13(5):507–15PubMedCrossRef
207.
Zurück zum Zitat Can SS, Gencay-Can A, Gunendi Z (2012) Validity and reliability of the clock drawing test as a screening tool for cognitive impairment in patients with fibromyalgia. Compr Psychiatry 53(1):81–6PubMedCrossRef Can SS, Gencay-Can A, Gunendi Z (2012) Validity and reliability of the clock drawing test as a screening tool for cognitive impairment in patients with fibromyalgia. Compr Psychiatry 53(1):81–6PubMedCrossRef
208.
Zurück zum Zitat Rodriguez-Andreu J, Ibanez-Bosch R, Portero-Vazquez A, Masramon X, Rejas J, Galvez R (2009) Cognitive impairment in patients with fibromyalgia syndrome as assessed by the Mini-Mental State Examination. BMC Musculoskelet Disord 10:162PubMedCentralPubMedCrossRef Rodriguez-Andreu J, Ibanez-Bosch R, Portero-Vazquez A, Masramon X, Rejas J, Galvez R (2009) Cognitive impairment in patients with fibromyalgia syndrome as assessed by the Mini-Mental State Examination. BMC Musculoskelet Disord 10:162PubMedCentralPubMedCrossRef
209.
Zurück zum Zitat Walteros C, Sánchez-Navarro JP, Muñoz MA, Martínez-Selva JM, Chialvo D, Montoya P (2011) Altered associative learning and emotional decision making in fibromyalgia. J Psychosom Res 70(3):294–301PubMedCrossRef Walteros C, Sánchez-Navarro JP, Muñoz MA, Martínez-Selva JM, Chialvo D, Montoya P (2011) Altered associative learning and emotional decision making in fibromyalgia. J Psychosom Res 70(3):294–301PubMedCrossRef
210.
Zurück zum Zitat Koenigs M, Grafman J (2009) The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex. Behav Brain Res 201(2):239–43PubMedCentralPubMedCrossRef Koenigs M, Grafman J (2009) The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex. Behav Brain Res 201(2):239–43PubMedCentralPubMedCrossRef
211.
Zurück zum Zitat Luerding R, Weigand T, Bogdahn U, Schmidt-Wilcke T (2008) Working memory performance is correlated with local brain morphology in the medial frontal and anterior cingulate cortex in fibromyalgia patients: structural correlates of pain-cognition interaction. Brain 131(Pt 12):3222–31PubMedCrossRef Luerding R, Weigand T, Bogdahn U, Schmidt-Wilcke T (2008) Working memory performance is correlated with local brain morphology in the medial frontal and anterior cingulate cortex in fibromyalgia patients: structural correlates of pain-cognition interaction. Brain 131(Pt 12):3222–31PubMedCrossRef
212.
Zurück zum Zitat Oncu J, Basoglu F, Kuran B (2013) A comparison of impact of fatigue on cognitive, physical, and psychosocial status in patients with fibromyalgia and rheumatoid arthritis. Rheumatol Int 33(12):3031–7PubMedCrossRef Oncu J, Basoglu F, Kuran B (2013) A comparison of impact of fatigue on cognitive, physical, and psychosocial status in patients with fibromyalgia and rheumatoid arthritis. Rheumatol Int 33(12):3031–7PubMedCrossRef
213.
Zurück zum Zitat Williams DA, Clauw DJ, Glass JM (2011) Perceived cognitive dysfunction in fibromyalgia syndrome. J Musculoskelet Pain 19(2):66–75CrossRef Williams DA, Clauw DJ, Glass JM (2011) Perceived cognitive dysfunction in fibromyalgia syndrome. J Musculoskelet Pain 19(2):66–75CrossRef
214.
Zurück zum Zitat Cook DB, Lange G, Ciccone DS, Liu WC, Steffener J, Natelson BH (2004) Functional imaging of pain in patients with primary fibromyalgia. J Rheumatol 31(2):364–78PubMed Cook DB, Lange G, Ciccone DS, Liu WC, Steffener J, Natelson BH (2004) Functional imaging of pain in patients with primary fibromyalgia. J Rheumatol 31(2):364–78PubMed
215.
Zurück zum Zitat Crombez G, Eccleston C, Van den Broeck A, Goubert L, Van Houdenhove B (2004) Hypervigilance to pain in fibromyalgia: the mediating role of pain intensity and catastrophic thinking about pain. Clin J Pain 20(2):98–102PubMedCrossRef Crombez G, Eccleston C, Van den Broeck A, Goubert L, Van Houdenhove B (2004) Hypervigilance to pain in fibromyalgia: the mediating role of pain intensity and catastrophic thinking about pain. Clin J Pain 20(2):98–102PubMedCrossRef
216.
Zurück zum Zitat Gracely RH, Geisser ME, Giesecke T, Grant MA, Petzke F, Williams DA et al (2004) Pain catastrophizing and neural responses to pain among persons with fibromyalgia. Brain 127(Pt 4):835–43PubMedCrossRef Gracely RH, Geisser ME, Giesecke T, Grant MA, Petzke F, Williams DA et al (2004) Pain catastrophizing and neural responses to pain among persons with fibromyalgia. Brain 127(Pt 4):835–43PubMedCrossRef
217.
Zurück zum Zitat Jensen KB, Petzke F, Carville S, Fransson P, Marcus H, Williams SC et al (2010) Anxiety and depressive symptoms in fibromyalgia are related to poor perception of health but not to pain sensitivity or cerebral processing of pain. Arthritis Rheum 62(11):3488–95PubMedCrossRef Jensen KB, Petzke F, Carville S, Fransson P, Marcus H, Williams SC et al (2010) Anxiety and depressive symptoms in fibromyalgia are related to poor perception of health but not to pain sensitivity or cerebral processing of pain. Arthritis Rheum 62(11):3488–95PubMedCrossRef
218.
219.
Zurück zum Zitat Schmidt-Wilcke T, Luerding R, Weigand T, Jürgens T, Schuierer G, Leinisch E et al (2007) Striatal grey matter increase in patients suffering from fibromyalgia—a voxel-based morphometry study. Pain 132(Suppl 1):S109–16PubMedCrossRef Schmidt-Wilcke T, Luerding R, Weigand T, Jürgens T, Schuierer G, Leinisch E et al (2007) Striatal grey matter increase in patients suffering from fibromyalgia—a voxel-based morphometry study. Pain 132(Suppl 1):S109–16PubMedCrossRef
220.
Zurück zum Zitat Schmidt-Wilcke T (2008) Variations in brain volume and regional morphology associated with chronic pain. Curr Rheumatol Rep 10(6):467–74PubMedCrossRef Schmidt-Wilcke T (2008) Variations in brain volume and regional morphology associated with chronic pain. Curr Rheumatol Rep 10(6):467–74PubMedCrossRef
221.
222.
Zurück zum Zitat Burgmer M, Gaubitz M, Konrad C, Wrenger M, Hilgart S, Heuft G et al (2009) Decreased gray matter volumes in the cingulo-frontal cortex and the amygdala in patients with fibromyalgia. Psychosom Med 71(5):566–73PubMedCrossRef Burgmer M, Gaubitz M, Konrad C, Wrenger M, Hilgart S, Heuft G et al (2009) Decreased gray matter volumes in the cingulo-frontal cortex and the amygdala in patients with fibromyalgia. Psychosom Med 71(5):566–73PubMedCrossRef
223.
Zurück zum Zitat Wood PB, Glabus MF, Simpson R, Patterson JC 2nd (2009) Changes in gray matter density in fibromyalgia: correlation with dopamine metabolism. J Pain 10(6):609–18PubMedCrossRef Wood PB, Glabus MF, Simpson R, Patterson JC 2nd (2009) Changes in gray matter density in fibromyalgia: correlation with dopamine metabolism. J Pain 10(6):609–18PubMedCrossRef
224.
Zurück zum Zitat Robinson ME, Craggs JG, Price DD, Perlstein WM, Staud R (2011) Gray matter volumes of pain-related brain areas are decreased in fibromyalgia syndrome. J Pain 12(4):436–43PubMedCentralPubMedCrossRef Robinson ME, Craggs JG, Price DD, Perlstein WM, Staud R (2011) Gray matter volumes of pain-related brain areas are decreased in fibromyalgia syndrome. J Pain 12(4):436–43PubMedCentralPubMedCrossRef
225.
Zurück zum Zitat Kuchinad A, Schweinhardt P, Seminowicz DA, Wood PB, Chizh BA, Bushnell MC (2007) Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain? J Neurosci 27(15):4004–7PubMedCrossRef Kuchinad A, Schweinhardt P, Seminowicz DA, Wood PB, Chizh BA, Bushnell MC (2007) Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain? J Neurosci 27(15):4004–7PubMedCrossRef
226.
Zurück zum Zitat Gervais RO, Russell AS, Green P, Allen LM 3rd, Ferrari R, Pieschl SD (2001) Effort testing in patients with fibromyalgia and disability incentives. J Rheumatol 28(8):1892–9PubMed Gervais RO, Russell AS, Green P, Allen LM 3rd, Ferrari R, Pieschl SD (2001) Effort testing in patients with fibromyalgia and disability incentives. J Rheumatol 28(8):1892–9PubMed
227.
Zurück zum Zitat Côté KA, Moldofsky H (1997) Sleep, daytime symptoms, and cognitive performance in patients with fibromyalgia. J Rheumatol 24(10):2014–23 Côté KA, Moldofsky H (1997) Sleep, daytime symptoms, and cognitive performance in patients with fibromyalgia. J Rheumatol 24(10):2014–23
228.
Zurück zum Zitat Bangert AS, Glass JM, Welsh RC, Crofford LJ, Taylor SF, Park DC (2003) Functional magnetic resonance imaging of working memory in fibromyalgia. Arthritis Rheum 48:S90CrossRef Bangert AS, Glass JM, Welsh RC, Crofford LJ, Taylor SF, Park DC (2003) Functional magnetic resonance imaging of working memory in fibromyalgia. Arthritis Rheum 48:S90CrossRef
229.
Zurück zum Zitat Sephton SE, Studts JL, Hoover K, Weissbecker I, Lynch G, Ho I et al (2003) Biological and psychological factors associated with memory function in fibromyalgia syndrome. Health Psychol 22(6):592–7PubMedCrossRef Sephton SE, Studts JL, Hoover K, Weissbecker I, Lynch G, Ho I et al (2003) Biological and psychological factors associated with memory function in fibromyalgia syndrome. Health Psychol 22(6):592–7PubMedCrossRef
230.
Zurück zum Zitat Geisser ME, Clauw DJ, Strand V, Gendreau RM, Palmer R, Williams DA (2010) Contributions of change in clinical status parameters to patient global impression of change (PGIC) scores among persons with fibromyalgia treated with milnacipran. Pain 149(2):373–8PubMedCrossRef Geisser ME, Clauw DJ, Strand V, Gendreau RM, Palmer R, Williams DA (2010) Contributions of change in clinical status parameters to patient global impression of change (PGIC) scores among persons with fibromyalgia treated with milnacipran. Pain 149(2):373–8PubMedCrossRef
231.
Zurück zum Zitat Kim JL, Rele S, Marks DM, Masand PS, Yerramsetty P, Millet RA et al (2013) Effects of milnacipran on neurocognition, pain, and fatigue in fibromyalgia: a 13 weeks, randomized, placebo-controlled, crossover trial. Prim Care Companion CNS Disord 15(6):13m01555 Kim JL, Rele S, Marks DM, Masand PS, Yerramsetty P, Millet RA et al (2013) Effects of milnacipran on neurocognition, pain, and fatigue in fibromyalgia: a 13 weeks, randomized, placebo-controlled, crossover trial. Prim Care Companion CNS Disord 15(6):13m01555
232.
Zurück zum Zitat Mohs R, Mease P, Arnold LM, Wang F, Ahl J, Gaynor PJ et al (2012) The effect of duloxetine treatment on cognition in patients with fibromyalgia. Psychosom Med 74(6):628–34PubMedCrossRef Mohs R, Mease P, Arnold LM, Wang F, Ahl J, Gaynor PJ et al (2012) The effect of duloxetine treatment on cognition in patients with fibromyalgia. Psychosom Med 74(6):628–34PubMedCrossRef
233.
Zurück zum Zitat Kirmayer LJ, Robbins JM, Kapusta MA (1988) Somatization and depression in fibromyalgia syndrome. Am J Psychiatry 145(8):950–4PubMedCrossRef Kirmayer LJ, Robbins JM, Kapusta MA (1988) Somatization and depression in fibromyalgia syndrome. Am J Psychiatry 145(8):950–4PubMedCrossRef
234.
Zurück zum Zitat Epstein SA, Kay G, Clauw D, Heaton R, Klein D, Krupp L et al (1999) Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics 40(1):57–63PubMedCrossRef Epstein SA, Kay G, Clauw D, Heaton R, Klein D, Krupp L et al (1999) Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics 40(1):57–63PubMedCrossRef
235.
Zurück zum Zitat Thieme K, Turk DC, Flor H (2004) Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosom Med 66(6):837–44PubMedCrossRef Thieme K, Turk DC, Flor H (2004) Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosom Med 66(6):837–44PubMedCrossRef
236.
Zurück zum Zitat Malt EA, Berle JE, Olafsson S, Lund A, Ursin H (2000) Fibromyalgia is associated with panic disorder and functional dyspepsia with mood disorders. A study of women with random sample population controls. J Psychosom Res 49(5):285–9PubMedCrossRef Malt EA, Berle JE, Olafsson S, Lund A, Ursin H (2000) Fibromyalgia is associated with panic disorder and functional dyspepsia with mood disorders. A study of women with random sample population controls. J Psychosom Res 49(5):285–9PubMedCrossRef
237.
Zurück zum Zitat Ahles TA, Khan SA, Yunus MB, Spiegel DA, Masi AT (1991) Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis, and subjects without pain: a blind comparison of DSM-III diagnoses. Am J Psychiatry 148(12):1721–6PubMedCrossRef Ahles TA, Khan SA, Yunus MB, Spiegel DA, Masi AT (1991) Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis, and subjects without pain: a blind comparison of DSM-III diagnoses. Am J Psychiatry 148(12):1721–6PubMedCrossRef
238.
Zurück zum Zitat Nordahl HM, Stiles TC (2007) Personality styles in patients with fibromyalgia, major depression and healthy controls. Ann Gen Psychiatr 6:9CrossRef Nordahl HM, Stiles TC (2007) Personality styles in patients with fibromyalgia, major depression and healthy controls. Ann Gen Psychiatr 6:9CrossRef
239.
Zurück zum Zitat Walker EA, Keegan D, Gardner G, Sullivan M, Katon WJ, Bernstein D (1997) Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: I. Psychiatric diagnoses and functional disability. Psychosom Med 59(6):565–71PubMedCrossRef Walker EA, Keegan D, Gardner G, Sullivan M, Katon WJ, Bernstein D (1997) Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: I. Psychiatric diagnoses and functional disability. Psychosom Med 59(6):565–71PubMedCrossRef
240.
Zurück zum Zitat Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, Auchenbach MB et al (2004) Family study of fibromyalgia. Arthritis Rheum 50(3):944–52PubMedCrossRef Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, Auchenbach MB et al (2004) Family study of fibromyalgia. Arthritis Rheum 50(3):944–52PubMedCrossRef
241.
Zurück zum Zitat Hudson JI, Hudson MS, Pliner LF, Goldenberg DL, Pope HG Jr (1985) Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry 142(4):441–6PubMedCrossRef Hudson JI, Hudson MS, Pliner LF, Goldenberg DL, Pope HG Jr (1985) Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry 142(4):441–6PubMedCrossRef
242.
Zurück zum Zitat Rose S, Cottencin O, Chouraki V, Wattier JM, Houvenagel E, Vallet B et al (2009) Importance des troubles de la personnalité et des comorbidités psychiatriques chez 30 patients attenits de frbromyalgie [Study on personality and psychiatric disorder in fibromyalgia]. Presse Med 38(5):695–700PubMedCrossRef Rose S, Cottencin O, Chouraki V, Wattier JM, Houvenagel E, Vallet B et al (2009) Importance des troubles de la personnalité et des comorbidités psychiatriques chez 30 patients attenits de frbromyalgie [Study on personality and psychiatric disorder in fibromyalgia]. Presse Med 38(5):695–700PubMedCrossRef
243.
Zurück zum Zitat Martinez JE, Ferraz MB, Fontana AM, Atra E (1995) Psychological aspects of Brazilian women with fibromyalgia. J Psychosom Res 39(2):167–74PubMedCrossRef Martinez JE, Ferraz MB, Fontana AM, Atra E (1995) Psychological aspects of Brazilian women with fibromyalgia. J Psychosom Res 39(2):167–74PubMedCrossRef
244.
Zurück zum Zitat Roy-Byrne P, Smith WR, Goldberg J, Afari N, Buchwald D (2004) Post-traumatic stress disorder among patients with chronic pain and chronic fatigue. Psychol Med 34(2):363–8PubMedCrossRef Roy-Byrne P, Smith WR, Goldberg J, Afari N, Buchwald D (2004) Post-traumatic stress disorder among patients with chronic pain and chronic fatigue. Psychol Med 34(2):363–8PubMedCrossRef
245.
Zurück zum Zitat Häuser W, Galek A, Erbslöh-Möller B, Köllner V, Kühn-Becker H, Langhorst J et al (2013) Posttraumatic stress disorder in fibromyalgia syndrome: prevalence, temporal relationship between posttraumatic stress and fibromyalgia symptoms, and impact on clinical outcome. Pain 154(8):1216–23PubMedCrossRef Häuser W, Galek A, Erbslöh-Möller B, Köllner V, Kühn-Becker H, Langhorst J et al (2013) Posttraumatic stress disorder in fibromyalgia syndrome: prevalence, temporal relationship between posttraumatic stress and fibromyalgia symptoms, and impact on clinical outcome. Pain 154(8):1216–23PubMedCrossRef
246.
Zurück zum Zitat Cohen H, Neumann L, Haiman Y, Matar MA, Press J, Buskila D (2002) Prevalence of post-traumatic stress disorder in fibromyalgia patients: overlapping syndromes or post-traumatic fibromyalgia syndrome? Semin Arthritis Rheum 32(1):38–50PubMedCrossRef Cohen H, Neumann L, Haiman Y, Matar MA, Press J, Buskila D (2002) Prevalence of post-traumatic stress disorder in fibromyalgia patients: overlapping syndromes or post-traumatic fibromyalgia syndrome? Semin Arthritis Rheum 32(1):38–50PubMedCrossRef
247.
Zurück zum Zitat Sherman JJ, Turk DC, Okifuji A (2000) Prevalence and impact of posttraumatic stress disorder-like symptoms on patients with fibromyalgia syndrome. Clin J Pain 16(2):127–34PubMedCrossRef Sherman JJ, Turk DC, Okifuji A (2000) Prevalence and impact of posttraumatic stress disorder-like symptoms on patients with fibromyalgia syndrome. Clin J Pain 16(2):127–34PubMedCrossRef
248.
Zurück zum Zitat Amir M, Kaplan Z, Neumann L, Sharabani R, Shani N, Buskila D (1997) Posttraumatic stress disorder, tenderness and fibromyalgia. J Psychosom Res 42(6):607–13PubMedCrossRef Amir M, Kaplan Z, Neumann L, Sharabani R, Shani N, Buskila D (1997) Posttraumatic stress disorder, tenderness and fibromyalgia. J Psychosom Res 42(6):607–13PubMedCrossRef
249.
Zurück zum Zitat Amital D, Fostick L, Polliack ML, Segev S, Zohar J, Rubinow A et al (2006) Posttraumatic stress disorder, tenderness, and fibromyalgia syndrome: are they different entities? J Psychosom Res 61(5):663–9PubMedCrossRef Amital D, Fostick L, Polliack ML, Segev S, Zohar J, Rubinow A et al (2006) Posttraumatic stress disorder, tenderness, and fibromyalgia syndrome: are they different entities? J Psychosom Res 61(5):663–9PubMedCrossRef
250.
Zurück zum Zitat Desmeules J, Piguet V, Besson M, Chabert J, Rapiti E, Rebsamen M et al (2012) Psychological distress in fibromyalgia patients: a role for catechol-O-methyl-transferase Val158met polymorphism. Health Psychol 31(2):242–9PubMedCrossRef Desmeules J, Piguet V, Besson M, Chabert J, Rapiti E, Rebsamen M et al (2012) Psychological distress in fibromyalgia patients: a role for catechol-O-methyl-transferase Val158met polymorphism. Health Psychol 31(2):242–9PubMedCrossRef
251.
Zurück zum Zitat Güven AZ, Kul Panza E, Gündüz OH (2005) Depression and psychosocial factors in Turkish women with fibromyalgia syndrome. Eura Medicophys 41(4):309–13PubMed Güven AZ, Kul Panza E, Gündüz OH (2005) Depression and psychosocial factors in Turkish women with fibromyalgia syndrome. Eura Medicophys 41(4):309–13PubMed
252.
Zurück zum Zitat Celiker R, Borman P, Oktem F, Gokce-Kutsal Y, Basgoze O (1997) Psychological disturbance in fibromyalgia: relation to pain severity. Clin Rheumatol 16(2):179–84PubMedCrossRef Celiker R, Borman P, Oktem F, Gokce-Kutsal Y, Basgoze O (1997) Psychological disturbance in fibromyalgia: relation to pain severity. Clin Rheumatol 16(2):179–84PubMedCrossRef
253.
Zurück zum Zitat Gormsen L, Rosenberg R, Bach FW, Jensen TS (2010) Depression, anxiety, health-related quality of life and pain in patients with chronic fibromyalgia and neuropathic pain. Eur J Pain 14(2):127 e1–8PubMedCrossRef Gormsen L, Rosenberg R, Bach FW, Jensen TS (2010) Depression, anxiety, health-related quality of life and pain in patients with chronic fibromyalgia and neuropathic pain. Eur J Pain 14(2):127 e1–8PubMedCrossRef
254.
Zurück zum Zitat Mostoufi SM, Afari N, Ahumada SM, Reis V, Wetherell JL (2012) Health and distress predictors of heart rate variability in fibromyalgia and other forms of chronic pain. J Psychosom Res 72(1):39–44PubMedCrossRef Mostoufi SM, Afari N, Ahumada SM, Reis V, Wetherell JL (2012) Health and distress predictors of heart rate variability in fibromyalgia and other forms of chronic pain. J Psychosom Res 72(1):39–44PubMedCrossRef
255.
Zurück zum Zitat White KP, Nielson WR, Harth M, Ostbye T, Speechley M (2002) Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a representative community adult sample. J Rheumatol 29(3):588–94PubMed White KP, Nielson WR, Harth M, Ostbye T, Speechley M (2002) Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a representative community adult sample. J Rheumatol 29(3):588–94PubMed
257.
Zurück zum Zitat Lacerda-Pinheiro SF, Pinheiro RF Jr, de Lima Pereira MA, da Silva Lima CG, Dos Santos Vieira MS, Teixeira AG Jr et al (2014) Are there depression and anxiety genetic markers and mutations? A systematic review. J Affect Disord 168:387–98PubMedCrossRef Lacerda-Pinheiro SF, Pinheiro RF Jr, de Lima Pereira MA, da Silva Lima CG, Dos Santos Vieira MS, Teixeira AG Jr et al (2014) Are there depression and anxiety genetic markers and mutations? A systematic review. J Affect Disord 168:387–98PubMedCrossRef
258.
Zurück zum Zitat Raphael KG, Janal MN, Nayak S, Schwartz JE, Gallagher RM (2004) Familial aggregation of depression in fibromyalgia: a community-based test of alternate hypotheses. Pain 110(1–2):449–60PubMedCrossRef Raphael KG, Janal MN, Nayak S, Schwartz JE, Gallagher RM (2004) Familial aggregation of depression in fibromyalgia: a community-based test of alternate hypotheses. Pain 110(1–2):449–60PubMedCrossRef
259.
Zurück zum Zitat Häuser W, Kosseva M, Üceyler N, Klose P, Sommer C (2011) Emotional, physical, and sexual abuse in fibromyalgia syndrome: a systematic review with meta-analysis. Arthritis Care Res 63(6):808–20CrossRef Häuser W, Kosseva M, Üceyler N, Klose P, Sommer C (2011) Emotional, physical, and sexual abuse in fibromyalgia syndrome: a systematic review with meta-analysis. Arthritis Care Res 63(6):808–20CrossRef
260.
Zurück zum Zitat Lindert J, von Ehrenstein OS, Grashow R, Gal G, Braehler E, Weisskopf MG (2014) Sexual and physical abuse in childhood is associated with depression and anxiety over the life course: systematic review and meta-analysis. Int J Public Health 59(2):359–72PubMedCrossRef Lindert J, von Ehrenstein OS, Grashow R, Gal G, Braehler E, Weisskopf MG (2014) Sexual and physical abuse in childhood is associated with depression and anxiety over the life course: systematic review and meta-analysis. Int J Public Health 59(2):359–72PubMedCrossRef
261.
Zurück zum Zitat Raphael KG, Natelson BH, Janal MN, Nayak S (2002) A community-based survey of fibromyalgia-like pain complaints following the World Trade Center terrorist attacks. Pain 100(1–2):131–9PubMedCrossRef Raphael KG, Natelson BH, Janal MN, Nayak S (2002) A community-based survey of fibromyalgia-like pain complaints following the World Trade Center terrorist attacks. Pain 100(1–2):131–9PubMedCrossRef
262.
Zurück zum Zitat Aguglia A, Salvi V, Maina G, Rossetto I, Aguglia E (2011) Fibromyalgia syndrome and depressive symptoms: comorbidity and clinical correlates. J Affect Disord 128(3):262–6PubMedCrossRef Aguglia A, Salvi V, Maina G, Rossetto I, Aguglia E (2011) Fibromyalgia syndrome and depressive symptoms: comorbidity and clinical correlates. J Affect Disord 128(3):262–6PubMedCrossRef
263.
Zurück zum Zitat Burckhardt CS, Clark SR, Bennett RM (1992) A comparison of pain perceptions in women with fibromyalgia and rheumatoid arthritis: relationship to depression and pain extent. Arthritis Care Res 5(4):216–22PubMedCrossRef Burckhardt CS, Clark SR, Bennett RM (1992) A comparison of pain perceptions in women with fibromyalgia and rheumatoid arthritis: relationship to depression and pain extent. Arthritis Care Res 5(4):216–22PubMedCrossRef
264.
Zurück zum Zitat Nicassio PM, Moxham EG, Schuman CE, Gevirtz RN (2002) The contribution of pain, reported sleep quality, and depressive symptoms to fatigue in fibromyalgia. Pain 100(3):271–9PubMedCrossRef Nicassio PM, Moxham EG, Schuman CE, Gevirtz RN (2002) The contribution of pain, reported sleep quality, and depressive symptoms to fatigue in fibromyalgia. Pain 100(3):271–9PubMedCrossRef
265.
Zurück zum Zitat Kurtze N, Gundersen KT, Svebak S (1998) The role of anxiety and depression in fatigue and patterns of pain among subgroups of fibromyalgia patients. Br J Med Psychol 71(Pt 2):185–94PubMedCrossRef Kurtze N, Gundersen KT, Svebak S (1998) The role of anxiety and depression in fatigue and patterns of pain among subgroups of fibromyalgia patients. Br J Med Psychol 71(Pt 2):185–94PubMedCrossRef
266.
Zurück zum Zitat Kurtze N, Svebak S (2001) Fatigue and patterns of pain in fibromyalgia: correlations with anxiety, depression and co-morbidity in a female county sample. Br J Med Psychol 74(Pt 4):523–37PubMedCrossRef Kurtze N, Svebak S (2001) Fatigue and patterns of pain in fibromyalgia: correlations with anxiety, depression and co-morbidity in a female county sample. Br J Med Psychol 74(Pt 4):523–37PubMedCrossRef
267.
Zurück zum Zitat Landrø NI, Stiles TC, Sletvold H (1997) Memory functioning in patients with primary fibromyalgia and major depression and healthy controls. J Psychosom Res 42(3):297–306PubMedCrossRef Landrø NI, Stiles TC, Sletvold H (1997) Memory functioning in patients with primary fibromyalgia and major depression and healthy controls. J Psychosom Res 42(3):297–306PubMedCrossRef
268.
Zurück zum Zitat Neumann L, Berzak A, Buskila D (2000) Measuring health status in Israeli patients with fibromyalgia syndrome and widespread pain and healthy individuals: utility of the short form 36-item health survey (SF-36). Semin Arthritis Rheum 29(6):400–8PubMedCrossRef Neumann L, Berzak A, Buskila D (2000) Measuring health status in Israeli patients with fibromyalgia syndrome and widespread pain and healthy individuals: utility of the short form 36-item health survey (SF-36). Semin Arthritis Rheum 29(6):400–8PubMedCrossRef
269.
Zurück zum Zitat Jones CJ, Rutledge DN, Aquino J (2010) Predictors of physical performance and functional ability in people 50+ with and without fibromyalgia. J Aging Phys Act 18(3):353–68PubMed Jones CJ, Rutledge DN, Aquino J (2010) Predictors of physical performance and functional ability in people 50+ with and without fibromyalgia. J Aging Phys Act 18(3):353–68PubMed
270.
Zurück zum Zitat Kassam A, Patten SB (2006) Major depression, fibromyalgia and labour force participation: a population-based cross-sectional study. BMC Musculoskelet Disord 7:4PubMedCentralPubMedCrossRef Kassam A, Patten SB (2006) Major depression, fibromyalgia and labour force participation: a population-based cross-sectional study. BMC Musculoskelet Disord 7:4PubMedCentralPubMedCrossRef
271.
Zurück zum Zitat Ercolani M, Trombini G, Chattat R, Cervini C, Piergiacomi G, Salaffi F et al (1994) Fibromyalgic syndrome: depression and abnormal illness behavior. Multicenter investigation. Psychother Psychosom 61(3–4):178–86PubMedCrossRef Ercolani M, Trombini G, Chattat R, Cervini C, Piergiacomi G, Salaffi F et al (1994) Fibromyalgic syndrome: depression and abnormal illness behavior. Multicenter investigation. Psychother Psychosom 61(3–4):178–86PubMedCrossRef
272.
Zurück zum Zitat Viitanen JV, Kautiainen H, Isomaki H (1993) Pain intensity in patients with fibromyalgia and rheumatoid arthritis. Scand J Rheumatol 22(3):131–5PubMedCrossRef Viitanen JV, Kautiainen H, Isomaki H (1993) Pain intensity in patients with fibromyalgia and rheumatoid arthritis. Scand J Rheumatol 22(3):131–5PubMedCrossRef
273.
Zurück zum Zitat Marangell LB, Clauw DJ, Choy E, Wang F, Shoemaker S, Bradley L et al (2011) Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder: secondary analyses of four pooled randomized controlled trials of duloxetine. Pain 152(1):31–7PubMedCrossRef Marangell LB, Clauw DJ, Choy E, Wang F, Shoemaker S, Bradley L et al (2011) Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder: secondary analyses of four pooled randomized controlled trials of duloxetine. Pain 152(1):31–7PubMedCrossRef
274.
Zurück zum Zitat Moore RA, Straube S, Paine J, Phillips CJ, Derry S, McQuay HJ (2010) Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain. Pain 149(2):360–4PubMedCrossRef Moore RA, Straube S, Paine J, Phillips CJ, Derry S, McQuay HJ (2010) Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain. Pain 149(2):360–4PubMedCrossRef
275.
Zurück zum Zitat Nicassio PM, Radojevic V, Schoenfeld-Smith K, Dwyer K (1995) The contribution of family cohesion and the pain-coping process to depressive symptoms in fibromyalgia. Ann Behav Med 17(4):349–56PubMedCrossRef Nicassio PM, Radojevic V, Schoenfeld-Smith K, Dwyer K (1995) The contribution of family cohesion and the pain-coping process to depressive symptoms in fibromyalgia. Ann Behav Med 17(4):349–56PubMedCrossRef
276.
Zurück zum Zitat Okifuji A, Turk DC, Sherman JJ (2000) Evaluation of the relationship between depression and fibromyalgia syndrome: why aren’t all patients depressed? J Rheumatol 27(1):212–9PubMed Okifuji A, Turk DC, Sherman JJ (2000) Evaluation of the relationship between depression and fibromyalgia syndrome: why aren’t all patients depressed? J Rheumatol 27(1):212–9PubMed
278.
Zurück zum Zitat Cagnie B, Coppieters I, Denecker S, Six J, Danneels L, Meeus M (2014) Central sensitization in fibromyalgia? A systematic review on structural and functional brain MRI. Semin Arthritis Rheum 44(1):68–75PubMedCrossRef Cagnie B, Coppieters I, Denecker S, Six J, Danneels L, Meeus M (2014) Central sensitization in fibromyalgia? A systematic review on structural and functional brain MRI. Semin Arthritis Rheum 44(1):68–75PubMedCrossRef
279.
Zurück zum Zitat Rodriguez-Raecke R, Niemeier A, Ihle K, Ruether W, May A (2009) Brain gray matter decrease in chronic pain is the consequence and not the cause of pain. J Neurosci 29(44):13746–50PubMedCrossRef Rodriguez-Raecke R, Niemeier A, Ihle K, Ruether W, May A (2009) Brain gray matter decrease in chronic pain is the consequence and not the cause of pain. J Neurosci 29(44):13746–50PubMedCrossRef
280.
Zurück zum Zitat Gracely RH, Ambrose KR (2011) Neuroimaging of fibromyalgia. Best Pract Res Clin Rheumatol 25(2):271–84PubMedCrossRef Gracely RH, Ambrose KR (2011) Neuroimaging of fibromyalgia. Best Pract Res Clin Rheumatol 25(2):271–84PubMedCrossRef
281.
Zurück zum Zitat Jorge LL, Amaro E Jr (2012) Brain imaging in fibromyalgia. Curr Pain Headache Rep 16(5):388–98PubMedCrossRef Jorge LL, Amaro E Jr (2012) Brain imaging in fibromyalgia. Curr Pain Headache Rep 16(5):388–98PubMedCrossRef
282.
Zurück zum Zitat Ichesco E, Schmidt-Wilcke T, Bhavsar R, Clauw DJ, Peltier SJ, Kim J et al (2014) Altered resting state connectivity of the insular cortex in individuals with fibromyalgia. J Pain 15(8):815–26, e1 PubMedCentralPubMedCrossRef Ichesco E, Schmidt-Wilcke T, Bhavsar R, Clauw DJ, Peltier SJ, Kim J et al (2014) Altered resting state connectivity of the insular cortex in individuals with fibromyalgia. J Pain 15(8):815–26, e1 PubMedCentralPubMedCrossRef
283.
Zurück zum Zitat Pujol J, Macia D, Garcia-Fontanals A, Blanco-Hinojo L, Lopez-Sola M, Garcia-Blanco S et al (2014) The contribution of sensory system functional connectivity reduction to clinical pain in fibromyalgia. Pain 155(8):1492–503PubMedCrossRef Pujol J, Macia D, Garcia-Fontanals A, Blanco-Hinojo L, Lopez-Sola M, Garcia-Blanco S et al (2014) The contribution of sensory system functional connectivity reduction to clinical pain in fibromyalgia. Pain 155(8):1492–503PubMedCrossRef
284.
Zurück zum Zitat Harris RE, Napadow V, Huggins JP, Pauer L, Kim J, Hampson J et al (2013) Pregabalin rectifies aberrant brain chemistry, connectivity, and functional response in chronic pain patients. Anesthesiology 119(6):1453–64PubMedCrossRef Harris RE, Napadow V, Huggins JP, Pauer L, Kim J, Hampson J et al (2013) Pregabalin rectifies aberrant brain chemistry, connectivity, and functional response in chronic pain patients. Anesthesiology 119(6):1453–64PubMedCrossRef
285.
Zurück zum Zitat Napadow V, Kim J, Clauw DJ, Harris RE (2012) Decreased intrinsic brain connectivity is associated with reduced clinical pain in fibromyalgia. Arthritis Rheum 64(7):2398–403PubMedCentralPubMedCrossRef Napadow V, Kim J, Clauw DJ, Harris RE (2012) Decreased intrinsic brain connectivity is associated with reduced clinical pain in fibromyalgia. Arthritis Rheum 64(7):2398–403PubMedCentralPubMedCrossRef
286.
Zurück zum Zitat Schmidt-Wilcke T, Ichesco E, Hampson JP, Kairys A, Peltier S, Harte S et al (2014) Resting state connectivity correlates with drug and placebo response in fibromyalgia patients. Neuroimage Clin 6:252–61PubMedCentralPubMedCrossRef Schmidt-Wilcke T, Ichesco E, Hampson JP, Kairys A, Peltier S, Harte S et al (2014) Resting state connectivity correlates with drug and placebo response in fibromyalgia patients. Neuroimage Clin 6:252–61PubMedCentralPubMedCrossRef
287.
Zurück zum Zitat Tracey I, Mantyh PW (2007) The cerebral signature for pain perception and its modulation. Neuron 55(3):377–91PubMedCrossRef Tracey I, Mantyh PW (2007) The cerebral signature for pain perception and its modulation. Neuron 55(3):377–91PubMedCrossRef
288.
Zurück zum Zitat Burgmer M, Pogatzki-Zahn E, Gaubitz M, Wessoleck E, Heuft G, Pfleiderer B (2009) Altered brain activity during pain processing in fibromyalgia. Neuroimage 44(2):502–8PubMedCrossRef Burgmer M, Pogatzki-Zahn E, Gaubitz M, Wessoleck E, Heuft G, Pfleiderer B (2009) Altered brain activity during pain processing in fibromyalgia. Neuroimage 44(2):502–8PubMedCrossRef
289.
Zurück zum Zitat Burgmer M, Pogatzki-Zahn E, Gaubitz M, Stuber C, Wessoleck E, Heuft G et al (2010) Fibromyalgia unique temporal brain activation during experimental pain: a controlled fMRI study. J Neural Transm 117(1):123–31PubMedCrossRef Burgmer M, Pogatzki-Zahn E, Gaubitz M, Stuber C, Wessoleck E, Heuft G et al (2010) Fibromyalgia unique temporal brain activation during experimental pain: a controlled fMRI study. J Neural Transm 117(1):123–31PubMedCrossRef
290.
Zurück zum Zitat Burgmer M, Pfleiderer B, Maihofner C, Gaubitz M, Wessolleck E, Heuft G et al (2012) Cerebral mechanisms of experimental hyperalgesia in fibromyalgia. Eur J Pain 16(5):636–47PubMedCrossRef Burgmer M, Pfleiderer B, Maihofner C, Gaubitz M, Wessolleck E, Heuft G et al (2012) Cerebral mechanisms of experimental hyperalgesia in fibromyalgia. Eur J Pain 16(5):636–47PubMedCrossRef
291.
Zurück zum Zitat Giesecke T, Gracely RH, Williams DA, Geisser ME, Petzke FW, Clauw DJ (2005) The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum 52(5):1577–84PubMedCrossRef Giesecke T, Gracely RH, Williams DA, Geisser ME, Petzke FW, Clauw DJ (2005) The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum 52(5):1577–84PubMedCrossRef
292.
Zurück zum Zitat Jensen KB, Loitoile R, Kosek E, Petzke F, Carville S, Fransson P et al (2012) Patients with fibromyalgia display less functional connectivity in the brain’s pain inhibitory network. Mol Pain 8:32PubMedCentralPubMedCrossRef Jensen KB, Loitoile R, Kosek E, Petzke F, Carville S, Fransson P et al (2012) Patients with fibromyalgia display less functional connectivity in the brain’s pain inhibitory network. Mol Pain 8:32PubMedCentralPubMedCrossRef
293.
Zurück zum Zitat Pamuk ON, Yesil Y, Cakir N (2006) Factors that affect the number of tender points in fibromyalgia and chronic widespread pain patients who did not meet the ACR 1990 criteria for fibromyalgia: are tender points a reflection of neuropathic pain? Semin Arthritis Rheum 36(2):130–4PubMedCrossRef Pamuk ON, Yesil Y, Cakir N (2006) Factors that affect the number of tender points in fibromyalgia and chronic widespread pain patients who did not meet the ACR 1990 criteria for fibromyalgia: are tender points a reflection of neuropathic pain? Semin Arthritis Rheum 36(2):130–4PubMedCrossRef
294.
Zurück zum Zitat Staud R, Robinson ME, Vierck CJ Jr, Cannon RC, Mauderli AP, Price DD (2003) Ratings of experimental pain and pain-related negative affect predict clinical pain in patients with fibromyalgia syndrome. Pain 105(1–2):215–22PubMedCrossRef Staud R, Robinson ME, Vierck CJ Jr, Cannon RC, Mauderli AP, Price DD (2003) Ratings of experimental pain and pain-related negative affect predict clinical pain in patients with fibromyalgia syndrome. Pain 105(1–2):215–22PubMedCrossRef
295.
Zurück zum Zitat Burgmer M, Petzke F, Giesecke T, Gaubitz M, Heuft G, Pfleiderer B (2011) Cerebral activation and catastrophizing during pain anticipation in patients with fibromyalgia. Psychosom Med 73(9):751–9PubMedCrossRef Burgmer M, Petzke F, Giesecke T, Gaubitz M, Heuft G, Pfleiderer B (2011) Cerebral activation and catastrophizing during pain anticipation in patients with fibromyalgia. Psychosom Med 73(9):751–9PubMedCrossRef
296.
Zurück zum Zitat Fayed N, Garcia-Campayo J, Magallon R, Andres-Bergareche H, Luciano JV, Andres E et al (2010) Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartate. Arthritis Res Ther 12(4):R134PubMedCentralPubMedCrossRef Fayed N, Garcia-Campayo J, Magallon R, Andres-Bergareche H, Luciano JV, Andres E et al (2010) Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartate. Arthritis Res Ther 12(4):R134PubMedCentralPubMedCrossRef
297.
Zurück zum Zitat Fayed N, Andres E, Rojas G, Moreno S, Serrano-Blanco A, Roca M et al (2012) Brain dysfunction in fibromyalgia and somatization disorder using proton magnetic resonance spectroscopy: a controlled study. Acta Psychiatr Scand 126(2):115–25PubMedCrossRef Fayed N, Andres E, Rojas G, Moreno S, Serrano-Blanco A, Roca M et al (2012) Brain dysfunction in fibromyalgia and somatization disorder using proton magnetic resonance spectroscopy: a controlled study. Acta Psychiatr Scand 126(2):115–25PubMedCrossRef
298.
Zurück zum Zitat Emad Y, Ragab Y, Zeinhom F, El-Khouly G, Abou-Zeid A, Rasker JJ (2008) Hippocampus dysfunction may explain symptoms of fibromyalgia syndrome. A study with single-voxel magnetic resonance spectroscopy. J Rheumatol 35(7):1371–7PubMed Emad Y, Ragab Y, Zeinhom F, El-Khouly G, Abou-Zeid A, Rasker JJ (2008) Hippocampus dysfunction may explain symptoms of fibromyalgia syndrome. A study with single-voxel magnetic resonance spectroscopy. J Rheumatol 35(7):1371–7PubMed
299.
Zurück zum Zitat Wood PB, Ledbetter CR, Glabus MF, Broadwell LK, Patterson JC 2nd (2009) Hippocampal metabolite abnormalities in fibromyalgia: correlation with clinical features. J Pain 10(1):47–52PubMedCrossRef Wood PB, Ledbetter CR, Glabus MF, Broadwell LK, Patterson JC 2nd (2009) Hippocampal metabolite abnormalities in fibromyalgia: correlation with clinical features. J Pain 10(1):47–52PubMedCrossRef
300.
Zurück zum Zitat Peres MF, Zukerman E, Senne Soares CA, Alonso EO, Santos BF, Faulhaber MH (2004) Cerebrospinal fluid glutamate levels in chronic migraine. Cephalalgia 24(9):735–9PubMedCrossRef Peres MF, Zukerman E, Senne Soares CA, Alonso EO, Santos BF, Faulhaber MH (2004) Cerebrospinal fluid glutamate levels in chronic migraine. Cephalalgia 24(9):735–9PubMedCrossRef
301.
Zurück zum Zitat Sarchielli P, Mancini ML, Floridi A, Coppola F, Rossi C, Nardi K et al (2007) Increased levels of neurotrophins are not specific for chronic migraine: evidence from primary fibromyalgia syndrome. J Pain 8(9):737–45PubMedCrossRef Sarchielli P, Mancini ML, Floridi A, Coppola F, Rossi C, Nardi K et al (2007) Increased levels of neurotrophins are not specific for chronic migraine: evidence from primary fibromyalgia syndrome. J Pain 8(9):737–45PubMedCrossRef
302.
Zurück zum Zitat Larson AA, Giovengo SL, Russell IJ, Michalek JE (2000) Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways. Pain 87(2):201–11PubMedCrossRef Larson AA, Giovengo SL, Russell IJ, Michalek JE (2000) Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways. Pain 87(2):201–11PubMedCrossRef
303.
Zurück zum Zitat Cohen SP, Verdolin MH, Chang AS, Kurihara C, Morlando BJ, Mao J (2006) The intravenous ketamine test predicts subsequent response to an oral dextromethorphan treatment regimen in fibromyalgia patients. J Pain 7(6):391–8PubMedCrossRef Cohen SP, Verdolin MH, Chang AS, Kurihara C, Morlando BJ, Mao J (2006) The intravenous ketamine test predicts subsequent response to an oral dextromethorphan treatment regimen in fibromyalgia patients. J Pain 7(6):391–8PubMedCrossRef
304.
Zurück zum Zitat Feraco P, Bacci A, Pedrabissi F, Passamonti L, Zampogna G, Malavolta N et al (2011) Metabolic abnormalities in pain-processing regions of patients with fibromyalgia: a 3T MR spectroscopy study. AJNR Am J Neuroradiol 32(9):1585–90PubMedCrossRef Feraco P, Bacci A, Pedrabissi F, Passamonti L, Zampogna G, Malavolta N et al (2011) Metabolic abnormalities in pain-processing regions of patients with fibromyalgia: a 3T MR spectroscopy study. AJNR Am J Neuroradiol 32(9):1585–90PubMedCrossRef
305.
Zurück zum Zitat Valdés M, Collado A, Bargalló N, Vázquez M, Rami L, Gómez E et al (2010) Increased glutamate/glutamine compounds in the brains of patients with fibromyalgia: a magnetic resonance spectroscopy study. Arthritis Rheum 62(6):1829–36PubMedCrossRef Valdés M, Collado A, Bargalló N, Vázquez M, Rami L, Gómez E et al (2010) Increased glutamate/glutamine compounds in the brains of patients with fibromyalgia: a magnetic resonance spectroscopy study. Arthritis Rheum 62(6):1829–36PubMedCrossRef
306.
Zurück zum Zitat Harris RE, Sundgren PC, Craig AD, Kirshenbaum E, Sen A, Napadow V et al (2009) Elevated insular glutamate in fibromyalgia is associated with experimental pain. Arthritis Rheum 60(10):3146–52PubMedCentralPubMedCrossRef Harris RE, Sundgren PC, Craig AD, Kirshenbaum E, Sen A, Napadow V et al (2009) Elevated insular glutamate in fibromyalgia is associated with experimental pain. Arthritis Rheum 60(10):3146–52PubMedCentralPubMedCrossRef
307.
Zurück zum Zitat Harris RE, Sundgren PC, Pang Y, Hsu M, Petrou M, Kim SH et al (2008) Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia. Arthritis Rheum 58(3):903–7PubMedCrossRef Harris RE, Sundgren PC, Pang Y, Hsu M, Petrou M, Kim SH et al (2008) Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia. Arthritis Rheum 58(3):903–7PubMedCrossRef
308.
Zurück zum Zitat Becker S, Schweinhardt P (2012) Dysfunctional neurotransmitter systems in fibromyalgia, their role in central stress circuitry and pharmacological actions on these systems. Pain Res Treat 2012:741746PubMedCentralPubMed Becker S, Schweinhardt P (2012) Dysfunctional neurotransmitter systems in fibromyalgia, their role in central stress circuitry and pharmacological actions on these systems. Pain Res Treat 2012:741746PubMedCentralPubMed
309.
Zurück zum Zitat Giovengo SL, Russell IJ, Larson AA (1999) Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. J Rheumatol 26(7):1564–9PubMed Giovengo SL, Russell IJ, Larson AA (1999) Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. J Rheumatol 26(7):1564–9PubMed
310.
Zurück zum Zitat Foerster BR, Petrou M, Edden RA, Sundgren PC, Schmidt-Wilcke T, Lowe SE et al (2012) Reduced insular γ-aminobutyric acid in fibromyalgia. Arthritis Rheum 64(2):579–83PubMedCentralPubMedCrossRef Foerster BR, Petrou M, Edden RA, Sundgren PC, Schmidt-Wilcke T, Lowe SE et al (2012) Reduced insular γ-aminobutyric acid in fibromyalgia. Arthritis Rheum 64(2):579–83PubMedCentralPubMedCrossRef
311.
Zurück zum Zitat Legangneux E, Mora JJ, Spreux-Varoquaux O, Thorin I, Herrou M, Alvado G et al (2001) Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome. Rheumatology (Oxford) 40(3):290–6CrossRef Legangneux E, Mora JJ, Spreux-Varoquaux O, Thorin I, Herrou M, Alvado G et al (2001) Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome. Rheumatology (Oxford) 40(3):290–6CrossRef
312.
Zurück zum Zitat Russell IJ, Vaeroy H, Javors M, Nyberg F (1992) Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 35(5):550–6PubMedCrossRef Russell IJ, Vaeroy H, Javors M, Nyberg F (1992) Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 35(5):550–6PubMedCrossRef
313.
Zurück zum Zitat Russell IJ, Michalek JE, Vipraio GA, Fletcher EM, Javors MA, Bowden CA (1992) Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 19(1):104–9PubMed Russell IJ, Michalek JE, Vipraio GA, Fletcher EM, Javors MA, Bowden CA (1992) Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 19(1):104–9PubMed
314.
Zurück zum Zitat Bazzichi L, Giannaccini G, Betti L, Mascia G, Fabbrini L, Italiani P et al (2006) Alteration of serotonin transporter density and activity in fibromyalgia. Arthritis Res Ther 8(4):R99PubMedCentralPubMedCrossRef Bazzichi L, Giannaccini G, Betti L, Mascia G, Fabbrini L, Italiani P et al (2006) Alteration of serotonin transporter density and activity in fibromyalgia. Arthritis Res Ther 8(4):R99PubMedCentralPubMedCrossRef
315.
Zurück zum Zitat Kravitz HM, Katz R, Kot E, Helmke N, Fawcett J (1992) Biochemical clues to a fibromyalgia-depression link: imipramine binding in patients with fibromyalgia or depression and in healthy controls. J Rheumatol 19(9):1428–32PubMed Kravitz HM, Katz R, Kot E, Helmke N, Fawcett J (1992) Biochemical clues to a fibromyalgia-depression link: imipramine binding in patients with fibromyalgia or depression and in healthy controls. J Rheumatol 19(9):1428–32PubMed
316.
Zurück zum Zitat Maes M, Verkerk R, Delmeire L, Van Gastel A, van Hunsel F, Scharpe S (2000) Serotonergic markers and lowered plasma branched-chain-amino acid concentrations in fibromyalgia. Psychiatry Res 97(1):11–20PubMedCrossRef Maes M, Verkerk R, Delmeire L, Van Gastel A, van Hunsel F, Scharpe S (2000) Serotonergic markers and lowered plasma branched-chain-amino acid concentrations in fibromyalgia. Psychiatry Res 97(1):11–20PubMedCrossRef
317.
Zurück zum Zitat Wood PB, Patterson JC 2nd, Sunderland JJ, Tainter KH, Glabus MF, Lilien DL (2007) Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: a pilot study. J Pain 8(1):51–8PubMedCrossRef Wood PB, Patterson JC 2nd, Sunderland JJ, Tainter KH, Glabus MF, Lilien DL (2007) Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: a pilot study. J Pain 8(1):51–8PubMedCrossRef
318.
Zurück zum Zitat Wood PB, Schweinhardt P, Jaeger E, Dagher A, Hakyemez H, Rabiner EA et al (2007) Fibromyalgia patients show an abnormal dopamine response to pain. Eur J Neurosci 25(12):3576–82PubMedCrossRef Wood PB, Schweinhardt P, Jaeger E, Dagher A, Hakyemez H, Rabiner EA et al (2007) Fibromyalgia patients show an abnormal dopamine response to pain. Eur J Neurosci 25(12):3576–82PubMedCrossRef
319.
Zurück zum Zitat Harris RE, Clauw DJ, Scott DJ, McLean SA, Gracely RH, Zubieta JK (2007) Decreased central μ-opioid receptor availability in fibromyalgia. J Neurosci 27(37):10000–6PubMedCrossRef Harris RE, Clauw DJ, Scott DJ, McLean SA, Gracely RH, Zubieta JK (2007) Decreased central μ-opioid receptor availability in fibromyalgia. J Neurosci 27(37):10000–6PubMedCrossRef
320.
Zurück zum Zitat Baraniuk JN, Whalen G, Cunningham J, Clauw DJ (2004) Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain. BMC Musculoskelet Disord 5:48PubMedCentralPubMedCrossRef Baraniuk JN, Whalen G, Cunningham J, Clauw DJ (2004) Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain. BMC Musculoskelet Disord 5:48PubMedCentralPubMedCrossRef
321.
Zurück zum Zitat Vaeroy H, Nyberg F, Terenius L (1991) No evidence for endorphin deficiency in fibromyalgia following investigation of cerebrospinal fluid (CSF) dynorphin A and Met-enkephalin-Arg6-Phe7. Pain 46(2):139–43PubMedCrossRef Vaeroy H, Nyberg F, Terenius L (1991) No evidence for endorphin deficiency in fibromyalgia following investigation of cerebrospinal fluid (CSF) dynorphin A and Met-enkephalin-Arg6-Phe7. Pain 46(2):139–43PubMedCrossRef
322.
Zurück zum Zitat Liu Z, Welin M, Bragee B, Nyberg F (2000) A high-recovery extraction procedure for quantitative analysis of substance P and opioid peptides in human cerebrospinal fluid. Peptides 21(6):853–60PubMedCrossRef Liu Z, Welin M, Bragee B, Nyberg F (2000) A high-recovery extraction procedure for quantitative analysis of substance P and opioid peptides in human cerebrospinal fluid. Peptides 21(6):853–60PubMedCrossRef
323.
Zurück zum Zitat Jones GT, Nicholl BI, McBeth J, Davies KA, Morriss RK, Dickens C et al (2011) Role of road traffic accidents and other traumatic events in the onset of chronic widespread pain: results from a population-based prospective study. Arthritis Care Res 63(5):696–701CrossRef Jones GT, Nicholl BI, McBeth J, Davies KA, Morriss RK, Dickens C et al (2011) Role of road traffic accidents and other traumatic events in the onset of chronic widespread pain: results from a population-based prospective study. Arthritis Care Res 63(5):696–701CrossRef
324.
Zurück zum Zitat Wolfe F, Hauser W, Walitt BT, Katz RS, Rasker JJ, Russell AS (2014) Fibromyalgia and physical trauma: the concepts we invent. J Rheumatol 42(2):351 Wolfe F, Hauser W, Walitt BT, Katz RS, Rasker JJ, Russell AS (2014) Fibromyalgia and physical trauma: the concepts we invent. J Rheumatol 42(2):351
325.
Zurück zum Zitat Wingenfeld K, Wagner D, Schmidt I, Meinlschmidt G, Hellhammer DH, Heim C (2007) The low-dose dexamethasone suppression test in fibromyalgia. J Psychosom Res 62(1):85–91PubMedCrossRef Wingenfeld K, Wagner D, Schmidt I, Meinlschmidt G, Hellhammer DH, Heim C (2007) The low-dose dexamethasone suppression test in fibromyalgia. J Psychosom Res 62(1):85–91PubMedCrossRef
326.
Zurück zum Zitat Van Houdenhove B, Neerinckx E, Onghena P, Vingerhoets A, Lysens R, Vertommen H (2002) Daily hassles reported by chronic fatigue syndrome and fibromyalgia patients in tertiary care: a controlled quantitative and qualitative study. Psychother Psychosom 71(4):207–13PubMedCrossRef Van Houdenhove B, Neerinckx E, Onghena P, Vingerhoets A, Lysens R, Vertommen H (2002) Daily hassles reported by chronic fatigue syndrome and fibromyalgia patients in tertiary care: a controlled quantitative and qualitative study. Psychother Psychosom 71(4):207–13PubMedCrossRef
327.
Zurück zum Zitat Anderberg UM, Marteinsdottir I, Theorell T, von Knorring L (2000) The impact of life events in female patients with fibromyalgia and in female healthy controls. Eur Psychiatr 15(5):295–301CrossRef Anderberg UM, Marteinsdottir I, Theorell T, von Knorring L (2000) The impact of life events in female patients with fibromyalgia and in female healthy controls. Eur Psychiatr 15(5):295–301CrossRef
328.
Zurück zum Zitat Uveges JM, Parker JC, Smarr KL, McGowan JF, Lyon MG, Irvin WS et al (1990) Psychological symptoms in primary fibromyalgia syndrome: relationship to pain, life stress, and sleep disturbance. Arthritis Rheum 33(8):1279–83PubMedCrossRef Uveges JM, Parker JC, Smarr KL, McGowan JF, Lyon MG, Irvin WS et al (1990) Psychological symptoms in primary fibromyalgia syndrome: relationship to pain, life stress, and sleep disturbance. Arthritis Rheum 33(8):1279–83PubMedCrossRef
329.
Zurück zum Zitat Dailey PA, Bishop GD, Russell IJ, Fletcher EM (1990) Psychological stress and the fibrositis/fibromyalgia syndrome. J Rheumatol 17(10):1380–5PubMed Dailey PA, Bishop GD, Russell IJ, Fletcher EM (1990) Psychological stress and the fibrositis/fibromyalgia syndrome. J Rheumatol 17(10):1380–5PubMed
330.
Zurück zum Zitat Ahles TA, Yunus MB, Riley SD, Bradley JM, Masi AT (1984) Psychological factors associated with primary fibromyalgia syndrome. Arthritis Rheum 27(10):1101–6PubMedCrossRef Ahles TA, Yunus MB, Riley SD, Bradley JM, Masi AT (1984) Psychological factors associated with primary fibromyalgia syndrome. Arthritis Rheum 27(10):1101–6PubMedCrossRef
331.
Zurück zum Zitat Kivimäki M, Leino-Arjas P, Virtanen M, Elovainio M, Keltikangas-Järvinen L, Puttonen S et al (2004) Work stress and incidence of newly diagnosed fibromyalgia: prospective cohort study. J Psychosom Res 57(5):417–22PubMed Kivimäki M, Leino-Arjas P, Virtanen M, Elovainio M, Keltikangas-Järvinen L, Puttonen S et al (2004) Work stress and incidence of newly diagnosed fibromyalgia: prospective cohort study. J Psychosom Res 57(5):417–22PubMed
332.
Zurück zum Zitat Crofford LJ, Young EA, Engleberg NC, Korszun A, Brucksch CB, McClure LA et al (2004) Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome. Brain Behav Immun 18(4):314–25PubMedCrossRef Crofford LJ, Young EA, Engleberg NC, Korszun A, Brucksch CB, McClure LA et al (2004) Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome. Brain Behav Immun 18(4):314–25PubMedCrossRef
333.
Zurück zum Zitat Tak LM, Cleare AJ, Ormel J, Manoharan A, Kok IC, Wessely S et al (2011) Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders. Biol Psychol 87(2):183–94PubMedCrossRef Tak LM, Cleare AJ, Ormel J, Manoharan A, Kok IC, Wessely S et al (2011) Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders. Biol Psychol 87(2):183–94PubMedCrossRef
334.
Zurück zum Zitat Adler GK, Kinsley BT, Hurwitz S, Mossey CJ, Goldenberg DL (1999) Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med 106(5):534–43PubMedCrossRef Adler GK, Kinsley BT, Hurwitz S, Mossey CJ, Goldenberg DL (1999) Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med 106(5):534–43PubMedCrossRef
335.
Zurück zum Zitat Bote ME, García JJ, Hinchado MD, Ortega E (2012) Inflammatory/stress feedback dysregulation in women with fibromyalgia. Neuroimmunomodulation 19(6):343–51PubMedCrossRef Bote ME, García JJ, Hinchado MD, Ortega E (2012) Inflammatory/stress feedback dysregulation in women with fibromyalgia. Neuroimmunomodulation 19(6):343–51PubMedCrossRef
336.
Zurück zum Zitat Ferraccioli G, Cavalieri F, Salaffi F, Fontana S, Scita F, Nolli M et al (1990) Neuroendocrinologic findings in primary fibromyalgia (soft tissue chronic pain syndrome) and in other chronic rheumatic conditions (rheumatoid arthritis, low back pain). J Rheumatol 17(7):869–73PubMed Ferraccioli G, Cavalieri F, Salaffi F, Fontana S, Scita F, Nolli M et al (1990) Neuroendocrinologic findings in primary fibromyalgia (soft tissue chronic pain syndrome) and in other chronic rheumatic conditions (rheumatoid arthritis, low back pain). J Rheumatol 17(7):869–73PubMed
337.
Zurück zum Zitat Gur A, Cevik R, Sarac AJ, Colpan L, Em S (2004) Hypothalamic-pituitary-gonadal axis and cortisol in young women with primary fibromyalgia: the potential roles of depression, fatigue, and sleep disturbance in the occurrence of hypocortisolism. Ann Rheum Dis 63(11):1504–6PubMedCentralPubMedCrossRef Gur A, Cevik R, Sarac AJ, Colpan L, Em S (2004) Hypothalamic-pituitary-gonadal axis and cortisol in young women with primary fibromyalgia: the potential roles of depression, fatigue, and sleep disturbance in the occurrence of hypocortisolism. Ann Rheum Dis 63(11):1504–6PubMedCentralPubMedCrossRef
338.
Zurück zum Zitat Lentjes EG, Griep EN, Boersma JW, Romijn FP, de Kloet ER (1997) Glucocorticoid receptors, fibromyalgia and low back pain. Psychoneuroendocrinology 22(8):603–14PubMedCrossRef Lentjes EG, Griep EN, Boersma JW, Romijn FP, de Kloet ER (1997) Glucocorticoid receptors, fibromyalgia and low back pain. Psychoneuroendocrinology 22(8):603–14PubMedCrossRef
339.
Zurück zum Zitat Wingenfeld K, Heim C, Schmidt I, Wagner D, Meinlschmidt G, Hellhammer DH (2008) HPA axis reactivity and lymphocyte glucocorticoid sensitivity in fibromyalgia syndrome and chronic pelvic pain. Psychosom Med 70(1):65–72PubMedCrossRef Wingenfeld K, Heim C, Schmidt I, Wagner D, Meinlschmidt G, Hellhammer DH (2008) HPA axis reactivity and lymphocyte glucocorticoid sensitivity in fibromyalgia syndrome and chronic pelvic pain. Psychosom Med 70(1):65–72PubMedCrossRef
340.
Zurück zum Zitat Geiss A, Rohleder N, Anton F (2012) Evidence for an association between an enhanced reactivity of interleukin-6 levels and reduced glucocorticoid sensitivity in patients with fibromyalgia. Psychoneuroendocrinology 37(5):671–84PubMedCrossRef Geiss A, Rohleder N, Anton F (2012) Evidence for an association between an enhanced reactivity of interleukin-6 levels and reduced glucocorticoid sensitivity in patients with fibromyalgia. Psychoneuroendocrinology 37(5):671–84PubMedCrossRef
341.
Zurück zum Zitat Wingenfeld K, Nutzinger D, Kauth J, Hellhammer DH, Lautenbacher S (2010) Salivary cortisol release and hypothalamic pituitary adrenal axis feedback sensitivity in fibromyalgia is associated with depression but not with pain. J Pain 11(11):1195–202PubMedCrossRef Wingenfeld K, Nutzinger D, Kauth J, Hellhammer DH, Lautenbacher S (2010) Salivary cortisol release and hypothalamic pituitary adrenal axis feedback sensitivity in fibromyalgia is associated with depression but not with pain. J Pain 11(11):1195–202PubMedCrossRef
342.
Zurück zum Zitat Klingmann PO, Kugler I, Steffke TS, Bellingrath S, Kudielka BM, Hellhammer DH (2008) Sex-specific prenatal programming: a risk for fibromyalgia? Ann N Y Acad Sci 1148:446–55PubMedCrossRef Klingmann PO, Kugler I, Steffke TS, Bellingrath S, Kudielka BM, Hellhammer DH (2008) Sex-specific prenatal programming: a risk for fibromyalgia? Ann N Y Acad Sci 1148:446–55PubMedCrossRef
343.
Zurück zum Zitat Riva R, Mork PJ, Westgaard RH, Lundberg U (2012) Comparison of the cortisol awakening response in women with shoulder and neck pain and women with fibromyalgia. Psychoneuroendocrinology 37(2):299–306PubMedCrossRef Riva R, Mork PJ, Westgaard RH, Lundberg U (2012) Comparison of the cortisol awakening response in women with shoulder and neck pain and women with fibromyalgia. Psychoneuroendocrinology 37(2):299–306PubMedCrossRef
344.
Zurück zum Zitat Griep EN, Boersma JW, Lentjes EG, Prins AP, van der Korst JK, de Kloet ER (1998) Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain. J Rheumatol 25(7):1374–81PubMed Griep EN, Boersma JW, Lentjes EG, Prins AP, van der Korst JK, de Kloet ER (1998) Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain. J Rheumatol 25(7):1374–81PubMed
345.
Zurück zum Zitat Macedo JA, Hesse J, Turner JD, Meyer J, Hellhammer DH, Muller CP (2008) Glucocorticoid sensitivity in fibromyalgia patients: decreased expression of corticosteroid receptors and glucocorticoid-induced leucine zipper. Psychoneuroendocrinology 33(6):799–809PubMedCrossRef Macedo JA, Hesse J, Turner JD, Meyer J, Hellhammer DH, Muller CP (2008) Glucocorticoid sensitivity in fibromyalgia patients: decreased expression of corticosteroid receptors and glucocorticoid-induced leucine zipper. Psychoneuroendocrinology 33(6):799–809PubMedCrossRef
346.
Zurück zum Zitat Crofford LJ, Pillemer SR, Kalogeras KT, Cash JM, Michelson D, Kling MA et al (1994) Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 37(11):1583–92PubMedCrossRef Crofford LJ, Pillemer SR, Kalogeras KT, Cash JM, Michelson D, Kling MA et al (1994) Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 37(11):1583–92PubMedCrossRef
347.
Zurück zum Zitat McCain GA, Tilbe KS (1989) Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. J Rheumatol Suppl 19:154–7PubMed McCain GA, Tilbe KS (1989) Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. J Rheumatol Suppl 19:154–7PubMed
348.
Zurück zum Zitat Maes M, Lin A, Bonaccorso S, van Hunsel F, Van Gastel A, Delmeire L et al (1998) Increased 24 hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia. Acta Psychiatr Scand 98(4):328–35PubMedCrossRef Maes M, Lin A, Bonaccorso S, van Hunsel F, Van Gastel A, Delmeire L et al (1998) Increased 24 hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia. Acta Psychiatr Scand 98(4):328–35PubMedCrossRef
349.
Zurück zum Zitat McCall-Hosenfeld JS, Goldenberg DL, Hurwitz S, Adler GK (2003) Growth hormone and insulin-like growth factor-1 concentrations in women with fibromyalgia. J Rheumatol 30(4):809–14PubMed McCall-Hosenfeld JS, Goldenberg DL, Hurwitz S, Adler GK (2003) Growth hormone and insulin-like growth factor-1 concentrations in women with fibromyalgia. J Rheumatol 30(4):809–14PubMed
350.
Zurück zum Zitat Riedel W, Schlapp U, Leck S, Netter P, Neeck G (2002) Blunted ACTH and cortisol responses to systemic injection of corticotropin-releasing hormone (CRH) in fibromyalgia: role of somatostatin and CRH-binding protein. Ann N Y Acad Sci 966:483–90PubMedCrossRef Riedel W, Schlapp U, Leck S, Netter P, Neeck G (2002) Blunted ACTH and cortisol responses to systemic injection of corticotropin-releasing hormone (CRH) in fibromyalgia: role of somatostatin and CRH-binding protein. Ann N Y Acad Sci 966:483–90PubMedCrossRef
351.
Zurück zum Zitat Torpy DJ, Papanicolaou DA, Lotsikas AJ, Wilder RL, Chrousos GP, Pillemer SR (2000) Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia. Arthritis Rheum 43(4):872–80PubMedCrossRef Torpy DJ, Papanicolaou DA, Lotsikas AJ, Wilder RL, Chrousos GP, Pillemer SR (2000) Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia. Arthritis Rheum 43(4):872–80PubMedCrossRef
352.
Zurück zum Zitat Gürsel Y, Ergin S, Ulus Y, Erdogan MF, Yalcin P, Evcik D (2001) Hormonal responses to exercise stress test in patients with fibromyalgia syndrome. Clin Rheumatol 20(6):401–5PubMedCrossRef Gürsel Y, Ergin S, Ulus Y, Erdogan MF, Yalcin P, Evcik D (2001) Hormonal responses to exercise stress test in patients with fibromyalgia syndrome. Clin Rheumatol 20(6):401–5PubMedCrossRef
353.
Zurück zum Zitat Griep EN, Boersma JW, de Kloet ER (1993) Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 20(3):469–74PubMed Griep EN, Boersma JW, de Kloet ER (1993) Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 20(3):469–74PubMed
354.
Zurück zum Zitat Catley D, Kaell AT, Kirschbaum C, Stone AA (2000) A naturalistic evaluation of cortisol secretion in persons with fibromyalgia and rheumatoid arthritis. Arthritis Care Res 13(1):51–61PubMedCrossRef Catley D, Kaell AT, Kirschbaum C, Stone AA (2000) A naturalistic evaluation of cortisol secretion in persons with fibromyalgia and rheumatoid arthritis. Arthritis Care Res 13(1):51–61PubMedCrossRef
355.
Zurück zum Zitat McLean SA, Williams DA, Harris RE, Kop WJ, Groner KH, Ambrose K et al (2005) Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia. Arthritis Rheum 52(11):3660–9PubMedCrossRef McLean SA, Williams DA, Harris RE, Kop WJ, Groner KH, Ambrose K et al (2005) Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia. Arthritis Rheum 52(11):3660–9PubMedCrossRef
356.
Zurück zum Zitat Weissbecker I, Floyd A, Dedert E, Salmon P, Sephton S (2006) Childhood trauma and diurnal cortisol disruption in fibromyalgia syndrome. Psychoneuroendocrinology 31(3):312–24PubMedCrossRef Weissbecker I, Floyd A, Dedert E, Salmon P, Sephton S (2006) Childhood trauma and diurnal cortisol disruption in fibromyalgia syndrome. Psychoneuroendocrinology 31(3):312–24PubMedCrossRef
357.
Zurück zum Zitat Ataoglu S, Ozcetin A, Yildiz O, Ataoglu A (2003) Evaluation of dexamethasone suppression test in fibromyalgia patients with or without depression. Swiss Med Wkly 133(15–16):241–4PubMed Ataoglu S, Ozcetin A, Yildiz O, Ataoglu A (2003) Evaluation of dexamethasone suppression test in fibromyalgia patients with or without depression. Swiss Med Wkly 133(15–16):241–4PubMed
358.
Zurück zum Zitat Handwerger K (2009) Differential patterns of HPA activity and reactivity in adult posttraumatic stress disorder and major depressive disorder. Harv Rev Psychiatr 17(3):184–205CrossRef Handwerger K (2009) Differential patterns of HPA activity and reactivity in adult posttraumatic stress disorder and major depressive disorder. Harv Rev Psychiatr 17(3):184–205CrossRef
359.
Zurück zum Zitat Morris MC, Compas BE, Garber J (2012) Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: a systematic review and meta-analysis. Clin Psychol Rev 32(4):301–15PubMedCentralPubMedCrossRef Morris MC, Compas BE, Garber J (2012) Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: a systematic review and meta-analysis. Clin Psychol Rev 32(4):301–15PubMedCentralPubMedCrossRef
360.
Zurück zum Zitat Riedel W, Layka H, Neeck G (1998) Secretory pattern of GH, TSH, thyroid hormones, ACTH, cortisol, FSH, and LH in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic-releasing hormones. Z Rheumatol 57(Suppl 2):81–7PubMedCrossRef Riedel W, Layka H, Neeck G (1998) Secretory pattern of GH, TSH, thyroid hormones, ACTH, cortisol, FSH, and LH in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic-releasing hormones. Z Rheumatol 57(Suppl 2):81–7PubMedCrossRef
361.
Zurück zum Zitat Meeus M, Goubert D, De Backer F, Struyf F, Hermans L, Coppieters I et al (2013) Heart rate variability in patients with fibromyalgia and patients with chronic fatigue syndrome: a systematic review. Semin Arthritis Rheum 43(2):279–87PubMedCrossRef Meeus M, Goubert D, De Backer F, Struyf F, Hermans L, Coppieters I et al (2013) Heart rate variability in patients with fibromyalgia and patients with chronic fatigue syndrome: a systematic review. Semin Arthritis Rheum 43(2):279–87PubMedCrossRef
362.
Zurück zum Zitat Lowry CA (2002) Functional subsets of serotonergic neurones: implications for control of the hypothalamic-pituitary-adrenal axis. J Neuroendocrinol 14(11):911–23PubMedCrossRef Lowry CA (2002) Functional subsets of serotonergic neurones: implications for control of the hypothalamic-pituitary-adrenal axis. J Neuroendocrinol 14(11):911–23PubMedCrossRef
363.
Zurück zum Zitat Calis M, Gökçe C, Ates F, Ülker S, Izgi HB, Demir H et al (2004) Investigation of the hypothalamo-pituitary-adrenal axis (HPA) by 1 μg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome. J Endocrinol Investig 27(1):42–6CrossRef Calis M, Gökçe C, Ates F, Ülker S, Izgi HB, Demir H et al (2004) Investigation of the hypothalamo-pituitary-adrenal axis (HPA) by 1 μg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome. J Endocrinol Investig 27(1):42–6CrossRef
364.
Zurück zum Zitat Kirnap M, Çolak R, Eser C, Özsoy O, Tutus A, Kelestimur F (2001) A comparison between low-dose (1 μg), standard-dose (250 μg) ACTH stimulation tests and insulin tolerance test in the evaluation of hypothalamo-pituitary-adrenal axis in primary fibromyalgia syndrome. Clin Endocrinol (Oxf) 55(4):455–9CrossRef Kirnap M, Çolak R, Eser C, Özsoy O, Tutus A, Kelestimur F (2001) A comparison between low-dose (1 μg), standard-dose (250 μg) ACTH stimulation tests and insulin tolerance test in the evaluation of hypothalamo-pituitary-adrenal axis in primary fibromyalgia syndrome. Clin Endocrinol (Oxf) 55(4):455–9CrossRef
365.
Zurück zum Zitat Aschbacher K, Adam EK, Crofford LJ, Kemeny ME, Demitrack MA, Ben-Zvi A (2012) Linking disease symptoms and subtypes with personalized systems-based phenotypes: a proof of concept study. Brain Behav Immun 26(7):1047–56PubMedCentralPubMedCrossRef Aschbacher K, Adam EK, Crofford LJ, Kemeny ME, Demitrack MA, Ben-Zvi A (2012) Linking disease symptoms and subtypes with personalized systems-based phenotypes: a proof of concept study. Brain Behav Immun 26(7):1047–56PubMedCentralPubMedCrossRef
366.
Zurück zum Zitat Petzke F, Clauw DJ (2000) Sympathetic nervous system function in fibromyalgia. Curr Rheumatol Rep 2(2):116–23PubMedCrossRef Petzke F, Clauw DJ (2000) Sympathetic nervous system function in fibromyalgia. Curr Rheumatol Rep 2(2):116–23PubMedCrossRef
367.
Zurück zum Zitat Nilsen KB, Sand T, Westgaard RH, Stovner LJ, White LR, Bang Leistad R et al (2007) Autonomic activation and pain in response to low-grade mental stress in fibromyalgia and shoulder/neck pain patients. Eur J Pain 11(7):743–55PubMedCrossRef Nilsen KB, Sand T, Westgaard RH, Stovner LJ, White LR, Bang Leistad R et al (2007) Autonomic activation and pain in response to low-grade mental stress in fibromyalgia and shoulder/neck pain patients. Eur J Pain 11(7):743–55PubMedCrossRef
368.
Zurück zum Zitat Giske L, Vollestad NK, Mengshoel AM, Jensen J, Knardahl S, Roe C (2008) Attenuated adrenergic responses to exercise in women with fibromyalgia—a controlled study. Eur J Pain 12(3):351–60PubMedCrossRef Giske L, Vollestad NK, Mengshoel AM, Jensen J, Knardahl S, Roe C (2008) Attenuated adrenergic responses to exercise in women with fibromyalgia—a controlled study. Eur J Pain 12(3):351–60PubMedCrossRef
369.
Zurück zum Zitat Loevinger BL, Muller D, Alonso C, Coe CL (2007) Metabolic syndrome in women with chronic pain. Metabolism 56(1):87–93PubMedCrossRef Loevinger BL, Muller D, Alonso C, Coe CL (2007) Metabolic syndrome in women with chronic pain. Metabolism 56(1):87–93PubMedCrossRef
370.
Zurück zum Zitat Furlan R, Colombo S, Perego F, Atzeni F, Diana A, Barbic F et al (2005) Abnormalities of cardiovascular neural control and reduced orthostatic tolerance in patients with primary fibromyalgia. J Rheumatol 32(9):1787–93PubMed Furlan R, Colombo S, Perego F, Atzeni F, Diana A, Barbic F et al (2005) Abnormalities of cardiovascular neural control and reduced orthostatic tolerance in patients with primary fibromyalgia. J Rheumatol 32(9):1787–93PubMed
371.
Zurück zum Zitat Light KC, Bragdon EE, Grewen KM, Brownley KA, Girdler SS, Maixner W (2009) Adrenergic dysregulation and pain with and without acute beta-blockade in women with fibromyalgia and temporomandibular disorder. J Pain 10(5):542–52PubMedCentralPubMedCrossRef Light KC, Bragdon EE, Grewen KM, Brownley KA, Girdler SS, Maixner W (2009) Adrenergic dysregulation and pain with and without acute beta-blockade in women with fibromyalgia and temporomandibular disorder. J Pain 10(5):542–52PubMedCentralPubMedCrossRef
372.
Zurück zum Zitat Riva R, Mork PJ, Westgaard RH, Okkenhaug Johansen T, Lundberg U (2012) Catecholamines and heart rate in female fibromyalgia patients. J Psychosom Res 72(1):51–7PubMedCrossRef Riva R, Mork PJ, Westgaard RH, Okkenhaug Johansen T, Lundberg U (2012) Catecholamines and heart rate in female fibromyalgia patients. J Psychosom Res 72(1):51–7PubMedCrossRef
373.
Zurück zum Zitat Kadetoff D, Kosek E (2010) Evidence of reduced sympatho-adrenal and hypothalamic-pituitary activity during static muscular work in patients with fibromyalgia. J Rehabil Med 42(8):765–72PubMedCrossRef Kadetoff D, Kosek E (2010) Evidence of reduced sympatho-adrenal and hypothalamic-pituitary activity during static muscular work in patients with fibromyalgia. J Rehabil Med 42(8):765–72PubMedCrossRef
374.
Zurück zum Zitat Di Franco M, Iannuccelli C, Alessandri C, Paradiso M, Riccieri V, Libri F et al (2009) Autonomic dysfunction and neuropeptide Y in fibromyalgia. Clin Exp Rheumatol 27(5 Suppl 56):S75–8PubMed Di Franco M, Iannuccelli C, Alessandri C, Paradiso M, Riccieri V, Libri F et al (2009) Autonomic dysfunction and neuropeptide Y in fibromyalgia. Clin Exp Rheumatol 27(5 Suppl 56):S75–8PubMed
375.
Zurück zum Zitat Anderberg UM, Liu Z, Berglund L, Nyberg F (1999) Elevated plasma levels of neuropeptide Y in female fibromyalgia patients. Eur J Pain 3(1):19–30PubMedCrossRef Anderberg UM, Liu Z, Berglund L, Nyberg F (1999) Elevated plasma levels of neuropeptide Y in female fibromyalgia patients. Eur J Pain 3(1):19–30PubMedCrossRef
376.
Zurück zum Zitat van Denderen JC, Boersma JW, Zeinstra P, Hollander AP, van Neerbos BR (1992) Physiological effects of exhaustive physical exercise in primary fibromyalgia syndrome (PFS): is PFS a disorder of neuroendocrine reactivity? Scand J Rheumatol 21(1):35–7PubMedCrossRef van Denderen JC, Boersma JW, Zeinstra P, Hollander AP, van Neerbos BR (1992) Physiological effects of exhaustive physical exercise in primary fibromyalgia syndrome (PFS): is PFS a disorder of neuroendocrine reactivity? Scand J Rheumatol 21(1):35–7PubMedCrossRef
377.
Zurück zum Zitat Stein PK, Domitrovich PP, Ambrose K, Lyden A, Fine M, Gracely RH et al (2004) Sex effects on heart rate variability in fibromyalgia and Gulf War illness. Arthritis Rheum 51(5):700–8PubMedCrossRef Stein PK, Domitrovich PP, Ambrose K, Lyden A, Fine M, Gracely RH et al (2004) Sex effects on heart rate variability in fibromyalgia and Gulf War illness. Arthritis Rheum 51(5):700–8PubMedCrossRef
378.
Zurück zum Zitat Shaffer F, McCraty R, Zerr CL (2014) A healthy heart is not a metronome: an integrative review of the heart’s anatomy and heart rate variability. Front Psychol 5:1040PubMedCentralPubMedCrossRef Shaffer F, McCraty R, Zerr CL (2014) A healthy heart is not a metronome: an integrative review of the heart’s anatomy and heart rate variability. Front Psychol 5:1040PubMedCentralPubMedCrossRef
379.
Zurück zum Zitat Reyes del Paso GA, Langewitz W, Mulder LJ, van Roon A, Duschek S (2013) The utility of low frequency heart rate variability as an index of sympathetic cardiac tone: a review with emphasis on a reanalysis of previous studies. Psychophysiology 50(5):477–87PubMedCrossRef Reyes del Paso GA, Langewitz W, Mulder LJ, van Roon A, Duschek S (2013) The utility of low frequency heart rate variability as an index of sympathetic cardiac tone: a review with emphasis on a reanalysis of previous studies. Psychophysiology 50(5):477–87PubMedCrossRef
380.
Zurück zum Zitat Tak LM, Riese H, de Bock GH, Manoharan A, Kok IC, Rosmalen JG (2009) As good as it gets? A meta-analysis and systematic review of methodological quality of heart rate variability studies in functional somatic disorders. Biol Psychol 82(2):101–10PubMedCrossRef Tak LM, Riese H, de Bock GH, Manoharan A, Kok IC, Rosmalen JG (2009) As good as it gets? A meta-analysis and systematic review of methodological quality of heart rate variability studies in functional somatic disorders. Biol Psychol 82(2):101–10PubMedCrossRef
381.
Zurück zum Zitat da Cunha Ribeiro RP, Roschel H, Artioli GG, Dassouki T, Perandini LA, Calich AL et al (2011) Cardiac autonomic impairment and chronotropic incompetence in fibromyalgia. Arthritis Res Ther 13(6):R190PubMedCentralPubMedCrossRef da Cunha Ribeiro RP, Roschel H, Artioli GG, Dassouki T, Perandini LA, Calich AL et al (2011) Cardiac autonomic impairment and chronotropic incompetence in fibromyalgia. Arthritis Res Ther 13(6):R190PubMedCentralPubMedCrossRef
382.
Zurück zum Zitat Kadetoff D, Kosek E (2007) The effects of static muscular contraction on blood pressure, heart rate, pain ratings and pressure pain thresholds in healthy individuals and patients with fibromyalgia. Eur J Pain 11(1):39–47PubMedCrossRef Kadetoff D, Kosek E (2007) The effects of static muscular contraction on blood pressure, heart rate, pain ratings and pressure pain thresholds in healthy individuals and patients with fibromyalgia. Eur J Pain 11(1):39–47PubMedCrossRef
383.
Zurück zum Zitat Kingsley JD, Panton LB, McMillan V, Figueroa A (2009) Cardiovascular autonomic modulation after acute resistance exercise in women with fibromyalgia. Arch Phys Med Rehabil 90(9):1628–34PubMedCrossRef Kingsley JD, Panton LB, McMillan V, Figueroa A (2009) Cardiovascular autonomic modulation after acute resistance exercise in women with fibromyalgia. Arch Phys Med Rehabil 90(9):1628–34PubMedCrossRef
384.
Zurück zum Zitat Reyes Del Paso GA, Garrido S, Pulgar A, Martin-Vazquez M, Duschek S (2010) Aberrances in autonomic cardiovascular regulation in fibromyalgia syndrome and their relevance for clinical pain reports. Psychosom Med 72(5):462–70PubMedCrossRef Reyes Del Paso GA, Garrido S, Pulgar A, Martin-Vazquez M, Duschek S (2010) Aberrances in autonomic cardiovascular regulation in fibromyalgia syndrome and their relevance for clinical pain reports. Psychosom Med 72(5):462–70PubMedCrossRef
385.
Zurück zum Zitat Maekawa K, Clark GT, Kuboki T (2002) Intramuscular hypoperfusion, adrenergic receptors, and chronic muscle pain. J Pain 3(4):251–60PubMedCrossRef Maekawa K, Clark GT, Kuboki T (2002) Intramuscular hypoperfusion, adrenergic receptors, and chronic muscle pain. J Pain 3(4):251–60PubMedCrossRef
386.
Zurück zum Zitat Jeschonneck M, Grohmann G, Hein G, Sprott H (2000) Abnormal microcirculation and temperature in skin above tender points in patients with fibromyalgia. Rheumatology (Oxford) 39(8):917–21CrossRef Jeschonneck M, Grohmann G, Hein G, Sprott H (2000) Abnormal microcirculation and temperature in skin above tender points in patients with fibromyalgia. Rheumatology (Oxford) 39(8):917–21CrossRef
387.
Zurück zum Zitat Morf S, Amann-Vesti B, Forster A, Franzeck UK, Koppensteiner R, Uebelhart D et al (2005) Microcirculation abnormalities in patients with fibromyalgia—measured by capillary microscopy and laser fluxmetry. Arthritis Res Ther 7(2):R209–16PubMedCentralPubMedCrossRef Morf S, Amann-Vesti B, Forster A, Franzeck UK, Koppensteiner R, Uebelhart D et al (2005) Microcirculation abnormalities in patients with fibromyalgia—measured by capillary microscopy and laser fluxmetry. Arthritis Res Ther 7(2):R209–16PubMedCentralPubMedCrossRef
388.
Zurück zum Zitat Elam M, Johansson G, Wallin BG (1992) Do patients with primary fibromyalgia have an altered muscle sympathetic nerve activity? Pain 48(3):371–5PubMedCrossRef Elam M, Johansson G, Wallin BG (1992) Do patients with primary fibromyalgia have an altered muscle sympathetic nerve activity? Pain 48(3):371–5PubMedCrossRef
389.
Zurück zum Zitat Cuatrecasas G, Gonzalez MJ, Alegre C, Sesmilo G, Fernandez-Solà J, Casanueva FF et al (2010) High prevalence of growth hormone deficiency in severe fibromyalgia syndromes. J Clin Endocrinol Metab 95(9):4331–7PubMedCrossRef Cuatrecasas G, Gonzalez MJ, Alegre C, Sesmilo G, Fernandez-Solà J, Casanueva FF et al (2010) High prevalence of growth hormone deficiency in severe fibromyalgia syndromes. J Clin Endocrinol Metab 95(9):4331–7PubMedCrossRef
390.
Zurück zum Zitat Ross RL, Jones KD, Bennett RM, Ward RL, Druker BJ, Wood LJ (2010) Preliminary evidence of increased pain and elevated cytokines in fibromyalgia patients with defective growth hormone response to exercise. Open Immunol J 3:9–18PubMedCentralPubMedCrossRef Ross RL, Jones KD, Bennett RM, Ward RL, Druker BJ, Wood LJ (2010) Preliminary evidence of increased pain and elevated cytokines in fibromyalgia patients with defective growth hormone response to exercise. Open Immunol J 3:9–18PubMedCentralPubMedCrossRef
391.
Zurück zum Zitat Bennett RM, Cook DM, Clark SR, Burckhardt CS, Campbell SM (1997) Hypothalamic-pituitary-insulin-like growth factor-I axis dysfunction in patients with fibromyalgia. J Rheumatol 24(7):1384–9PubMed Bennett RM, Cook DM, Clark SR, Burckhardt CS, Campbell SM (1997) Hypothalamic-pituitary-insulin-like growth factor-I axis dysfunction in patients with fibromyalgia. J Rheumatol 24(7):1384–9PubMed
392.
Zurück zum Zitat Leal-Cerro A, Povedano J, Astorga R, Gonzalez M, Silva H, Garcia-Pesquera F et al (1999) The growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-1 axis in patients with fibromyalgia syndrome. J Clin Endocrinol Metab 84(9):3378–81PubMed Leal-Cerro A, Povedano J, Astorga R, Gonzalez M, Silva H, Garcia-Pesquera F et al (1999) The growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-1 axis in patients with fibromyalgia syndrome. J Clin Endocrinol Metab 84(9):3378–81PubMed
393.
Zurück zum Zitat Paiva ES, Deodhar A, Jones KD, Bennett R (2002) Impaired growth hormone secretion in fibromyalgia patients: evidence for augmented hypothalamic somatostatin tone. Arthritis Rheum 46(5):1344–50PubMedCrossRef Paiva ES, Deodhar A, Jones KD, Bennett R (2002) Impaired growth hormone secretion in fibromyalgia patients: evidence for augmented hypothalamic somatostatin tone. Arthritis Rheum 46(5):1344–50PubMedCrossRef
394.
Zurück zum Zitat Sarchielli P, Alberti A, Candeliere A, Floridi A, Capocchi G, Calabresi P (2006) Glial cell line-derived neurotrophic factor and somatostatin levels in cerebrospinal fluid of patients affected by chronic migraine and fibromyalgia. Cephalalgia 26(4):409–15PubMedCrossRef Sarchielli P, Alberti A, Candeliere A, Floridi A, Capocchi G, Calabresi P (2006) Glial cell line-derived neurotrophic factor and somatostatin levels in cerebrospinal fluid of patients affected by chronic migraine and fibromyalgia. Cephalalgia 26(4):409–15PubMedCrossRef
395.
Zurück zum Zitat Cuatrecasas G, Alegre C, Fernandez-Sola J, Gonzalez MJ, Garcia-Fructuoso F, Poca-Dias V et al (2012) Growth hormone treatment for sustained pain reduction and improvement in quality of life in severe fibromyalgia. Pain 153(7):1382–9PubMedCrossRef Cuatrecasas G, Alegre C, Fernandez-Sola J, Gonzalez MJ, Garcia-Fructuoso F, Poca-Dias V et al (2012) Growth hormone treatment for sustained pain reduction and improvement in quality of life in severe fibromyalgia. Pain 153(7):1382–9PubMedCrossRef
397.
Zurück zum Zitat Turk DC, Okifuji A, Starz TW, Sinclair JD (1996) Effects of type of symptom onset on psychological distress and disability in fibromyalgia syndrome patients. Pain 68(2–3):423–30PubMedCrossRef Turk DC, Okifuji A, Starz TW, Sinclair JD (1996) Effects of type of symptom onset on psychological distress and disability in fibromyalgia syndrome patients. Pain 68(2–3):423–30PubMedCrossRef
398.
Zurück zum Zitat Greenfield S, Fitzcharles MA, Esdaile JM (1992) Reactive fibromyalgia syndrome. Arthritis Rheum 35(6):678–81PubMedCrossRef Greenfield S, Fitzcharles MA, Esdaile JM (1992) Reactive fibromyalgia syndrome. Arthritis Rheum 35(6):678–81PubMedCrossRef
399.
Zurück zum Zitat Ledingham J, Doherty S, Doherty M (1993) Primary fibromyalgia syndrome—an outcome study. Br J Rheumatol 32(2):139–42PubMedCrossRef Ledingham J, Doherty S, Doherty M (1993) Primary fibromyalgia syndrome—an outcome study. Br J Rheumatol 32(2):139–42PubMedCrossRef
400.
Zurück zum Zitat Buchwald D, Goldenberg DL, Sullivan JL, Komaroff AL (1987) The “chronic, active Epstein-Barr virus infection” syndrome and primary fibromyalgia. Arthritis Rheum 30(10):1132–6PubMedCrossRef Buchwald D, Goldenberg DL, Sullivan JL, Komaroff AL (1987) The “chronic, active Epstein-Barr virus infection” syndrome and primary fibromyalgia. Arthritis Rheum 30(10):1132–6PubMedCrossRef
401.
Zurück zum Zitat Cassisi G, Sarzi-Puttini P, Cazzola M (2011) Chronic widespread pain and fibromyalgia: could there be some relationships with infections and vaccinations? Clin Exp Rheumatol 29(6 Suppl 69):S118–26PubMed Cassisi G, Sarzi-Puttini P, Cazzola M (2011) Chronic widespread pain and fibromyalgia: could there be some relationships with infections and vaccinations? Clin Exp Rheumatol 29(6 Suppl 69):S118–26PubMed
402.
Zurück zum Zitat Ozsahin M, Gonen I, Ermis F, Oktay M, Besir FH, Kutlucan A et al (2013) The prevalence of fibromyalgia among patients with hepatitis B virus infection. Int J Clin Exp Med 6(9):804–8PubMedCentralPubMed Ozsahin M, Gonen I, Ermis F, Oktay M, Besir FH, Kutlucan A et al (2013) The prevalence of fibromyalgia among patients with hepatitis B virus infection. Int J Clin Exp Med 6(9):804–8PubMedCentralPubMed
403.
Zurück zum Zitat Mohammad A, Carey JJ, Storan E, Scarry M, Coughlan RJ, Lee JM (2012) Prevalence of fibromyalgia among patients with chronic hepatitis C infection: relationship to viral characteristics and quality of life. J Clin Gastroenterol 46(5):407–12PubMedCrossRef Mohammad A, Carey JJ, Storan E, Scarry M, Coughlan RJ, Lee JM (2012) Prevalence of fibromyalgia among patients with chronic hepatitis C infection: relationship to viral characteristics and quality of life. J Clin Gastroenterol 46(5):407–12PubMedCrossRef
404.
Zurück zum Zitat Akkaya N, Akkaya S, Polat Y, Turk M, Turk T, Turhal E et al (2011) Helicobacter pylori seropositivity in fibromyalgia syndrome. Clin Rheumatol 30(1):43–9PubMedCrossRef Akkaya N, Akkaya S, Polat Y, Turk M, Turk T, Turhal E et al (2011) Helicobacter pylori seropositivity in fibromyalgia syndrome. Clin Rheumatol 30(1):43–9PubMedCrossRef
405.
Zurück zum Zitat Wormser GP, Weitzner E, McKenna D, Nadelman RB, Scavarda C, Farber S et al (2014) Long-term assessment of fibromyalgia in patients with culture-confirmed Lyme disease. Arthritis Rheumatol. doi:10.1002/art.38972 PubMedCentral Wormser GP, Weitzner E, McKenna D, Nadelman RB, Scavarda C, Farber S et al (2014) Long-term assessment of fibromyalgia in patients with culture-confirmed Lyme disease. Arthritis Rheumatol. doi:10.​1002/​art.​38972 PubMedCentral
406.
Zurück zum Zitat Kole AK, Roy R, Kole DC (2013) Musculoskeletal and rheumatological disorders in HIV infection: experience in a tertiary referral center. Indian J Sex Transm Dis 34(2):107–12PubMedCentralPubMedCrossRef Kole AK, Roy R, Kole DC (2013) Musculoskeletal and rheumatological disorders in HIV infection: experience in a tertiary referral center. Indian J Sex Transm Dis 34(2):107–12PubMedCentralPubMedCrossRef
407.
Zurück zum Zitat Narvaez J, Nolla JM, Valverde J (2005) No serological evidence that fibromyalgia is linked with exposure to human parvovirus B19. Joint Bone Spine 72(6):592–4PubMedCrossRef Narvaez J, Nolla JM, Valverde J (2005) No serological evidence that fibromyalgia is linked with exposure to human parvovirus B19. Joint Bone Spine 72(6):592–4PubMedCrossRef
408.
Zurück zum Zitat Kim YK, Maes M (2003) The role of the cytokine network in psychological stress. Acta Neuropsychiatrica 15:143–55, Blackwell Munksgaard Kim YK, Maes M (2003) The role of the cytokine network in psychological stress. Acta Neuropsychiatrica 15:143–55, Blackwell Munksgaard
409.
Zurück zum Zitat Rohleder N, Aringer M, Boentert M (2012) Role of interleukin-6 in stress, sleep, and fatigue. Ann N Y Acad Sci 1261:88–96PubMedCrossRef Rohleder N, Aringer M, Boentert M (2012) Role of interleukin-6 in stress, sleep, and fatigue. Ann N Y Acad Sci 1261:88–96PubMedCrossRef
410.
Zurück zum Zitat Marshall GD Jr (2011) The adverse effects of psychological stress on immunoregulatory balance: applications to human inflammatory diseases. Immunol Allergy Clin N Am 31(1):133–40CrossRef Marshall GD Jr (2011) The adverse effects of psychological stress on immunoregulatory balance: applications to human inflammatory diseases. Immunol Allergy Clin N Am 31(1):133–40CrossRef
411.
Zurück zum Zitat Haack M, Sanchez E, Mullington JM (2007) Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep 30(9):1145–52PubMedCentralPubMed Haack M, Sanchez E, Mullington JM (2007) Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep 30(9):1145–52PubMedCentralPubMed
412.
Zurück zum Zitat Weschenfelder J, Sander C, Kluge M, Kirkby KC, Himmerich H (2012) The influence of cytokines on wakefulness regulation: clinical relevance, mechanisms and methodological problems. Psychiatr Danub 24(2):112–26PubMed Weschenfelder J, Sander C, Kluge M, Kirkby KC, Himmerich H (2012) The influence of cytokines on wakefulness regulation: clinical relevance, mechanisms and methodological problems. Psychiatr Danub 24(2):112–26PubMed
413.
Zurück zum Zitat Schäfers M, Sorkin L (2008) Effect of cytokines on neuronal excitability. Neurosci Lett 437(3):188–93PubMedCrossRef Schäfers M, Sorkin L (2008) Effect of cytokines on neuronal excitability. Neurosci Lett 437(3):188–93PubMedCrossRef
414.
Zurück zum Zitat Üceyler N, Schäfers M, Sommer C (2009) Mode of action of cytokines on nociceptive neurons. Exp Brain Res 196(1):67–78PubMedCrossRef Üceyler N, Schäfers M, Sommer C (2009) Mode of action of cytokines on nociceptive neurons. Exp Brain Res 196(1):67–78PubMedCrossRef
415.
Zurück zum Zitat Hakim AW, Dong X, Cairns BE (2011) TNFα mechanically sensitizes masseter muscle nociceptors by increasing prostaglandin E2 levels. J Neurophysiol 105(1):154–61PubMedCrossRef Hakim AW, Dong X, Cairns BE (2011) TNFα mechanically sensitizes masseter muscle nociceptors by increasing prostaglandin E2 levels. J Neurophysiol 105(1):154–61PubMedCrossRef
416.
Zurück zum Zitat Üçeyler N, Häuser W, Sommer C (2011) Systematic review with meta-analysis: cytokines in fibromyalgia syndrome. BMC Musculoskelet Disord 12:245PubMedCentralPubMedCrossRef Üçeyler N, Häuser W, Sommer C (2011) Systematic review with meta-analysis: cytokines in fibromyalgia syndrome. BMC Musculoskelet Disord 12:245PubMedCentralPubMedCrossRef
417.
Zurück zum Zitat Behm FG, Gavin IM, Karpenko O, Lindgren V, Gaitonde S, Gashkoff PA et al (2012) Unique immunologic patterns in fibromyalgia. BMC Clin Pathol 12:25PubMedCentralPubMedCrossRef Behm FG, Gavin IM, Karpenko O, Lindgren V, Gaitonde S, Gashkoff PA et al (2012) Unique immunologic patterns in fibromyalgia. BMC Clin Pathol 12:25PubMedCentralPubMedCrossRef
418.
Zurück zum Zitat Cordero MD, Diaz-Parrado E, Carrion AM, Alfonsi S, Sanchez-Alcazar JA, Bullon P et al (2013) Is inflammation a mitochondrial dysfunction-dependent event in fibromyalgia? Antioxid Redox Signal 18(7):800–7PubMedCentralPubMedCrossRef Cordero MD, Diaz-Parrado E, Carrion AM, Alfonsi S, Sanchez-Alcazar JA, Bullon P et al (2013) Is inflammation a mitochondrial dysfunction-dependent event in fibromyalgia? Antioxid Redox Signal 18(7):800–7PubMedCentralPubMedCrossRef
419.
Zurück zum Zitat Fatima G, Mahdi AA, Das SK, Anjum B, Verma NS, Kumar P et al (2012) Lack of circadian pattern of serum TNF-alpha and IL-6 in patients with fibromyalgia syndrome. Indian J Clin Biochem 27(4):340–3PubMedCentralPubMedCrossRef Fatima G, Mahdi AA, Das SK, Anjum B, Verma NS, Kumar P et al (2012) Lack of circadian pattern of serum TNF-alpha and IL-6 in patients with fibromyalgia syndrome. Indian J Clin Biochem 27(4):340–3PubMedCentralPubMedCrossRef
420.
Zurück zum Zitat Kadetoff D, Lampa J, Westman M, Andersson M, Kosek E (2012) Evidence of central inflammation in fibromyalgia-increased cerebrospinal fluid interleukin-8 levels. J Neuroimmunol 242(1–2):33–8PubMedCrossRef Kadetoff D, Lampa J, Westman M, Andersson M, Kosek E (2012) Evidence of central inflammation in fibromyalgia-increased cerebrospinal fluid interleukin-8 levels. J Neuroimmunol 242(1–2):33–8PubMedCrossRef
421.
Zurück zum Zitat Kim SK, Kim KS, Lee YS, Park SH, Choe JY (2010) Arterial stiffness and proinflammatory cytokines in fibromyalgia syndrome. Clin Exp Rheumatol 28(6 Suppl 63):S71–7PubMed Kim SK, Kim KS, Lee YS, Park SH, Choe JY (2010) Arterial stiffness and proinflammatory cytokines in fibromyalgia syndrome. Clin Exp Rheumatol 28(6 Suppl 63):S71–7PubMed
422.
Zurück zum Zitat Nugraha B, Korallus C, Gutenbrunner C (2013) Serum level of brain-derived neurotrophic factor in fibromyalgia syndrome correlates with depression but not anxiety. Neurochem Int 62(3):281–6PubMedCrossRef Nugraha B, Korallus C, Gutenbrunner C (2013) Serum level of brain-derived neurotrophic factor in fibromyalgia syndrome correlates with depression but not anxiety. Neurochem Int 62(3):281–6PubMedCrossRef
423.
Zurück zum Zitat Topal G, Donmez A, Dogan BS, Kucur M, Cengiz DT, Berkoz FB et al (2011) Asymmetric dimethylarginine (ADMA) levels are increased in patients with fibromyalgia: correlation with tumor necrosis factor-alpha (TNF-alpha) and 8-iso-prostaglandin F(2alpha) (8-iso-PGF(2alpha)). Clin Biochem 44(5–6):364–7PubMedCrossRef Topal G, Donmez A, Dogan BS, Kucur M, Cengiz DT, Berkoz FB et al (2011) Asymmetric dimethylarginine (ADMA) levels are increased in patients with fibromyalgia: correlation with tumor necrosis factor-alpha (TNF-alpha) and 8-iso-prostaglandin F(2alpha) (8-iso-PGF(2alpha)). Clin Biochem 44(5–6):364–7PubMedCrossRef
424.
Zurück zum Zitat Xiao Y, Haynes WL, Michalek JE, Russell IJ (2013) Elevated serum high-sensitivity C-reactive protein levels in fibromyalgia syndrome patients correlate with body mass index, interleukin-6, interleukin-8, erythrocyte sedimentation rate. Rheumatol Int 33(5):1259–64PubMedCrossRef Xiao Y, Haynes WL, Michalek JE, Russell IJ (2013) Elevated serum high-sensitivity C-reactive protein levels in fibromyalgia syndrome patients correlate with body mass index, interleukin-6, interleukin-8, erythrocyte sedimentation rate. Rheumatol Int 33(5):1259–64PubMedCrossRef
425.
Zurück zum Zitat Bazzichi L, Rossi A, Massimetti G, Giannaccini G, Giuliano T, De Feo F et al (2007) Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol 25(2):225–30PubMed Bazzichi L, Rossi A, Massimetti G, Giannaccini G, Giuliano T, De Feo F et al (2007) Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol 25(2):225–30PubMed
426.
Zurück zum Zitat Nakamura T, Schwander SK, Donnelly R, Ortega F, Togo F, Broderick G et al (2010) Cytokines across the night in chronic fatigue syndrome with and without fibromyalgia. Clin Vaccine Immunol 17(4):582–7PubMedCentralPubMedCrossRef Nakamura T, Schwander SK, Donnelly R, Ortega F, Togo F, Broderick G et al (2010) Cytokines across the night in chronic fatigue syndrome with and without fibromyalgia. Clin Vaccine Immunol 17(4):582–7PubMedCentralPubMedCrossRef
427.
428.
Zurück zum Zitat Togo F, Natelson BH, Adler GK, Ottenweller JE, Goldenberg DL, Struzik ZR et al (2009) Plasma cytokine fluctuations over time in healthy controls and patients with fibromyalgia. Exp Biol Med (Maywood) 234(2):232–40CrossRef Togo F, Natelson BH, Adler GK, Ottenweller JE, Goldenberg DL, Struzik ZR et al (2009) Plasma cytokine fluctuations over time in healthy controls and patients with fibromyalgia. Exp Biol Med (Maywood) 234(2):232–40CrossRef
429.
Zurück zum Zitat Garcia JJ, Cidoncha A, Bote ME, Hinchado MD, Ortega E (2014) Altered profile of chemokines in fibromyalgia patients. Ann Clin Biochem 51(Pt 5):576–81PubMedCrossRef Garcia JJ, Cidoncha A, Bote ME, Hinchado MD, Ortega E (2014) Altered profile of chemokines in fibromyalgia patients. Ann Clin Biochem 51(Pt 5):576–81PubMedCrossRef
430.
Zurück zum Zitat Zhang Z, Cherryholmes G, Mao A, Marek C, Longmate J, Kalos M et al (2008) High plasma levels of MCP-1 and eotaxin provide evidence for an immunological basis of fibromyalgia. Exp Biol Med (Maywood) 233(9):1171–80CrossRef Zhang Z, Cherryholmes G, Mao A, Marek C, Longmate J, Kalos M et al (2008) High plasma levels of MCP-1 and eotaxin provide evidence for an immunological basis of fibromyalgia. Exp Biol Med (Maywood) 233(9):1171–80CrossRef
431.
Zurück zum Zitat Ang DC, Moore MN, Hilligoss J, Tabbey R (2011) MCP-1 and IL-8 as pain biomarkers in fibromyalgia: a pilot study. Pain Med 12(8):1154–61PubMedCrossRef Ang DC, Moore MN, Hilligoss J, Tabbey R (2011) MCP-1 and IL-8 as pain biomarkers in fibromyalgia: a pilot study. Pain Med 12(8):1154–61PubMedCrossRef
432.
Zurück zum Zitat Gür A, Karakoç M, Nas K, Remzi C, Denli A et al (2002) Cytokines and depression in cases with fibromyalgia. J Rheumatol 29(2):358–61PubMed Gür A, Karakoç M, Nas K, Remzi C, Denli A et al (2002) Cytokines and depression in cases with fibromyalgia. J Rheumatol 29(2):358–61PubMed
433.
Zurück zum Zitat Sturgeon JA, Darnall BD, Zwickey HL, Wood LJ, Hanes DA, Zava DT et al (2014) Proinflammatory cytokines and DHEA-S in women with fibromyalgia: impact of psychological distress and menopausal status. J Pain Res 7:707–16PubMedCentralPubMedCrossRef Sturgeon JA, Darnall BD, Zwickey HL, Wood LJ, Hanes DA, Zava DT et al (2014) Proinflammatory cytokines and DHEA-S in women with fibromyalgia: impact of psychological distress and menopausal status. J Pain Res 7:707–16PubMedCentralPubMedCrossRef
434.
Zurück zum Zitat Wang H, Moser M, Schiltenwolf M, Buchner M (2008) Circulating cytokine levels compared to pain in patients with fibromyalgia—a prospective longitudinal study over 6 months. J Rheumatol 35(7):1366–70PubMed Wang H, Moser M, Schiltenwolf M, Buchner M (2008) Circulating cytokine levels compared to pain in patients with fibromyalgia—a prospective longitudinal study over 6 months. J Rheumatol 35(7):1366–70PubMed
435.
Zurück zum Zitat Cordero MD, Alcocer-Gomez E, Culic O, Carrion AM, de Miguel M, Diaz-Parrado E et al (2014) NLRP3 inflammasome is activated in fibromyalgia: the effect of coenzyme Q10. Antioxid Redox Signal 20(8):1169–80PubMedCentralPubMedCrossRef Cordero MD, Alcocer-Gomez E, Culic O, Carrion AM, de Miguel M, Diaz-Parrado E et al (2014) NLRP3 inflammasome is activated in fibromyalgia: the effect of coenzyme Q10. Antioxid Redox Signal 20(8):1169–80PubMedCentralPubMedCrossRef
436.
Zurück zum Zitat Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK et al (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67(5):446–57PubMedCrossRef Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK et al (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67(5):446–57PubMedCrossRef
437.
Zurück zum Zitat Young JJ, Bruno D, Pomara N (2014) A review of the relationship between proinflammatory cytokines and major depressive disorder. J Affect Disord 169:15–20PubMedCrossRef Young JJ, Bruno D, Pomara N (2014) A review of the relationship between proinflammatory cytokines and major depressive disorder. J Affect Disord 169:15–20PubMedCrossRef
438.
Zurück zum Zitat Iannuccelli C, Di Franco M, Alessandri C, Guzzo MP, Croia C, Di Sabato F et al (2010) Pathophysiology of fibromyalgia: a comparison with the tension-type headache, a localized pain syndrome. Ann N Y Acad Sci 1193:78–83PubMedCrossRef Iannuccelli C, Di Franco M, Alessandri C, Guzzo MP, Croia C, Di Sabato F et al (2010) Pathophysiology of fibromyalgia: a comparison with the tension-type headache, a localized pain syndrome. Ann N Y Acad Sci 1193:78–83PubMedCrossRef
439.
Zurück zum Zitat Menzies V, Lyon DE, Elswick RK Jr, Montpetit AJ, McCain NL (2013) Psychoneuroimmunological relationships in women with fibromyalgia. Biol Res Nurs 15(2):219–25PubMedCentralPubMedCrossRef Menzies V, Lyon DE, Elswick RK Jr, Montpetit AJ, McCain NL (2013) Psychoneuroimmunological relationships in women with fibromyalgia. Biol Res Nurs 15(2):219–25PubMedCentralPubMedCrossRef
440.
Zurück zum Zitat Amel Kashipaz MR, Swinden D, Todd I, Powell RJ (2003) Normal production of inflammatory cytokines in chronic fatigue and fibromyalgia syndromes determined by intracellular cytokine staining in short-term cultured blood mononuclear cells. Clin Exp Immunol 132(2):360–5PubMedCentralPubMedCrossRef Amel Kashipaz MR, Swinden D, Todd I, Powell RJ (2003) Normal production of inflammatory cytokines in chronic fatigue and fibromyalgia syndromes determined by intracellular cytokine staining in short-term cultured blood mononuclear cells. Clin Exp Immunol 132(2):360–5PubMedCentralPubMedCrossRef
441.
Zurück zum Zitat Maes M, Libbrecht I, Van Hunsel F, Lin AH, De Clerck L, Stevens W et al (1999) The immune-inflammatory pathophysiology of fibromyalgia: increased serum soluble gp130, the common signal transducer protein of various neurotrophic cytokines. Psychoneuroendocrinology 24(4):371–83PubMedCrossRef Maes M, Libbrecht I, Van Hunsel F, Lin AH, De Clerck L, Stevens W et al (1999) The immune-inflammatory pathophysiology of fibromyalgia: increased serum soluble gp130, the common signal transducer protein of various neurotrophic cytokines. Psychoneuroendocrinology 24(4):371–83PubMedCrossRef
442.
Zurück zum Zitat Okifuji A, Bradshaw DH, Olson C (2009) Evaluating obesity in fibromyalgia: neuroendocrine biomarkers, symptoms, and functions. Clin Rheumatol 28(4):475–8PubMedCentralPubMedCrossRef Okifuji A, Bradshaw DH, Olson C (2009) Evaluating obesity in fibromyalgia: neuroendocrine biomarkers, symptoms, and functions. Clin Rheumatol 28(4):475–8PubMedCentralPubMedCrossRef
443.
Zurück zum Zitat Senna MK, Sallam RA, Ashour HS, Elarman M (2012) Effect of weight reduction on the quality of life in obese patients with fibromyalgia syndrome: a randomized controlled trial. Clin Rheumatol 31(11):1591–7PubMedCrossRef Senna MK, Sallam RA, Ashour HS, Elarman M (2012) Effect of weight reduction on the quality of life in obese patients with fibromyalgia syndrome: a randomized controlled trial. Clin Rheumatol 31(11):1591–7PubMedCrossRef
444.
Zurück zum Zitat Dessein PH, Shipton EA, Joffe BI, Hadebe DP, Stanwix AE, Van der Merwe BA (1999) Hyposecretion of adrenal androgens and the relation of serum adrenal steroids, serotonin and insulin-like growth factor-1 to clinical features in women with fibromyalgia. Pain 83(2):313–9PubMedCrossRef Dessein PH, Shipton EA, Joffe BI, Hadebe DP, Stanwix AE, Van der Merwe BA (1999) Hyposecretion of adrenal androgens and the relation of serum adrenal steroids, serotonin and insulin-like growth factor-1 to clinical features in women with fibromyalgia. Pain 83(2):313–9PubMedCrossRef
445.
Zurück zum Zitat Üceyler N, Valenza R, Stock M, Schedel R, Sprotte G, Sommer C (2006) Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum 54(8):2656–64PubMedCrossRef Üceyler N, Valenza R, Stock M, Schedel R, Sprotte G, Sommer C (2006) Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum 54(8):2656–64PubMedCrossRef
446.
Zurück zum Zitat Buskila D, Neumann L, Hazanov I, Carmi R (1996) Familial aggregation in the fibromyalgia syndrome. Semin Arthritis Rheum 26(3):605–11PubMedCrossRef Buskila D, Neumann L, Hazanov I, Carmi R (1996) Familial aggregation in the fibromyalgia syndrome. Semin Arthritis Rheum 26(3):605–11PubMedCrossRef
447.
Zurück zum Zitat Kato K, Sullivan PF, Evengard B, Pedersen NL (2006) Importance of genetic influences on chronic widespread pain. Arthritis Rheum 54(5):1682–6PubMedCrossRef Kato K, Sullivan PF, Evengard B, Pedersen NL (2006) Importance of genetic influences on chronic widespread pain. Arthritis Rheum 54(5):1682–6PubMedCrossRef
448.
Zurück zum Zitat Markkula R, Jarvinen P, Leino-Arjas P, Koskenvuo M, Kalso E, Kaprio J (2009) Clustering of symptoms associated with fibromyalgia in a Finnish twin cohort. Eur J Pain 13(7):744–50PubMedCrossRef Markkula R, Jarvinen P, Leino-Arjas P, Koskenvuo M, Kalso E, Kaprio J (2009) Clustering of symptoms associated with fibromyalgia in a Finnish twin cohort. Eur J Pain 13(7):744–50PubMedCrossRef
449.
Zurück zum Zitat Mikkelsson M, Kaprio J, Salminen JJ, Pulkkinen L, Rose RJ (2001) Widespread pain among 11-year-old Finnish twin pairs. Arthritis Rheum 44(2):481–5PubMedCrossRef Mikkelsson M, Kaprio J, Salminen JJ, Pulkkinen L, Rose RJ (2001) Widespread pain among 11-year-old Finnish twin pairs. Arthritis Rheum 44(2):481–5PubMedCrossRef
450.
Zurück zum Zitat Diatchenko L, Slade GD, Nackley AG, Bhalang K, Sigurdsson A, Belfer I et al (2005) Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 14(1):135–43PubMedCrossRef Diatchenko L, Slade GD, Nackley AG, Bhalang K, Sigurdsson A, Belfer I et al (2005) Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 14(1):135–43PubMedCrossRef
451.
Zurück zum Zitat Fillingim RB, Kaplan L, Staud R, Ness TJ, Glover TL, Campbell CM et al (2005) The A118G single nucleotide polymorphism of the μ-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J Pain 6(3):159–67PubMedCrossRef Fillingim RB, Kaplan L, Staud R, Ness TJ, Glover TL, Campbell CM et al (2005) The A118G single nucleotide polymorphism of the μ-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J Pain 6(3):159–67PubMedCrossRef
452.
Zurück zum Zitat Lötsch J, Stuck B, Hummel T (2006) The human μ-opioid receptor gene polymorphism 118A > G decreases cortical activation in response to specific nociceptive stimulation. Behav Neurosci 120(6):1218–24PubMedCrossRef Lötsch J, Stuck B, Hummel T (2006) The human μ-opioid receptor gene polymorphism 118A > G decreases cortical activation in response to specific nociceptive stimulation. Behav Neurosci 120(6):1218–24PubMedCrossRef
453.
Zurück zum Zitat Tegeder I, Costigan M, Griffin RS, Abele A, Belfer I, Schmidt H et al (2006) GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med 12(11):1269–77PubMedCrossRef Tegeder I, Costigan M, Griffin RS, Abele A, Belfer I, Schmidt H et al (2006) GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med 12(11):1269–77PubMedCrossRef
454.
Zurück zum Zitat Tegeder I, Adolph J, Schmidt H, Woolf CJ, Geisslinger G, Lotsch J (2008) Reduced hyperalgesia in homozygous carriers of a GTP cyclohydrolase 1 haplotype. Eur J Pain 12(8):1069–77PubMedCrossRef Tegeder I, Adolph J, Schmidt H, Woolf CJ, Geisslinger G, Lotsch J (2008) Reduced hyperalgesia in homozygous carriers of a GTP cyclohydrolase 1 haplotype. Eur J Pain 12(8):1069–77PubMedCrossRef
455.
Zurück zum Zitat Campbell CM, Edwards RR, Carmona C, Uhart M, Wand G, Carteret A et al (2009) Polymorphisms in the GTP cyclohydrolase gene (GCH1) are associated with ratings of capsaicin pain. Pain 141(1–2):114–8PubMedCentralPubMedCrossRef Campbell CM, Edwards RR, Carmona C, Uhart M, Wand G, Carteret A et al (2009) Polymorphisms in the GTP cyclohydrolase gene (GCH1) are associated with ratings of capsaicin pain. Pain 141(1–2):114–8PubMedCentralPubMedCrossRef
456.
Zurück zum Zitat Nicholl BI, Holliday KL, Macfarlane GJ, Thomson W, Davies KA, O’Neill TW et al (2010) No evidence for a role of the catechol-O-methyltransferase pain sensitivity haplotypes in chronic widespread pain. Ann Rheum Dis 69(11):2009–12PubMedCrossRef Nicholl BI, Holliday KL, Macfarlane GJ, Thomson W, Davies KA, O’Neill TW et al (2010) No evidence for a role of the catechol-O-methyltransferase pain sensitivity haplotypes in chronic widespread pain. Ann Rheum Dis 69(11):2009–12PubMedCrossRef
457.
Zurück zum Zitat Hagen K, Pettersen E, Stovner LJ, Skorpen F, Zwart JA (2006) No association between chronic musculoskeletal complaints and Val158Met polymorphism in the Catechol-O-methyltransferase gene. The HUNT study. BMC Musculoskelet Disord 7:40PubMedCentralPubMedCrossRef Hagen K, Pettersen E, Stovner LJ, Skorpen F, Zwart JA (2006) No association between chronic musculoskeletal complaints and Val158Met polymorphism in the Catechol-O-methyltransferase gene. The HUNT study. BMC Musculoskelet Disord 7:40PubMedCentralPubMedCrossRef
458.
Zurück zum Zitat Holliday KL, Nicholl BI, Macfarlane GJ, Thomson W, Davies KA, McBeth J (2009) Do genetic predictors of pain sensitivity associate with persistent widespread pain? Mol Pain 5:56PubMedCentralPubMedCrossRef Holliday KL, Nicholl BI, Macfarlane GJ, Thomson W, Davies KA, McBeth J (2009) Do genetic predictors of pain sensitivity associate with persistent widespread pain? Mol Pain 5:56PubMedCentralPubMedCrossRef
459.
Zurück zum Zitat Holliday KL, Macfarlane GJ, Nicholl BI, Creed F, Thomson W, McBeth J (2010) Genetic variation in neuroendocrine genes associates with somatic symptoms in the general population: results from the EPIFUND study. J Psychosom Res 68(5):469–74PubMedCentralPubMedCrossRef Holliday KL, Macfarlane GJ, Nicholl BI, Creed F, Thomson W, McBeth J (2010) Genetic variation in neuroendocrine genes associates with somatic symptoms in the general population: results from the EPIFUND study. J Psychosom Res 68(5):469–74PubMedCentralPubMedCrossRef
460.
Zurück zum Zitat Desmeules J, Chabert J, Rebsamen M, Rapiti E, Piguet V, Besson M et al (2014) Central pain sensitization, COMT Val158Met polymorphism, and emotional factors in fibromyalgia. J Pain 15(2):129–35PubMedCrossRef Desmeules J, Chabert J, Rebsamen M, Rapiti E, Piguet V, Besson M et al (2014) Central pain sensitization, COMT Val158Met polymorphism, and emotional factors in fibromyalgia. J Pain 15(2):129–35PubMedCrossRef
461.
Zurück zum Zitat Finan PH, Zautra AJ, Davis MC, Lemery-Chalfant K, Covault J, Tennen H (2011) COMT moderates the relation of daily maladaptive coping and pain in fibromyalgia. Pain 152(2):300–7PubMedCentralPubMedCrossRef Finan PH, Zautra AJ, Davis MC, Lemery-Chalfant K, Covault J, Tennen H (2011) COMT moderates the relation of daily maladaptive coping and pain in fibromyalgia. Pain 152(2):300–7PubMedCentralPubMedCrossRef
462.
Zurück zum Zitat Finan PH, Zautra AJ, Davis MC, Lemery-Chalfant K, Covault J, Tennen H (2010) Genetic influences on the dynamics of pain and affect in fibromyalgia. Health Psychol 29(2):134–42PubMedCentralPubMedCrossRef Finan PH, Zautra AJ, Davis MC, Lemery-Chalfant K, Covault J, Tennen H (2010) Genetic influences on the dynamics of pain and affect in fibromyalgia. Health Psychol 29(2):134–42PubMedCentralPubMedCrossRef
463.
Zurück zum Zitat Üceyler N, Zeller D, Kahn AK, Kewenig S, Kittel-Schneider S, Schmid A et al (2013) Small fibre pathology in patients with fibromyalgia syndrome. Brain 136(Pt 6):1857–67PubMedCrossRef Üceyler N, Zeller D, Kahn AK, Kewenig S, Kittel-Schneider S, Schmid A et al (2013) Small fibre pathology in patients with fibromyalgia syndrome. Brain 136(Pt 6):1857–67PubMedCrossRef
464.
Zurück zum Zitat Oaklander AL, Herzog ZD, Downs HM, Klein MM (2013) Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain 154(11):2310–6PubMedCrossRef Oaklander AL, Herzog ZD, Downs HM, Klein MM (2013) Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain 154(11):2310–6PubMedCrossRef
465.
Zurück zum Zitat Caro XJ, Winter EF (2014) Evidence of abnormal epidermal nerve fiber density in fibromyalgia: clinical and immunologic implications. Arthritis Rheumatol 66(7):1945–54PubMedCrossRef Caro XJ, Winter EF (2014) Evidence of abnormal epidermal nerve fiber density in fibromyalgia: clinical and immunologic implications. Arthritis Rheumatol 66(7):1945–54PubMedCrossRef
466.
Zurück zum Zitat Giannoccaro MP, Donadio V, Incensi A, Avoni P, Liguori R (2014) Small nerve fiber involvement in patients referred for fibromyalgia. Muscle Nerve 49(5):757–9PubMedCrossRef Giannoccaro MP, Donadio V, Incensi A, Avoni P, Liguori R (2014) Small nerve fiber involvement in patients referred for fibromyalgia. Muscle Nerve 49(5):757–9PubMedCrossRef
467.
Zurück zum Zitat de Tommaso M, Nolano M, Iannone F, Vecchio E, Ricci K, Lorenzo M et al (2014) Update on laser-evoked potential findings in fibromyalgia patients in light of clinical and skin biopsy features. J Neurol 261(3):461–72PubMedCrossRef de Tommaso M, Nolano M, Iannone F, Vecchio E, Ricci K, Lorenzo M et al (2014) Update on laser-evoked potential findings in fibromyalgia patients in light of clinical and skin biopsy features. J Neurol 261(3):461–72PubMedCrossRef
468.
Zurück zum Zitat Faber CG, Hoeijmakers JG, Ahn HS, Cheng X, Han C, Choi JS et al (2012) Gain of function Nav1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol 71(1):26–39PubMedCrossRef Faber CG, Hoeijmakers JG, Ahn HS, Cheng X, Han C, Choi JS et al (2012) Gain of function Nav1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol 71(1):26–39PubMedCrossRef
469.
Zurück zum Zitat Black JA, Frezel N, Dib-Hajj SD, Waxman SG (2012) Expression of Nav1.7 in DRG neurons extends from peripheral terminals in the skin to central preterminal branches and terminals in the dorsal horn. Mol Pain 8:82PubMedCentralPubMedCrossRef Black JA, Frezel N, Dib-Hajj SD, Waxman SG (2012) Expression of Nav1.7 in DRG neurons extends from peripheral terminals in the skin to central preterminal branches and terminals in the dorsal horn. Mol Pain 8:82PubMedCentralPubMedCrossRef
470.
Zurück zum Zitat Vargas-Alarcon G, Alvarez-Leon E, Fragoso JM, Vargas A, Martinez A, Vallejo M et al (2012) A SCN9A gene-encoded dorsal root ganglia sodium channel polymorphism associated with severe fibromyalgia. BMC Musculoskelet Disord 13:23PubMedCentralPubMedCrossRef Vargas-Alarcon G, Alvarez-Leon E, Fragoso JM, Vargas A, Martinez A, Vallejo M et al (2012) A SCN9A gene-encoded dorsal root ganglia sodium channel polymorphism associated with severe fibromyalgia. BMC Musculoskelet Disord 13:23PubMedCentralPubMedCrossRef
471.
Zurück zum Zitat Mergener M, Becker RM, dos Santos AF, dos Santos GA, de Andrade FM (2011) Influence of the interaction between environmental quality and T102C SNP in the HTR2A gene on fibromyalgia susceptibility. Rev Bras Reumatol 51(6):594–602PubMedCrossRef Mergener M, Becker RM, dos Santos AF, dos Santos GA, de Andrade FM (2011) Influence of the interaction between environmental quality and T102C SNP in the HTR2A gene on fibromyalgia susceptibility. Rev Bras Reumatol 51(6):594–602PubMedCrossRef
472.
Zurück zum Zitat Buskila D, Cohen H, Neumann L, Ebstein RP (2004) An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits. Mol Psychiatry 9(8):730–1PubMedCrossRef Buskila D, Cohen H, Neumann L, Ebstein RP (2004) An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits. Mol Psychiatry 9(8):730–1PubMedCrossRef
473.
Zurück zum Zitat Smith SB, Maixner DW, Fillingim RB, Slade G, Gracely RH, Ambrose K et al (2012) Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia. Arthritis Rheum 64(2):584–93PubMedCentralPubMedCrossRef Smith SB, Maixner DW, Fillingim RB, Slade G, Gracely RH, Ambrose K et al (2012) Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia. Arthritis Rheum 64(2):584–93PubMedCentralPubMedCrossRef
474.
Zurück zum Zitat Peters MJ, Broer L, Willemen HL, Eiriksdottir G, Hocking LJ, Holliday KL et al (2013) Genome-wide association study meta-analysis of chronic widespread pain: evidence for involvement of the 5p15.2 region. Ann Rheum Dis 72(3):427–36PubMedCentralPubMedCrossRef Peters MJ, Broer L, Willemen HL, Eiriksdottir G, Hocking LJ, Holliday KL et al (2013) Genome-wide association study meta-analysis of chronic widespread pain: evidence for involvement of the 5p15.2 region. Ann Rheum Dis 72(3):427–36PubMedCentralPubMedCrossRef
475.
Zurück zum Zitat Docampo E, Escaramis G, Gratacos M, Villatoro S, Puig A, Kogevinas M et al (2014) Genome-wide analysis of single nucleotide polymorphisms and copy number variants in fibromyalgia suggest a role for the central nervous system. Pain 155(6):1102–9PubMedCrossRef Docampo E, Escaramis G, Gratacos M, Villatoro S, Puig A, Kogevinas M et al (2014) Genome-wide analysis of single nucleotide polymorphisms and copy number variants in fibromyalgia suggest a role for the central nervous system. Pain 155(6):1102–9PubMedCrossRef
476.
Zurück zum Zitat Feng J, Zhang Z, Wu X, Mao A, Chang F, Deng X et al (2013) Discovery of potential new gene variants and inflammatory cytokine associations with fibromyalgia syndrome by whole exome sequencing. PLoS One 8(6):e65033PubMedCentralPubMedCrossRef Feng J, Zhang Z, Wu X, Mao A, Chang F, Deng X et al (2013) Discovery of potential new gene variants and inflammatory cytokine associations with fibromyalgia syndrome by whole exome sequencing. PLoS One 8(6):e65033PubMedCentralPubMedCrossRef
477.
Zurück zum Zitat Arnold LM, Fan J, Russell IJ, Yunus MB, Khan MA, Kushner I et al (2013) The fibromyalgia family study: a genome-wide linkage scan study. Arthritis Rheum 65(4):1122–8PubMedCentralPubMedCrossRef Arnold LM, Fan J, Russell IJ, Yunus MB, Khan MA, Kushner I et al (2013) The fibromyalgia family study: a genome-wide linkage scan study. Arthritis Rheum 65(4):1122–8PubMedCentralPubMedCrossRef
478.
Zurück zum Zitat Ghadirivasfi M, Nohesara S, Ahmadkhaniha HR, Eskandari MR, Mostafavi S, Thiagalingam S et al (2011) Hypomethylation of the serotonin receptor type-2A Gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 156B(5):536–45PubMedCrossRef Ghadirivasfi M, Nohesara S, Ahmadkhaniha HR, Eskandari MR, Mostafavi S, Thiagalingam S et al (2011) Hypomethylation of the serotonin receptor type-2A Gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 156B(5):536–45PubMedCrossRef
479.
Zurück zum Zitat Menzies V, Lyon DE, Archer KJ, Zhou Q, Brumelle J, Jones KH et al (2013) Epigenetic alterations and an increased frequency of micronuclei in women with fibromyalgia. Nurs Res Pract 2013:795784PubMedCentralPubMed Menzies V, Lyon DE, Archer KJ, Zhou Q, Brumelle J, Jones KH et al (2013) Epigenetic alterations and an increased frequency of micronuclei in women with fibromyalgia. Nurs Res Pract 2013:795784PubMedCentralPubMed
481.
Zurück zum Zitat Ang DC, Chakr R, France CR, Mazzuca SA, Stump TE, Hilligoss J et al (2011) Association of nociceptive responsivity with clinical pain and the moderating effect of depression. J Pain 12(3):384–9PubMedCrossRef Ang DC, Chakr R, France CR, Mazzuca SA, Stump TE, Hilligoss J et al (2011) Association of nociceptive responsivity with clinical pain and the moderating effect of depression. J Pain 12(3):384–9PubMedCrossRef
482.
Zurück zum Zitat Staud R, Price DD, Robinson ME, Vierck CJ Jr (2004) Body pain area and pain-related negative affect predict clinical pain intensity in patients with fibromyalgia. J Pain 5(6):338–43PubMedCrossRef Staud R, Price DD, Robinson ME, Vierck CJ Jr (2004) Body pain area and pain-related negative affect predict clinical pain intensity in patients with fibromyalgia. J Pain 5(6):338–43PubMedCrossRef
483.
Zurück zum Zitat Sörensen J, Bengtsson A, Ahlner J, Henriksson KG, Ekselius L, Bengtsson M (1997) Fibromyalgia—are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs. J Rheumatol 24(8):1615–21PubMed Sörensen J, Bengtsson A, Ahlner J, Henriksson KG, Ekselius L, Bengtsson M (1997) Fibromyalgia—are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs. J Rheumatol 24(8):1615–21PubMed
484.
Zurück zum Zitat Bendtsen L, Norregaard J, Jensen R, Olesen J (1997) Evidence of qualitatively altered nociception in patients with fibromyalgia. Arthritis Rheum 40(1):98–102PubMedCrossRef Bendtsen L, Norregaard J, Jensen R, Olesen J (1997) Evidence of qualitatively altered nociception in patients with fibromyalgia. Arthritis Rheum 40(1):98–102PubMedCrossRef
485.
Zurück zum Zitat Mikkelsson M, Latikka P, Kautiainen H, Isomeri R, Isomaki H (1992) Muscle and bone pressure pain threshold and pain tolerance in fibromyalgia patients and controls. Arch Phys Med Rehabil 73(9):814–8PubMed Mikkelsson M, Latikka P, Kautiainen H, Isomeri R, Isomaki H (1992) Muscle and bone pressure pain threshold and pain tolerance in fibromyalgia patients and controls. Arch Phys Med Rehabil 73(9):814–8PubMed
486.
Zurück zum Zitat Tunks E, Crook J, Norman G, Kalaher S (1988) Tender points in fibromyalgia. Pain 34(1):11–9PubMedCrossRef Tunks E, Crook J, Norman G, Kalaher S (1988) Tender points in fibromyalgia. Pain 34(1):11–9PubMedCrossRef
487.
Zurück zum Zitat Wilson HD, Starz TW, Robinson JP, Turk DC (2009) Heterogeneity within the fibromyalgia population: theoretical implications of variable tender point severity ratings. J Rheumatol 36(12):2795–801PubMedCrossRef Wilson HD, Starz TW, Robinson JP, Turk DC (2009) Heterogeneity within the fibromyalgia population: theoretical implications of variable tender point severity ratings. J Rheumatol 36(12):2795–801PubMedCrossRef
488.
Zurück zum Zitat Park JH, Niermann KJ, Olsen N (2000) Evidence for metabolic abnormalities in the muscles of patients with fibromyalgia. Curr Rheumatol Rep 2(2):131–40PubMedCrossRef Park JH, Niermann KJ, Olsen N (2000) Evidence for metabolic abnormalities in the muscles of patients with fibromyalgia. Curr Rheumatol Rep 2(2):131–40PubMedCrossRef
489.
490.
Zurück zum Zitat Srikuea R, Symons TB, Long DE, Lee JD, Shang Y, Chomentowski PJ et al (2013) Association of fibromyalgia with altered skeletal muscle characteristics which may contribute to postexertional fatigue in postmenopausal women. Arthritis Rheum 65(2):519–28PubMedCentralPubMedCrossRef Srikuea R, Symons TB, Long DE, Lee JD, Shang Y, Chomentowski PJ et al (2013) Association of fibromyalgia with altered skeletal muscle characteristics which may contribute to postexertional fatigue in postmenopausal women. Arthritis Rheum 65(2):519–28PubMedCentralPubMedCrossRef
491.
Zurück zum Zitat Yunus MB, Kalyan-Raman UP, Masi AT, Aldag JC (1989) Electron microscopic studies of muscle biopsy in primary fibromyalgia syndrome: a controlled and blinded study. J Rheumatol 16(1):97–101PubMed Yunus MB, Kalyan-Raman UP, Masi AT, Aldag JC (1989) Electron microscopic studies of muscle biopsy in primary fibromyalgia syndrome: a controlled and blinded study. J Rheumatol 16(1):97–101PubMed
492.
Zurück zum Zitat McIver KL, Evans C, Kraus RM, Ispas L, Sciotti VM, Hickner RC (2006) NO-mediated alterations in skeletal muscle nutritive blood flow and lactate metabolism in fibromyalgia. Pain 120(1–2):161–9PubMedCrossRef McIver KL, Evans C, Kraus RM, Ispas L, Sciotti VM, Hickner RC (2006) NO-mediated alterations in skeletal muscle nutritive blood flow and lactate metabolism in fibromyalgia. Pain 120(1–2):161–9PubMedCrossRef
493.
Zurück zum Zitat Lindh M, Johansson G, Hedberg M, Henning GB, Grimby G (1995) Muscle fiber characteristics, capillaries and enzymes in patients with fibromyalgia and controls. Scand J Rheumatol 24(1):34–7PubMedCrossRef Lindh M, Johansson G, Hedberg M, Henning GB, Grimby G (1995) Muscle fiber characteristics, capillaries and enzymes in patients with fibromyalgia and controls. Scand J Rheumatol 24(1):34–7PubMedCrossRef
494.
Zurück zum Zitat Park JH, Phothimat P, Oates CT, Hernanz-Schulman M, Olsen NJ (1998) Use of P-31 magnetic resonance spectroscopy to detect metabolic abnormalities in muscles of patients with fibromyalgia. Arthritis Rheum 41(3):406–13PubMedCrossRef Park JH, Phothimat P, Oates CT, Hernanz-Schulman M, Olsen NJ (1998) Use of P-31 magnetic resonance spectroscopy to detect metabolic abnormalities in muscles of patients with fibromyalgia. Arthritis Rheum 41(3):406–13PubMedCrossRef
495.
Zurück zum Zitat Sprott H, Rzanny R, Reichenbach JR, Kaiser WA, Hein G, Stein G (2000) 31P magnetic resonance spectroscopy in fibromyalgic muscle. Rheumatology (Oxford) 39(10):1121–5CrossRef Sprott H, Rzanny R, Reichenbach JR, Kaiser WA, Hein G, Stein G (2000) 31P magnetic resonance spectroscopy in fibromyalgic muscle. Rheumatology (Oxford) 39(10):1121–5CrossRef
496.
Zurück zum Zitat Gerdle B, Forsgren MF, Bengtsson A, Leinhard OD, Soren B, Karlsson A et al (2013) Decreased muscle concentrations of ATP and PCR in the quadriceps muscle of fibromyalgia patients--a 31P-MRS study. Eur J Pain 17(8):1205–15PubMedCrossRef Gerdle B, Forsgren MF, Bengtsson A, Leinhard OD, Soren B, Karlsson A et al (2013) Decreased muscle concentrations of ATP and PCR in the quadriceps muscle of fibromyalgia patients--a 31P-MRS study. Eur J Pain 17(8):1205–15PubMedCrossRef
497.
Zurück zum Zitat Cordero MD, De Miguel M, Moreno Fernandez AM, Carmona Lopez IM, Garrido Maraver J, Cotan D et al (2010) Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of fibromyalgia patients: implications in the pathogenesis of the disease. Arthritis Res Ther 12(1):R17PubMedCentralPubMedCrossRef Cordero MD, De Miguel M, Moreno Fernandez AM, Carmona Lopez IM, Garrido Maraver J, Cotan D et al (2010) Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of fibromyalgia patients: implications in the pathogenesis of the disease. Arthritis Res Ther 12(1):R17PubMedCentralPubMedCrossRef
498.
Zurück zum Zitat Cordero MD, Moreno-Fernandez AM, Carmona-Lopez MI, Sanchez-Alcazar JA, Rodriguez AF, Navas P et al (2010) Mitochondrial dysfunction in skin biopsies and blood mononuclear cells from two cases of fibromyalgia patients. Clin Biochem 43(13–14):1174–6PubMedCrossRef Cordero MD, Moreno-Fernandez AM, Carmona-Lopez MI, Sanchez-Alcazar JA, Rodriguez AF, Navas P et al (2010) Mitochondrial dysfunction in skin biopsies and blood mononuclear cells from two cases of fibromyalgia patients. Clin Biochem 43(13–14):1174–6PubMedCrossRef
499.
Zurück zum Zitat Duncan AJ, Heales SJ, Mills K, Eaton S, Land JM, Hargreaves IP (2005) Determination of coenzyme Q10 status in blood mononuclear cells, skeletal muscle, and plasma by HPLC with di-propoxy-coenzyme Q10 as an internal standard. Clin Chem 51(12):2380–2PubMedCrossRef Duncan AJ, Heales SJ, Mills K, Eaton S, Land JM, Hargreaves IP (2005) Determination of coenzyme Q10 status in blood mononuclear cells, skeletal muscle, and plasma by HPLC with di-propoxy-coenzyme Q10 as an internal standard. Clin Chem 51(12):2380–2PubMedCrossRef
500.
Zurück zum Zitat Rüster M, Franke S, Späth M, Pongratz DE, Stein G, Hein GE (2005) Detection of elevated Nε-carboxymethyllysine levels in muscular tissue and in serum of patients with fibromyalgia. Scand J Rheumatol 34(6):460–3PubMedCrossRef Rüster M, Franke S, Späth M, Pongratz DE, Stein G, Hein GE (2005) Detection of elevated Nε-carboxymethyllysine levels in muscular tissue and in serum of patients with fibromyalgia. Scand J Rheumatol 34(6):460–3PubMedCrossRef
501.
Zurück zum Zitat Liptan GL (2010) Fascia: a missing link in our understanding of the pathology of fibromyalgia. J Bodyw Mov Ther 14(1):3–12PubMedCrossRef Liptan GL (2010) Fascia: a missing link in our understanding of the pathology of fibromyalgia. J Bodyw Mov Ther 14(1):3–12PubMedCrossRef
502.
Zurück zum Zitat Lund N, Bengtsson A, Thorborg P (1986) Muscle tissue oxygen pressure in primary fibromyalgia. Scand J Rheumatol 15(2):165–73PubMedCrossRef Lund N, Bengtsson A, Thorborg P (1986) Muscle tissue oxygen pressure in primary fibromyalgia. Scand J Rheumatol 15(2):165–73PubMedCrossRef
503.
Zurück zum Zitat Grassi W, Core P, Carlino G, Salaffi F, Cervini C (1994) Capillary permeability in fibromyalgia. J Rheumatol 21(7):1328–31PubMed Grassi W, Core P, Carlino G, Salaffi F, Cervini C (1994) Capillary permeability in fibromyalgia. J Rheumatol 21(7):1328–31PubMed
504.
Zurück zum Zitat Elvin A, Siösteen AK, Nilsson A, Kosek E (2006) Decreased muscle blood flow in fibromyalgia patients during standardised muscle exercise: a contrast media enhanced colour Doppler study. Eur J Pain 10(2):137–44PubMedCrossRef Elvin A, Siösteen AK, Nilsson A, Kosek E (2006) Decreased muscle blood flow in fibromyalgia patients during standardised muscle exercise: a contrast media enhanced colour Doppler study. Eur J Pain 10(2):137–44PubMedCrossRef
505.
Zurück zum Zitat Shang Y, Gurley K, Symons B, Long D, Srikuea R, Crofford LJ et al (2012) Noninvasive optical characterization of muscle blood flow, oxygenation, and metabolism in women with fibromyalgia. Arthritis Res Ther 14(6):R236PubMedCentralPubMedCrossRef Shang Y, Gurley K, Symons B, Long D, Srikuea R, Crofford LJ et al (2012) Noninvasive optical characterization of muscle blood flow, oxygenation, and metabolism in women with fibromyalgia. Arthritis Res Ther 14(6):R236PubMedCentralPubMedCrossRef
506.
Zurück zum Zitat Katz DL, Greene L, Ali A, Faridi Z (2007) The pain of fibromyalgia syndrome is due to muscle hypoperfusion induced by regional vasomotor dysregulation. Med Hypotheses 69(3):517–25PubMedCrossRef Katz DL, Greene L, Ali A, Faridi Z (2007) The pain of fibromyalgia syndrome is due to muscle hypoperfusion induced by regional vasomotor dysregulation. Med Hypotheses 69(3):517–25PubMedCrossRef
507.
Zurück zum Zitat Bennett RM, Clark SR, Goldberg L, Nelson D, Bonafede RP, Porter J et al (1989) Aerobic fitness in patients with fibrositis. A controlled study of respiratory gas exchange and 133xenon clearance from exercising muscle. Arthritis Rheum 32(4):454–60PubMedCrossRef Bennett RM, Clark SR, Goldberg L, Nelson D, Bonafede RP, Porter J et al (1989) Aerobic fitness in patients with fibrositis. A controlled study of respiratory gas exchange and 133xenon clearance from exercising muscle. Arthritis Rheum 32(4):454–60PubMedCrossRef
508.
Zurück zum Zitat Nørregaard J, Bülow PM, Mehlsen J, Danneskiold-Samsøe B (1994) Biochemical changes in relation to a maximal exercise test in patients with fibromyalgia. Clin Physiol 14(2):159–67PubMedCrossRef Nørregaard J, Bülow PM, Mehlsen J, Danneskiold-Samsøe B (1994) Biochemical changes in relation to a maximal exercise test in patients with fibromyalgia. Clin Physiol 14(2):159–67PubMedCrossRef
509.
Zurück zum Zitat Valim V, Oliveira LM, Suda AL, Silva LE, Faro M, Neto TL et al (2002) Peak oxygen uptake and ventilatory anaerobic threshold in fibromyalgia. J Rheumatol 29(2):353–7PubMed Valim V, Oliveira LM, Suda AL, Silva LE, Faro M, Neto TL et al (2002) Peak oxygen uptake and ventilatory anaerobic threshold in fibromyalgia. J Rheumatol 29(2):353–7PubMed
510.
Zurück zum Zitat Bachasson D, Guinot M, Wuyam B, Favre-Juvin A, Millet GY, Levy P et al (2013) Neuromuscular fatigue and exercise capacity in fibromyalgia syndrome. Arthritis Care Res 65(3):432–40CrossRef Bachasson D, Guinot M, Wuyam B, Favre-Juvin A, Millet GY, Levy P et al (2013) Neuromuscular fatigue and exercise capacity in fibromyalgia syndrome. Arthritis Care Res 65(3):432–40CrossRef
511.
Zurück zum Zitat Sietsema KE, Cooper DM, Caro X, Leibling MR, Louie JS (1993) Oxygen uptake during exercise in patients with primary fibromyalgia syndrome. J Rheumatol 20(5):860–5PubMed Sietsema KE, Cooper DM, Caro X, Leibling MR, Louie JS (1993) Oxygen uptake during exercise in patients with primary fibromyalgia syndrome. J Rheumatol 20(5):860–5PubMed
512.
Zurück zum Zitat Simms RW, Roy SH, Hrovat M, Anderson JJ, Skrinar G, LePoole SR et al (1994) Lack of association between fibromyalgia syndrome and abnormalities in muscle energy metabolism. Arthritis Rheum 37(6):794–800PubMedCrossRef Simms RW, Roy SH, Hrovat M, Anderson JJ, Skrinar G, LePoole SR et al (1994) Lack of association between fibromyalgia syndrome and abnormalities in muscle energy metabolism. Arthritis Rheum 37(6):794–800PubMedCrossRef
513.
Zurück zum Zitat Valkeinen H, Hakkinen A, Alen M, Hannonen P, Kukkonen-Harjula K, Hakkinen K (2008) Physical fitness in postmenopausal women with fibromyalgia. Int J Sports Med 29(5):408–13PubMedCrossRef Valkeinen H, Hakkinen A, Alen M, Hannonen P, Kukkonen-Harjula K, Hakkinen K (2008) Physical fitness in postmenopausal women with fibromyalgia. Int J Sports Med 29(5):408–13PubMedCrossRef
514.
Zurück zum Zitat Lund E, Kendall SA, Janerot-Sjöberg B, Bengtsson A (2003) Muscle metabolism in fibromyalgia studied by P-31 magnetic resonance spectroscopy during aerobic and anaerobic exercise. Scand J Rheumatol 32(3):138–45PubMedCrossRef Lund E, Kendall SA, Janerot-Sjöberg B, Bengtsson A (2003) Muscle metabolism in fibromyalgia studied by P-31 magnetic resonance spectroscopy during aerobic and anaerobic exercise. Scand J Rheumatol 32(3):138–45PubMedCrossRef
515.
Zurück zum Zitat Valkeinen H, Hakkinen A, Hannonen P, Hakkinen K, Alen M (2006) Acute heavy-resistance exercise-induced pain and neuromuscular fatigue in elderly women with fibromyalgia and in healthy controls: effects of strength training. Arthritis Rheum 54(4):1334–9PubMedCrossRef Valkeinen H, Hakkinen A, Hannonen P, Hakkinen K, Alen M (2006) Acute heavy-resistance exercise-induced pain and neuromuscular fatigue in elderly women with fibromyalgia and in healthy controls: effects of strength training. Arthritis Rheum 54(4):1334–9PubMedCrossRef
516.
Zurück zum Zitat Gerdle B, Soderberg K, Salvador Puigvert L, Rosendal L, Larsson B (2010) Increased interstitial concentrations of pyruvate and lactate in the trapezius muscle of patients with fibromyalgia: a microdialysis study. J Rehabil Med 42(7):679–87PubMedCrossRef Gerdle B, Soderberg K, Salvador Puigvert L, Rosendal L, Larsson B (2010) Increased interstitial concentrations of pyruvate and lactate in the trapezius muscle of patients with fibromyalgia: a microdialysis study. J Rehabil Med 42(7):679–87PubMedCrossRef
517.
Zurück zum Zitat Pollak KA, Swenson JD, Vanhaitsma TA, Hughen RW, Jo D, White AT et al (2014) Exogenously applied muscle metabolites synergistically evoke sensations of muscle fatigue and pain in human subjects. Exp Physiol 99(2):368–80PubMedCentralPubMedCrossRef Pollak KA, Swenson JD, Vanhaitsma TA, Hughen RW, Jo D, White AT et al (2014) Exogenously applied muscle metabolites synergistically evoke sensations of muscle fatigue and pain in human subjects. Exp Physiol 99(2):368–80PubMedCentralPubMedCrossRef
518.
Zurück zum Zitat Nielens H, Boisset V, Masquelier E (2000) Fitness and perceived exertion in patients with fibromyalgia syndrome. Clin J Pain 16(3):209–13PubMedCrossRef Nielens H, Boisset V, Masquelier E (2000) Fitness and perceived exertion in patients with fibromyalgia syndrome. Clin J Pain 16(3):209–13PubMedCrossRef
519.
Zurück zum Zitat Falla D, Andersen H, Danneskiold-Samsoe B, Arendt-Nielsen L, Farina D (2010) Adaptations of upper trapezius muscle activity during sustained contractions in women with fibromyalgia. J Electromyogr Kinesiol 20(3):457–64PubMedCrossRef Falla D, Andersen H, Danneskiold-Samsoe B, Arendt-Nielsen L, Farina D (2010) Adaptations of upper trapezius muscle activity during sustained contractions in women with fibromyalgia. J Electromyogr Kinesiol 20(3):457–64PubMedCrossRef
520.
Zurück zum Zitat Casale R, Sarzi-Puttini P, Atzeni F, Gazzoni M, Buskila D, Rainoldi A (2009) Central motor control failure in fibromyalgia: a surface electromyography study. BMC Musculoskelet Disord 10:78PubMedCentralPubMedCrossRef Casale R, Sarzi-Puttini P, Atzeni F, Gazzoni M, Buskila D, Rainoldi A (2009) Central motor control failure in fibromyalgia: a surface electromyography study. BMC Musculoskelet Disord 10:78PubMedCentralPubMedCrossRef
521.
Zurück zum Zitat Klaver-Król EG, Rasker JJ, Henriquez NR, Verheijen WG, Zwarts MJ (2012) Muscle fiber velocity and electromyographic signs of fatigue in fibromyalgia. Muscle Nerve 46(5):738–45PubMedCrossRef Klaver-Król EG, Rasker JJ, Henriquez NR, Verheijen WG, Zwarts MJ (2012) Muscle fiber velocity and electromyographic signs of fatigue in fibromyalgia. Muscle Nerve 46(5):738–45PubMedCrossRef
522.
Zurück zum Zitat Bandak E, Amris K, Bliddal H, Danneskiold-Samsoe B, Henriksen M (2013) Muscle fatigue in fibromyalgia is in the brain, not in the muscles: a case–control study of perceived versus objective muscle fatigue. Ann Rheum Dis 72(6):963–6PubMedCrossRef Bandak E, Amris K, Bliddal H, Danneskiold-Samsoe B, Henriksen M (2013) Muscle fatigue in fibromyalgia is in the brain, not in the muscles: a case–control study of perceived versus objective muscle fatigue. Ann Rheum Dis 72(6):963–6PubMedCrossRef
523.
Zurück zum Zitat Bazzichi L, Dini M, Rossi A, Corbianco S, De Feo F, Giacomelli C et al (2009) Muscle modifications in fibromyalgic patients revealed by surface electromyography (SEMG) analysis. BMC Musculoskelet Disord 10:36PubMedCentralPubMedCrossRef Bazzichi L, Dini M, Rossi A, Corbianco S, De Feo F, Giacomelli C et al (2009) Muscle modifications in fibromyalgic patients revealed by surface electromyography (SEMG) analysis. BMC Musculoskelet Disord 10:36PubMedCentralPubMedCrossRef
524.
Zurück zum Zitat Elert JE, Rantapaa-Dahlqvist SB, Henriksson-Larsen K, Lorentzon R, Gerdle BU (1992) Muscle performance, electromyography and fibre type composition in fibromyalgia and work-related myalgia. Scand J Rheumatol 21(1):28–34PubMedCrossRef Elert JE, Rantapaa-Dahlqvist SB, Henriksson-Larsen K, Lorentzon R, Gerdle BU (1992) Muscle performance, electromyography and fibre type composition in fibromyalgia and work-related myalgia. Scand J Rheumatol 21(1):28–34PubMedCrossRef
525.
Zurück zum Zitat Gerdle B, Gronlund C, Karlsson SJ, Holtermann A, Roeleveld K (2010) Altered neuromuscular control mechanisms of the trapezius muscle in fibromyalgia. BMC Musculoskelet Disord 11:42PubMedCentralPubMedCrossRef Gerdle B, Gronlund C, Karlsson SJ, Holtermann A, Roeleveld K (2010) Altered neuromuscular control mechanisms of the trapezius muscle in fibromyalgia. BMC Musculoskelet Disord 11:42PubMedCentralPubMedCrossRef
526.
Zurück zum Zitat Bengtsson M, Bengtsson A, Jorfeldt L (1989) Diagnostic epidural opioid blockade in primary fibromyalgia at rest and during exercise. Pain 39(2):171–80PubMedCrossRef Bengtsson M, Bengtsson A, Jorfeldt L (1989) Diagnostic epidural opioid blockade in primary fibromyalgia at rest and during exercise. Pain 39(2):171–80PubMedCrossRef
527.
Zurück zum Zitat Bennett RM, Goldenberg DL (2011) Fibromyalgia, myofascial pain, tender points and trigger points: splitting or lumping? Arthritis Res Ther 13(3):117PubMedCentralPubMedCrossRef Bennett RM, Goldenberg DL (2011) Fibromyalgia, myofascial pain, tender points and trigger points: splitting or lumping? Arthritis Res Ther 13(3):117PubMedCentralPubMedCrossRef
528.
Zurück zum Zitat Ge HY, Wang Y, Danneskiold-Samsoe B, Graven-Nielsen T, Arendt-Nielsen L (2010) The predetermined sites of examination for tender points in fibromyalgia syndrome are frequently associated with myofascial trigger points. J Pain 11(7):644–51PubMedCrossRef Ge HY, Wang Y, Danneskiold-Samsoe B, Graven-Nielsen T, Arendt-Nielsen L (2010) The predetermined sites of examination for tender points in fibromyalgia syndrome are frequently associated with myofascial trigger points. J Pain 11(7):644–51PubMedCrossRef
529.
Zurück zum Zitat Alonso-Blanco C, Fernandez-de-las-Penas C, Morales-Cabezas M, Zarco-Moreno P, Ge HY, Florez-Garcia M (2011) Multiple active myofascial trigger points reproduce the overall spontaneous pain pattern in women with fibromyalgia and are related to widespread mechanical hypersensitivity. Clin J Pain 27(5):405–13PubMedCrossRef Alonso-Blanco C, Fernandez-de-las-Penas C, Morales-Cabezas M, Zarco-Moreno P, Ge HY, Florez-Garcia M (2011) Multiple active myofascial trigger points reproduce the overall spontaneous pain pattern in women with fibromyalgia and are related to widespread mechanical hypersensitivity. Clin J Pain 27(5):405–13PubMedCrossRef
530.
Zurück zum Zitat Giamberardino MA, Affaitati G, Fabrizio A, Costantini R (2011) Effects of treatment of myofascial trigger points on the pain of fibromyalgia. Curr Pain Headache Rep 15(5):393–9PubMedCrossRef Giamberardino MA, Affaitati G, Fabrizio A, Costantini R (2011) Effects of treatment of myofascial trigger points on the pain of fibromyalgia. Curr Pain Headache Rep 15(5):393–9PubMedCrossRef
531.
Zurück zum Zitat Xu YM, Ge HY, Arendt-Nielsen L (2010) Sustained nociceptive mechanical stimulation of latent myofascial trigger point induces central sensitization in healthy subjects. J Pain 11(12):1348–55PubMedCrossRef Xu YM, Ge HY, Arendt-Nielsen L (2010) Sustained nociceptive mechanical stimulation of latent myofascial trigger point induces central sensitization in healthy subjects. J Pain 11(12):1348–55PubMedCrossRef
532.
Zurück zum Zitat Simms RW, Goldenberg DL (1988) Symptoms mimicking neurologic disorders in fibromyalgia syndrome. J Rheumatol 15(8):1271–3PubMed Simms RW, Goldenberg DL (1988) Symptoms mimicking neurologic disorders in fibromyalgia syndrome. J Rheumatol 15(8):1271–3PubMed
533.
Zurück zum Zitat Martinez-Lavin M, Lopez S, Medina M, Nava A (2003) Use of the Leeds assessment of neuropathic symptoms and signs questionnaire in patients with fibromyalgia. Semin Arthritis Rheum 32(6):407–11PubMedCrossRef Martinez-Lavin M, Lopez S, Medina M, Nava A (2003) Use of the Leeds assessment of neuropathic symptoms and signs questionnaire in patients with fibromyalgia. Semin Arthritis Rheum 32(6):407–11PubMedCrossRef
534.
Zurück zum Zitat Rehm SE, Koroschetz J, Gockel U, Brosz M, Freynhagen R, Tolle TR et al (2010) A cross-sectional survey of 3035 patients with fibromyalgia: subgroups of patients with typical comorbidities and sensory symptom profiles. Rheumatology (Oxford) 49(6):1146–52CrossRef Rehm SE, Koroschetz J, Gockel U, Brosz M, Freynhagen R, Tolle TR et al (2010) A cross-sectional survey of 3035 patients with fibromyalgia: subgroups of patients with typical comorbidities and sensory symptom profiles. Rheumatology (Oxford) 49(6):1146–52CrossRef
535.
Zurück zum Zitat Üçeyler N, Sommer C (2013) Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain 154(11):2569PubMedCrossRef Üçeyler N, Sommer C (2013) Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain 154(11):2569PubMedCrossRef
536.
Zurück zum Zitat Garcia-Larrea L (2012) Objective pain diagnostics: clinical neurophysiology. Neurophysiol Clin 42(4):187–97PubMedCrossRef Garcia-Larrea L (2012) Objective pain diagnostics: clinical neurophysiology. Neurophysiol Clin 42(4):187–97PubMedCrossRef
537.
Zurück zum Zitat Lorenz J (1998) Hyperalgesia or hypervigilance? an evoked potential approach to the study of fibromyalgia syndrome. Z Rheumatol 57(Suppl 2):19–22PubMedCrossRef Lorenz J (1998) Hyperalgesia or hypervigilance? an evoked potential approach to the study of fibromyalgia syndrome. Z Rheumatol 57(Suppl 2):19–22PubMedCrossRef
538.
Zurück zum Zitat de Tommaso M, Federici A, Santostasi R, Calabrese R, Vecchio E, Lapadula G et al (2011) Laser-evoked potentials habituation in fibromyalgia. J Pain 12(1):116–24PubMedCrossRef de Tommaso M, Federici A, Santostasi R, Calabrese R, Vecchio E, Lapadula G et al (2011) Laser-evoked potentials habituation in fibromyalgia. J Pain 12(1):116–24PubMedCrossRef
539.
Zurück zum Zitat Gormsen L, Bach FW, Rosenberg R, Jensen TS (2012) Differential pain modulation in patients with peripheral neuropathic pain and fibromyalgia. Scand J Pain 3:116–23CrossRef Gormsen L, Bach FW, Rosenberg R, Jensen TS (2012) Differential pain modulation in patients with peripheral neuropathic pain and fibromyalgia. Scand J Pain 3:116–23CrossRef
540.
Zurück zum Zitat Oaklander AL, Herzog ZD, Downs HM, Klein MM (2013) Reply to the letter to the editor. Pain 154(11):2569–71PubMedCrossRef Oaklander AL, Herzog ZD, Downs HM, Klein MM (2013) Reply to the letter to the editor. Pain 154(11):2569–71PubMedCrossRef
541.
Zurück zum Zitat Serra J, Collado A, Sola R, Antonelli F, Torres X, Salgueiro M et al (2014) Hyperexcitable C nociceptors in fibromyalgia. Ann Neurol 75(2):196–208PubMedCrossRef Serra J, Collado A, Sola R, Antonelli F, Torres X, Salgueiro M et al (2014) Hyperexcitable C nociceptors in fibromyalgia. Ann Neurol 75(2):196–208PubMedCrossRef
542.
Zurück zum Zitat Albrecht PJ, Hou Q, Argoff CE, Storey JR, Wymer JP, Rice FL (2013) Excessive peptidergic sensory innervation of cutaneous arteriole-venule shunts (AVS) in the palmar glabrous skin of fibromyalgia patients: implications for widespread deep tissue pain and fatigue. Pain Med 14(6):895–915PubMedCrossRef Albrecht PJ, Hou Q, Argoff CE, Storey JR, Wymer JP, Rice FL (2013) Excessive peptidergic sensory innervation of cutaneous arteriole-venule shunts (AVS) in the palmar glabrous skin of fibromyalgia patients: implications for widespread deep tissue pain and fatigue. Pain Med 14(6):895–915PubMedCrossRef
543.
Zurück zum Zitat Friend R, Bennett RM (2011) Distinguishing fibromyalgia from rheumatoid arthritis and systemic lupus in clinical questionnaires: an analysis of the revised fibromyalgia impact questionnaire (FIQR) and its variant, the symptom impact questionnaire (SIQR), along with pain locations. Arthritis Res Ther 13(2):R58PubMedCentralPubMedCrossRef Friend R, Bennett RM (2011) Distinguishing fibromyalgia from rheumatoid arthritis and systemic lupus in clinical questionnaires: an analysis of the revised fibromyalgia impact questionnaire (FIQR) and its variant, the symptom impact questionnaire (SIQR), along with pain locations. Arthritis Res Ther 13(2):R58PubMedCentralPubMedCrossRef
545.
Zurück zum Zitat Gupta A, Silman AJ, Ray D, Morriss R, Dickens C, MacFarlane GJ et al (2007) The role of psychosocial factors in predicting the onset of chronic widespread pain: results from a prospective population-based study. Rheumatology (Oxford) 46(4):666–71CrossRef Gupta A, Silman AJ, Ray D, Morriss R, Dickens C, MacFarlane GJ et al (2007) The role of psychosocial factors in predicting the onset of chronic widespread pain: results from a prospective population-based study. Rheumatology (Oxford) 46(4):666–71CrossRef
546.
Zurück zum Zitat Mundal I, Grawe RW, Bjorngaard JH, Linaker OM, Fors EA (2014) Prevalence and long-term predictors of persistent chronic widespread pain in the general population in an 11 years prospective study: the HUNT study. BMC Musculoskelet Disord 15:213PubMedCentralPubMedCrossRef Mundal I, Grawe RW, Bjorngaard JH, Linaker OM, Fors EA (2014) Prevalence and long-term predictors of persistent chronic widespread pain in the general population in an 11 years prospective study: the HUNT study. BMC Musculoskelet Disord 15:213PubMedCentralPubMedCrossRef
547.
Zurück zum Zitat Nitter AK, Pripp AH, Forseth KO (2012) Are sleep problems and non-specific health complaints risk factors for chronic pain? a prospective population-based study with 17 years follow-up. Scand J Pain 3:210–7CrossRef Nitter AK, Pripp AH, Forseth KO (2012) Are sleep problems and non-specific health complaints risk factors for chronic pain? a prospective population-based study with 17 years follow-up. Scand J Pain 3:210–7CrossRef
548.
Zurück zum Zitat Odegård SS, Omland PM, Nilsen KB, Stjern M, Gravdahl GB, Sand T (2014) The effect of sleep restriction on laser evoked potentials, thermal sensory and pain thresholds and suprathreshold pain in healthy subjects. Clin Neurophysiol. doi:10.1016/j.clinph.2014.12.011, accessed 2/26/15 PubMed Odegård SS, Omland PM, Nilsen KB, Stjern M, Gravdahl GB, Sand T (2014) The effect of sleep restriction on laser evoked potentials, thermal sensory and pain thresholds and suprathreshold pain in healthy subjects. Clin Neurophysiol. doi:10.​1016/​j.​clinph.​2014.​12.​011, accessed 2/26/15 PubMed
549.
Zurück zum Zitat Schuh-Hofer S, Wodarski R, Pfau DB, Caspani O, Magerl W, Kennedy JD et al (2013) One night of total sleep deprivation promotes a state of generalized hyperalgesia: a surrogate pain model to study the relationship of insomnia and pain. Pain 154(9):1613–21PubMedCrossRef Schuh-Hofer S, Wodarski R, Pfau DB, Caspani O, Magerl W, Kennedy JD et al (2013) One night of total sleep deprivation promotes a state of generalized hyperalgesia: a surrogate pain model to study the relationship of insomnia and pain. Pain 154(9):1613–21PubMedCrossRef
550.
Zurück zum Zitat Roehrs TA, Harris E, Randall S, Roth T (2012) Pain sensitivity and recovery from mild chronic sleep loss. Sleep 35(12):1667–72PubMedCentralPubMed Roehrs TA, Harris E, Randall S, Roth T (2012) Pain sensitivity and recovery from mild chronic sleep loss. Sleep 35(12):1667–72PubMedCentralPubMed
551.
Zurück zum Zitat Onen SH, Alloui A, Gross A, Eschallier A, Dubray C (2001) The effects of total sleep deprivation, selective sleep interruption and sleep recovery on pain tolerance thresholds in healthy subjects. J Sleep Res 10(1):35–42PubMedCrossRef Onen SH, Alloui A, Gross A, Eschallier A, Dubray C (2001) The effects of total sleep deprivation, selective sleep interruption and sleep recovery on pain tolerance thresholds in healthy subjects. J Sleep Res 10(1):35–42PubMedCrossRef
552.
Zurück zum Zitat Busch V, Haas J, Cronlein T, Pieh C, Geisler P, Hajak G et al (2012) Sleep deprivation in chronic somatoform pain-effects on mood and pain regulation. Psychiatry Res 195(3):134–43PubMedCrossRef Busch V, Haas J, Cronlein T, Pieh C, Geisler P, Hajak G et al (2012) Sleep deprivation in chronic somatoform pain-effects on mood and pain regulation. Psychiatry Res 195(3):134–43PubMedCrossRef
553.
Zurück zum Zitat Azevedo E, Manzano GM, Silva A, Martins R, Andersen ML, Tufik S (2011) The effects of total and REM sleep deprivation on laser-evoked potential threshold and pain perception. Pain 152(9):2052–8PubMedCrossRef Azevedo E, Manzano GM, Silva A, Martins R, Andersen ML, Tufik S (2011) The effects of total and REM sleep deprivation on laser-evoked potential threshold and pain perception. Pain 152(9):2052–8PubMedCrossRef
554.
Zurück zum Zitat Haack M, Mullington JM (2005) Sustained sleep restriction reduces emotional and physical well-being. Pain 119(1–3):56–64PubMedCrossRef Haack M, Mullington JM (2005) Sustained sleep restriction reduces emotional and physical well-being. Pain 119(1–3):56–64PubMedCrossRef
555.
Zurück zum Zitat Haack M, Lee E, Cohen DA, Mullington JM (2009) Activation of the prostaglandin system in response to sleep loss in healthy humans: potential mediator of increased spontaneous pain. Pain 145(1–2):136–41PubMedCentralPubMedCrossRef Haack M, Lee E, Cohen DA, Mullington JM (2009) Activation of the prostaglandin system in response to sleep loss in healthy humans: potential mediator of increased spontaneous pain. Pain 145(1–2):136–41PubMedCentralPubMedCrossRef
556.
Zurück zum Zitat Irwin MR, Olmstead R, Carrillo C, Sadeghi N, Fitzgerald JD, Ranganath VK et al (2012) Sleep loss exacerbates fatigue, depression, and pain in rheumatoid arthritis. Sleep 35(4):537–43PubMedCentralPubMed Irwin MR, Olmstead R, Carrillo C, Sadeghi N, Fitzgerald JD, Ranganath VK et al (2012) Sleep loss exacerbates fatigue, depression, and pain in rheumatoid arthritis. Sleep 35(4):537–43PubMedCentralPubMed
557.
Zurück zum Zitat Smith MT, Edwards RR, McCann UD, Haythornthwaite JA (2007) The effects of sleep deprivation on pain inhibition and spontaneous pain in women. Sleep 30(4):494–505PubMed Smith MT, Edwards RR, McCann UD, Haythornthwaite JA (2007) The effects of sleep deprivation on pain inhibition and spontaneous pain in women. Sleep 30(4):494–505PubMed
558.
Zurück zum Zitat Kundermann B, Spernal J, Huber MT, Krieg JC, Lautenbacher S (2004) Sleep deprivation affects thermal pain thresholds but not somatosensory thresholds in healthy volunteers. Psychosom Med 66(6):932–7PubMedCrossRef Kundermann B, Spernal J, Huber MT, Krieg JC, Lautenbacher S (2004) Sleep deprivation affects thermal pain thresholds but not somatosensory thresholds in healthy volunteers. Psychosom Med 66(6):932–7PubMedCrossRef
559.
Zurück zum Zitat Kundermann B, Hemmeter-Spernal J, Huber MT, Krieg JC, Lautenbacher S (2008) Effects of total sleep deprivation in major depression: overnight improvement of mood is accompanied by increased pain sensitivity and augmented pain complaints. Psychosom Med 70(1):92–101PubMedCrossRef Kundermann B, Hemmeter-Spernal J, Huber MT, Krieg JC, Lautenbacher S (2008) Effects of total sleep deprivation in major depression: overnight improvement of mood is accompanied by increased pain sensitivity and augmented pain complaints. Psychosom Med 70(1):92–101PubMedCrossRef
560.
Zurück zum Zitat Tiede W, Magerl W, Baumgartner U, Durrer B, Ehlert U, Treede RD (2010) Sleep restriction attenuates amplitudes and attentional modulation of pain-related evoked potentials, but augments pain ratings in healthy volunteers. Pain 148(1):36–42PubMedCrossRef Tiede W, Magerl W, Baumgartner U, Durrer B, Ehlert U, Treede RD (2010) Sleep restriction attenuates amplitudes and attentional modulation of pain-related evoked potentials, but augments pain ratings in healthy volunteers. Pain 148(1):36–42PubMedCrossRef
561.
Zurück zum Zitat Imbe H, Iwai-Liao Y, Senba E (2006) Stress-induced hyperalgesia: animal models and putative mechanisms. Front Biosci 11:2179–92PubMedCrossRef Imbe H, Iwai-Liao Y, Senba E (2006) Stress-induced hyperalgesia: animal models and putative mechanisms. Front Biosci 11:2179–92PubMedCrossRef
562.
Zurück zum Zitat Jennings EM, Okine BN, Roche M, Finn DP (2014) Stress-induced hyperalgesia. Prog Neurobiol 121:1–18PubMedCrossRef Jennings EM, Okine BN, Roche M, Finn DP (2014) Stress-induced hyperalgesia. Prog Neurobiol 121:1–18PubMedCrossRef
563.
Zurück zum Zitat Michaux GP, Magerl W, Anton F, Treede RD (2012) Experimental characterization of the effects of acute stresslike doses of hydrocortisone in human neurogenic hyperalgesia models. Pain 153(2):420–8PubMedCrossRef Michaux GP, Magerl W, Anton F, Treede RD (2012) Experimental characterization of the effects of acute stresslike doses of hydrocortisone in human neurogenic hyperalgesia models. Pain 153(2):420–8PubMedCrossRef
564.
Zurück zum Zitat Kuehl LK, Michaux GP, Richter S, Schachinger H, Anton F (2010) Increased basal mechanical pain sensitivity but decreased perceptual wind-up in a human model of relative hypocortisolism. Pain 149(3):539–46PubMedCrossRef Kuehl LK, Michaux GP, Richter S, Schachinger H, Anton F (2010) Increased basal mechanical pain sensitivity but decreased perceptual wind-up in a human model of relative hypocortisolism. Pain 149(3):539–46PubMedCrossRef
565.
Zurück zum Zitat Bansevicius D, Westgaard RH, Stiles T (2001) EMG activity and pain development in fibromyalgia patients exposed to mental stress of long duration. Scand J Rheumatol 30(2):92–8PubMedCrossRef Bansevicius D, Westgaard RH, Stiles T (2001) EMG activity and pain development in fibromyalgia patients exposed to mental stress of long duration. Scand J Rheumatol 30(2):92–8PubMedCrossRef
566.
Zurück zum Zitat Nilsen KB, Westgaard RH, Stovner LJ, Helde G, Ro M, Sand TH (2006) Pain induced by low-grade stress in patients with fibromyalgia and chronic shoulder/neck pain, relation to surface electromyography. Eur J Pain 10(7):615–27PubMedCrossRef Nilsen KB, Westgaard RH, Stovner LJ, Helde G, Ro M, Sand TH (2006) Pain induced by low-grade stress in patients with fibromyalgia and chronic shoulder/neck pain, relation to surface electromyography. Eur J Pain 10(7):615–27PubMedCrossRef
567.
Zurück zum Zitat Crettaz B, Marziniak M, Willeke P, Young P, Hellhammer D, Stumpf A et al (2013) Stress-induced allodynia—evidence of increased pain sensitivity in healthy humans and patients with chronic pain after experimentally induced psychosocial stress. PLoS One 8(8):e69460PubMedCentralPubMedCrossRef Crettaz B, Marziniak M, Willeke P, Young P, Hellhammer D, Stumpf A et al (2013) Stress-induced allodynia—evidence of increased pain sensitivity in healthy humans and patients with chronic pain after experimentally induced psychosocial stress. PLoS One 8(8):e69460PubMedCentralPubMedCrossRef
568.
Zurück zum Zitat McBeth J, Macfarlane GJ, Benjamin S, Silman AJ (2001) Features of somatization predict the onset of chronic widespread pain: results of a large population-based study. Arthritis Rheum 44(4):940–6PubMedCrossRef McBeth J, Macfarlane GJ, Benjamin S, Silman AJ (2001) Features of somatization predict the onset of chronic widespread pain: results of a large population-based study. Arthritis Rheum 44(4):940–6PubMedCrossRef
569.
Zurück zum Zitat McBeth J, Chiu YH, Silman AJ, Ray D, Morriss R, Dickens C et al (2005) Hypothalamic-pituitary-adrenal stress axis function and the relationship with chronic widespread pain and its antecedents. Arthritis Res Ther 7(5):R992–R1000PubMedCentralPubMedCrossRef McBeth J, Chiu YH, Silman AJ, Ray D, Morriss R, Dickens C et al (2005) Hypothalamic-pituitary-adrenal stress axis function and the relationship with chronic widespread pain and its antecedents. Arthritis Res Ther 7(5):R992–R1000PubMedCentralPubMedCrossRef
570.
Zurück zum Zitat McBeth J, Silman AJ, Gupta A, Chiu YH, Ray D, Morriss R et al (2007) Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of chronic widespread musculoskeletal pain: findings of a population-based prospective cohort study. Arthritis Rheum 56(1):360–71PubMedCrossRef McBeth J, Silman AJ, Gupta A, Chiu YH, Ray D, Morriss R et al (2007) Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of chronic widespread musculoskeletal pain: findings of a population-based prospective cohort study. Arthritis Rheum 56(1):360–71PubMedCrossRef
571.
Zurück zum Zitat McLean SA, Williams DA, Stein PK, Harris RE, Lyden AK, Whalen G et al (2006) Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia. Neuropsychopharmacology 31(12):2776–82PubMedCrossRef McLean SA, Williams DA, Stein PK, Harris RE, Lyden AK, Whalen G et al (2006) Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia. Neuropsychopharmacology 31(12):2776–82PubMedCrossRef
572.
Zurück zum Zitat Loevinger BL, Shirtcliff EA, Muller D, Alonso C, Coe CL (2012) Delineating psychological and biomedical profiles in a heterogeneous fibromyalgia population using cluster analysis. Clin Rheumatol 31(4):677–85PubMedCentralPubMedCrossRef Loevinger BL, Shirtcliff EA, Muller D, Alonso C, Coe CL (2012) Delineating psychological and biomedical profiles in a heterogeneous fibromyalgia population using cluster analysis. Clin Rheumatol 31(4):677–85PubMedCentralPubMedCrossRef
573.
Zurück zum Zitat Häuser W, Thieme K, Turk DC (2010) Guidelines on the management of fibromyalgia syndrome—a systematic review. Eur J Pain 14(1):5–10PubMedCrossRef Häuser W, Thieme K, Turk DC (2010) Guidelines on the management of fibromyalgia syndrome—a systematic review. Eur J Pain 14(1):5–10PubMedCrossRef
574.
Zurück zum Zitat Fitzcharles MA, Ste-Marie PA, Panopalis P, Menard H, Shir Y, Wolfe F (2012) The 2010 American college of rheumatology fibromyalgia survey diagnostic criteria and symptom severity scale is a valid and reliable tool in a French speaking fibromyalgia cohort. BMC Musculoskelet Disord 13:179PubMedCentralPubMedCrossRef Fitzcharles MA, Ste-Marie PA, Panopalis P, Menard H, Shir Y, Wolfe F (2012) The 2010 American college of rheumatology fibromyalgia survey diagnostic criteria and symptom severity scale is a valid and reliable tool in a French speaking fibromyalgia cohort. BMC Musculoskelet Disord 13:179PubMedCentralPubMedCrossRef
575.
Zurück zum Zitat Carville SF, Arendt-Nielsen S, Bliddal H, Blotman F, Branco JC, Buskila D et al (2008) EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 67(4):536–41PubMedCrossRef Carville SF, Arendt-Nielsen S, Bliddal H, Blotman F, Branco JC, Buskila D et al (2008) EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 67(4):536–41PubMedCrossRef
576.
Zurück zum Zitat Häuser W, Bernardy K, Arnold B, Offenbächer M, Schiltenwolf M (2009) Efficacy of multicomponent treatment in fibromyalgia syndrome: a meta-analysis of randomized controlled clinical trials. Arthritis Rheum 61(2):216–24PubMedCrossRef Häuser W, Bernardy K, Arnold B, Offenbächer M, Schiltenwolf M (2009) Efficacy of multicomponent treatment in fibromyalgia syndrome: a meta-analysis of randomized controlled clinical trials. Arthritis Rheum 61(2):216–24PubMedCrossRef
577.
Zurück zum Zitat Hughes G, Martinez C, Myon E, Taieb C, Wessely S (2006) The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice. Arthritis Rheum 54(1):177–83PubMedCrossRef Hughes G, Martinez C, Myon E, Taieb C, Wessely S (2006) The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice. Arthritis Rheum 54(1):177–83PubMedCrossRef
578.
Zurück zum Zitat Annemans L, Wessely S, Spaepen E, Caekelbergh K, Caubere JP, Le Lay K et al (2008) Health economic consequences related to the diagnosis of fibromyalgia syndrome. Arthritis Rheum 58(3):895–902PubMedCrossRef Annemans L, Wessely S, Spaepen E, Caekelbergh K, Caubere JP, Le Lay K et al (2008) Health economic consequences related to the diagnosis of fibromyalgia syndrome. Arthritis Rheum 58(3):895–902PubMedCrossRef
579.
Zurück zum Zitat Sanchez RJ, Uribe C, Li H, Alvir J, Deminski M, Chandran A et al (2011) Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgia. Curr Med Res Opin 27(3):663–71PubMedCrossRef Sanchez RJ, Uribe C, Li H, Alvir J, Deminski M, Chandran A et al (2011) Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgia. Curr Med Res Opin 27(3):663–71PubMedCrossRef
580.
Zurück zum Zitat White LA, Robinson RL, Yu AP, Kaltenboeck A, Samuels S, Mallett D et al (2009) Comparison of health care use and costs in newly diagnosed and established patients with fibromyalgia. J Pain 10(9):976–83PubMedCrossRef White LA, Robinson RL, Yu AP, Kaltenboeck A, Samuels S, Mallett D et al (2009) Comparison of health care use and costs in newly diagnosed and established patients with fibromyalgia. J Pain 10(9):976–83PubMedCrossRef
581.
Zurück zum Zitat Berger A, Sadosky A, Dukes EM, Edelsberg J, Zlateva G, Oster G (2010) Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgia. Am J Manage Care 16(5 Suppl):S126–37 Berger A, Sadosky A, Dukes EM, Edelsberg J, Zlateva G, Oster G (2010) Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgia. Am J Manage Care 16(5 Suppl):S126–37
582.
Zurück zum Zitat Perrot S, Russell IJ (2014) More ubiquitous effects from non-pharmacologic than from pharmacologic treatments for fibromyalgia syndrome: a meta-analysis examining six core symptoms. Eur J Pain 18(8):1067–80PubMedCrossRef Perrot S, Russell IJ (2014) More ubiquitous effects from non-pharmacologic than from pharmacologic treatments for fibromyalgia syndrome: a meta-analysis examining six core symptoms. Eur J Pain 18(8):1067–80PubMedCrossRef
583.
Zurück zum Zitat Häuser W, Klose P, Langhorst J, Moradi B, Steinbach M, Schiltenwolf M et al (2010) Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomised controlled trials. Arthritis Res Ther 12(3):R79PubMedCentralPubMedCrossRef Häuser W, Klose P, Langhorst J, Moradi B, Steinbach M, Schiltenwolf M et al (2010) Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomised controlled trials. Arthritis Res Ther 12(3):R79PubMedCentralPubMedCrossRef
584.
Zurück zum Zitat Cunningham MM, Jillings C (2006) Individuals’ descriptions of living with fibromyalgia. Clin Nurs Res 15(4):258–73PubMedCrossRef Cunningham MM, Jillings C (2006) Individuals’ descriptions of living with fibromyalgia. Clin Nurs Res 15(4):258–73PubMedCrossRef
585.
Zurück zum Zitat Staud R, Robinson ME, Weyl EE, Price DD (2010) Pain variability in fibromyalgia is related to activity and rest: role of peripheral tissue impulse input. J Pain 11(12):1376–83PubMedCentralPubMedCrossRef Staud R, Robinson ME, Weyl EE, Price DD (2010) Pain variability in fibromyalgia is related to activity and rest: role of peripheral tissue impulse input. J Pain 11(12):1376–83PubMedCentralPubMedCrossRef
586.
Zurück zum Zitat Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ (2015) Amitriptyline for fibromyalgia in adults. Cochrane Database Syst Rev 7:CD011824PubMed Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ (2015) Amitriptyline for fibromyalgia in adults. Cochrane Database Syst Rev 7:CD011824PubMed
587.
Zurück zum Zitat Häuser W, Wolfe F, Tölle T, Üçeyler N, Sommer C (2012) The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis. CNS Drugs 26(4):297–307PubMedCrossRef Häuser W, Wolfe F, Tölle T, Üçeyler N, Sommer C (2012) The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis. CNS Drugs 26(4):297–307PubMedCrossRef
588.
Zurück zum Zitat Üceyler N, Sommer C, Walitt B, Häuser W (2013) Anticonvulsants for fibromyalgia. Cochrane Database Syst Rev 10:CD010782PubMed Üceyler N, Sommer C, Walitt B, Häuser W (2013) Anticonvulsants for fibromyalgia. Cochrane Database Syst Rev 10:CD010782PubMed
589.
Zurück zum Zitat Walitt B, Urrutia G, Nishishinya MB, Cantrell SE, Hauser W (2015) Selective serotonin reuptake inhibitors for fibromyalgia syndrome. Cochrane Database Syst Rev 6:CD011735PubMed Walitt B, Urrutia G, Nishishinya MB, Cantrell SE, Hauser W (2015) Selective serotonin reuptake inhibitors for fibromyalgia syndrome. Cochrane Database Syst Rev 6:CD011735PubMed
590.
Zurück zum Zitat Ursini F, Naty S, Grembiale RD (2011) Fibromyalgia and obesity: the hidden link. Rheumatol Int 31(11):1403–8PubMedCrossRef Ursini F, Naty S, Grembiale RD (2011) Fibromyalgia and obesity: the hidden link. Rheumatol Int 31(11):1403–8PubMedCrossRef
591.
Zurück zum Zitat Kim CH, Luedtke CA, Vincent A, Thompson JM, Oh TH (2012) Association of body mass index with symptom severity and quality of life in patients with fibromyalgia. Arthritis Care Res 64(2):222–8CrossRef Kim CH, Luedtke CA, Vincent A, Thompson JM, Oh TH (2012) Association of body mass index with symptom severity and quality of life in patients with fibromyalgia. Arthritis Care Res 64(2):222–8CrossRef
592.
Zurück zum Zitat Annemans L, Le Lay K, Taieb C (2009) Societal and patient burden of fibromyalgia syndrome. Pharmacoeconomics 27(7):547–59PubMedCrossRef Annemans L, Le Lay K, Taieb C (2009) Societal and patient burden of fibromyalgia syndrome. Pharmacoeconomics 27(7):547–59PubMedCrossRef
593.
Zurück zum Zitat Fitzcharles MA, Costa DD, Poyhia R (2003) A study of standard care in fibromyalgia syndrome: a favorable outcome. J Rheumatol 30(1):154–9PubMed Fitzcharles MA, Costa DD, Poyhia R (2003) A study of standard care in fibromyalgia syndrome: a favorable outcome. J Rheumatol 30(1):154–9PubMed
594.
Zurück zum Zitat Granges G, Zilko P, Littlejohn GO (1994) Fibromyalgia syndrome: assessment of the severity of the condition 2 years after diagnosis. J Rheumatol 21(3):523–9PubMed Granges G, Zilko P, Littlejohn GO (1994) Fibromyalgia syndrome: assessment of the severity of the condition 2 years after diagnosis. J Rheumatol 21(3):523–9PubMed
595.
Zurück zum Zitat Macfarlane GJ, Thomas E, Papageorgiou AC, Schollum J, Croft PR, Silman AJ (1996) The natural history of chronic pain in the community: a better prognosis than in the clinic? J Rheumatol 23(9):1617–20PubMed Macfarlane GJ, Thomas E, Papageorgiou AC, Schollum J, Croft PR, Silman AJ (1996) The natural history of chronic pain in the community: a better prognosis than in the clinic? J Rheumatol 23(9):1617–20PubMed
596.
Zurück zum Zitat Perrot S, Winkelmann A, Dukes E, Xu X, Schaefer C, Ryan K et al (2010) Characteristics of patients with fibromyalgia in France and Germany. Int J Clin Pract 64(8):1100–8PubMedCrossRef Perrot S, Winkelmann A, Dukes E, Xu X, Schaefer C, Ryan K et al (2010) Characteristics of patients with fibromyalgia in France and Germany. Int J Clin Pract 64(8):1100–8PubMedCrossRef
597.
Zurück zum Zitat Wolfe F, Hassett AL, Walitt B, Michaud K (2011) Mortality in fibromyalgia: a study of 8,186 patients over 35 years. Arthritis Care Res 63(1):94–101CrossRef Wolfe F, Hassett AL, Walitt B, Michaud K (2011) Mortality in fibromyalgia: a study of 8,186 patients over 35 years. Arthritis Care Res 63(1):94–101CrossRef
598.
Zurück zum Zitat Schwarz MJ, Offenbaecher M, Neumeister A, Ewert T, Willeit M, Praschak-Rieder N et al (2002) Evidence for an altered tryptophan metabolism in fibromyalgia. Neurobiol Dis 11(3):434–42PubMedCrossRef Schwarz MJ, Offenbaecher M, Neumeister A, Ewert T, Willeit M, Praschak-Rieder N et al (2002) Evidence for an altered tryptophan metabolism in fibromyalgia. Neurobiol Dis 11(3):434–42PubMedCrossRef
599.
Zurück zum Zitat Turk DC, Okifuji A, Sinclair JD, Starz TW (1996) Pain, disability, and physical functioning in subgroups of patients with fibromyalgia. J Rheumatol 23(7):1255–62PubMed Turk DC, Okifuji A, Sinclair JD, Starz TW (1996) Pain, disability, and physical functioning in subgroups of patients with fibromyalgia. J Rheumatol 23(7):1255–62PubMed
600.
Zurück zum Zitat Turk DC, Okifuji A, Sinclair JD, Starz TW (1998) Differential responses by psychosocial subgroups of fibromyalgia syndrome patients to an interdisciplinary treatment. Arthritis Care Res 11(5):397–404PubMedCrossRef Turk DC, Okifuji A, Sinclair JD, Starz TW (1998) Differential responses by psychosocial subgroups of fibromyalgia syndrome patients to an interdisciplinary treatment. Arthritis Care Res 11(5):397–404PubMedCrossRef
601.
Zurück zum Zitat Verra ML, Angst F, Brioschi R, Lehmann S, Keefe FJ, Staal JB et al (2009) Does classification of persons with fibromyalgia into multidimensional pain inventory subgroups detect differences in outcome after a standard chronic pain management program? Pain Res Manag 14(6):445–53PubMedCentralPubMed Verra ML, Angst F, Brioschi R, Lehmann S, Keefe FJ, Staal JB et al (2009) Does classification of persons with fibromyalgia into multidimensional pain inventory subgroups detect differences in outcome after a standard chronic pain management program? Pain Res Manag 14(6):445–53PubMedCentralPubMed
602.
Zurück zum Zitat Giesecke T, Williams DA, Harris RE, Cupps TR, Tian X, Tian TX et al (2003) Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum 48(10):2916–22PubMedCrossRef Giesecke T, Williams DA, Harris RE, Cupps TR, Tian X, Tian TX et al (2003) Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum 48(10):2916–22PubMedCrossRef
603.
Zurück zum Zitat Vincent A, Hoskin TL, Whipple MO, Clauw DJ, Barton DL, Benzo RP et al (2014) OMERACT-based fibromyalgia symptom subgroups: an exploratory cluster analysis. Arthritis Res Ther 16(5):463PubMedCentralPubMedCrossRef Vincent A, Hoskin TL, Whipple MO, Clauw DJ, Barton DL, Benzo RP et al (2014) OMERACT-based fibromyalgia symptom subgroups: an exploratory cluster analysis. Arthritis Res Ther 16(5):463PubMedCentralPubMedCrossRef
604.
605.
Zurück zum Zitat Docampo E, Collado A, Escaramis G, Carbonell J, Rivera J, Vidal J et al (2013) Cluster analysis of clinical data identifies fibromyalgia subgroups. PLoS One 8(9):e74873PubMedCentralPubMedCrossRef Docampo E, Collado A, Escaramis G, Carbonell J, Rivera J, Vidal J et al (2013) Cluster analysis of clinical data identifies fibromyalgia subgroups. PLoS One 8(9):e74873PubMedCentralPubMedCrossRef
606.
Zurück zum Zitat Torres X, Bailles E, Valdes M, Gutierrez F, Peri JM, Arias A et al (2013) Personality does not distinguish people with fibromyalgia but identifies subgroups of patients. Gen Hosp Psychiatry 35(6):640–8PubMedCrossRef Torres X, Bailles E, Valdes M, Gutierrez F, Peri JM, Arias A et al (2013) Personality does not distinguish people with fibromyalgia but identifies subgroups of patients. Gen Hosp Psychiatry 35(6):640–8PubMedCrossRef
607.
Zurück zum Zitat de Souza JB, Goffaux P, Julien N, Potvin S, Charest J, Marchand S (2009) Fibromyalgia subgroups: profiling distinct subgroups using the fibromyalgia impact questionnaire. A preliminary study. Rheumatol Int 29(5):509–15PubMedCrossRef de Souza JB, Goffaux P, Julien N, Potvin S, Charest J, Marchand S (2009) Fibromyalgia subgroups: profiling distinct subgroups using the fibromyalgia impact questionnaire. A preliminary study. Rheumatol Int 29(5):509–15PubMedCrossRef
608.
Zurück zum Zitat López-Pousa S, Garre-Olmo J, de Gracia M, Ribot J, Calvó-Perxas L, Vilalta-Franch J (2013) Development of a multidimensional measure of fibromyalgia symptomatology: the comprehensive rating scale for fibromyalgia symptomatology. J Psychosom Res 74(5):384–92PubMedCrossRef López-Pousa S, Garre-Olmo J, de Gracia M, Ribot J, Calvó-Perxas L, Vilalta-Franch J (2013) Development of a multidimensional measure of fibromyalgia symptomatology: the comprehensive rating scale for fibromyalgia symptomatology. J Psychosom Res 74(5):384–92PubMedCrossRef
609.
Zurück zum Zitat Henningsen P, Zimmermann T, Sattel H (2003) Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med 65(4):528–33PubMedCrossRef Henningsen P, Zimmermann T, Sattel H (2003) Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med 65(4):528–33PubMedCrossRef
610.
Zurück zum Zitat Hudson JI, Arnold LM, Keck PE Jr, Auchenbach MB, Pope HG Jr (2004) Family study of fibromyalgia and affective spectrum disorder. Biol Psychiatry 56(11):884–91PubMedCrossRef Hudson JI, Arnold LM, Keck PE Jr, Auchenbach MB, Pope HG Jr (2004) Family study of fibromyalgia and affective spectrum disorder. Biol Psychiatry 56(11):884–91PubMedCrossRef
611.
Zurück zum Zitat Witthöft M, Hiller W, Loch N, Jasper F (2013) The latent structure of medically unexplained symptoms and its relation to functional somatic syndromes. Int J Behav Med 20(2):172–83PubMedCrossRef Witthöft M, Hiller W, Loch N, Jasper F (2013) The latent structure of medically unexplained symptoms and its relation to functional somatic syndromes. Int J Behav Med 20(2):172–83PubMedCrossRef
612.
Zurück zum Zitat Lacourt T, Houtveen J, van Doornen L (2013) “Functional somatic syndromes, one or many?” An answer by cluster analysis. J Psychosom Res 74(1):6–11PubMedCrossRef Lacourt T, Houtveen J, van Doornen L (2013) “Functional somatic syndromes, one or many?” An answer by cluster analysis. J Psychosom Res 74(1):6–11PubMedCrossRef
613.
Zurück zum Zitat Fink P, Toft T, Hansen MS, Ornbol E, Olesen F (2007) Symptoms and syndromes of bodily distress: an exploratory study of 978 internal medical, neurological, and primary care patients. Psychosom Med 69(1):30–9PubMedCrossRef Fink P, Toft T, Hansen MS, Ornbol E, Olesen F (2007) Symptoms and syndromes of bodily distress: an exploratory study of 978 internal medical, neurological, and primary care patients. Psychosom Med 69(1):30–9PubMedCrossRef
614.
Zurück zum Zitat Sullivan PF, Smith W, Buchwald D (2002) Latent class analysis of symptoms associated with chronic fatigue syndrome and fibromyalgia. Psychol Med 32(5):881–8PubMedCrossRef Sullivan PF, Smith W, Buchwald D (2002) Latent class analysis of symptoms associated with chronic fatigue syndrome and fibromyalgia. Psychol Med 32(5):881–8PubMedCrossRef
615.
Zurück zum Zitat Nimnuan C, Rabe-Hesketh S, Wessely S, Hotopf M (2001) How many functional somatic syndromes? J Psychosom Res 51(4):549–57PubMedCrossRef Nimnuan C, Rabe-Hesketh S, Wessely S, Hotopf M (2001) How many functional somatic syndromes? J Psychosom Res 51(4):549–57PubMedCrossRef
616.
Zurück zum Zitat Robbins JM, Kirmayer LJ, Hemami S (1997) Latent variable models of functional somatic distress. J Nerv Ment Dis 185(10):606–15PubMedCrossRef Robbins JM, Kirmayer LJ, Hemami S (1997) Latent variable models of functional somatic distress. J Nerv Ment Dis 185(10):606–15PubMedCrossRef
617.
618.
Zurück zum Zitat Taylor RR, Jason LA, Schoeny ME (2001) Evaluating latent variable models of functional somatic distress in a community-based sample. J Ment Health 10(3):335–49CrossRef Taylor RR, Jason LA, Schoeny ME (2001) Evaluating latent variable models of functional somatic distress in a community-based sample. J Ment Health 10(3):335–49CrossRef
619.
Zurück zum Zitat Kato K, Sullivan PF, Pedersen NL (2010) Latent class analysis of functional somatic symptoms in a population-based sample of twins. J Psychosom Res 68(5):447–53PubMedCentralPubMedCrossRef Kato K, Sullivan PF, Pedersen NL (2010) Latent class analysis of functional somatic symptoms in a population-based sample of twins. J Psychosom Res 68(5):447–53PubMedCentralPubMedCrossRef
620.
Zurück zum Zitat Castro-Marrero J, Cordero MD, Saez-Francas N, Jimenez-Gutierrez C, Aguilar-Montilla FJ, Aliste L et al (2013) Could mitochondrial dysfunction be a differentiating marker between chronic fatigue syndrome and fibromyalgia? Antioxid Redox Signal 19(15):1855–60PubMedCrossRef Castro-Marrero J, Cordero MD, Saez-Francas N, Jimenez-Gutierrez C, Aguilar-Montilla FJ, Aliste L et al (2013) Could mitochondrial dysfunction be a differentiating marker between chronic fatigue syndrome and fibromyalgia? Antioxid Redox Signal 19(15):1855–60PubMedCrossRef
621.
Zurück zum Zitat Evengard B, Nilsson CG, Lindh G, Lindquist L, Eneroth P, Fredrikson S et al (1998) Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. Pain 78(2):153–5PubMedCrossRef Evengard B, Nilsson CG, Lindh G, Lindquist L, Eneroth P, Fredrikson S et al (1998) Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. Pain 78(2):153–5PubMedCrossRef
622.
Zurück zum Zitat Tanriverdi F, Karaca Z, Unluhizarci K, Kelestimur F (2007) The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome. Stress 10(1):13–25PubMedCrossRef Tanriverdi F, Karaca Z, Unluhizarci K, Kelestimur F (2007) The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome. Stress 10(1):13–25PubMedCrossRef
623.
Zurück zum Zitat Matsuda JB, Barbosa FR, Morel LJ, Franca Sde C, Zingaretti SM, da Silva LM et al (2010) Serotonin receptor (5-HT 2A) and catechol-O-methyltransferase (COMT) gene polymorphisms: triggers of fibromyalgia? Rev Bras Reumatol 50(2):141–9PubMedCrossRef Matsuda JB, Barbosa FR, Morel LJ, Franca Sde C, Zingaretti SM, da Silva LM et al (2010) Serotonin receptor (5-HT 2A) and catechol-O-methyltransferase (COMT) gene polymorphisms: triggers of fibromyalgia? Rev Bras Reumatol 50(2):141–9PubMedCrossRef
624.
Zurück zum Zitat Martinez-Jauand M, Sitges C, Rodriguez V, Picornell A, Ramon M, Buskila D et al (2013) Pain sensitivity in fibromyalgia is associated with catechol-O-methyltransferase (COMT) gene. Eur J Pain 17(1):16–27PubMedCrossRef Martinez-Jauand M, Sitges C, Rodriguez V, Picornell A, Ramon M, Buskila D et al (2013) Pain sensitivity in fibromyalgia is associated with catechol-O-methyltransferase (COMT) gene. Eur J Pain 17(1):16–27PubMedCrossRef
625.
Zurück zum Zitat García-Fructuoso F, Lao-Villadóniga JI, Beyer K, Santos C (2006) Relationship between CCOMT gene genotypes and severity of fibromyalgia. Reumatol Clin 2(4):168–72CrossRef García-Fructuoso F, Lao-Villadóniga JI, Beyer K, Santos C (2006) Relationship between CCOMT gene genotypes and severity of fibromyalgia. Reumatol Clin 2(4):168–72CrossRef
626.
Zurück zum Zitat Barbosa FR, Matsuda JB, Mazucato M, de Castro FS, Zingaretti SM, da Silva LM et al (2012) Influence of catechol-O-methyltransferase (COMT) gene polymorphisms in pain sensibility of Brazilian fibromialgia patients. Rheumatol Int 32(2):427–30PubMedCrossRef Barbosa FR, Matsuda JB, Mazucato M, de Castro FS, Zingaretti SM, da Silva LM et al (2012) Influence of catechol-O-methyltransferase (COMT) gene polymorphisms in pain sensibility of Brazilian fibromialgia patients. Rheumatol Int 32(2):427–30PubMedCrossRef
627.
Zurück zum Zitat Inanir A, Karakus N, Ates O, Sezer S, Bozkurt N, Inanir S et al (2014) Clinical symptoms in fibromyalgia are associated to catechol-O-methyltransferase (COMT) gene Val158Met polymorphism. Xenobiotica 44(10):952–6PubMedCrossRef Inanir A, Karakus N, Ates O, Sezer S, Bozkurt N, Inanir S et al (2014) Clinical symptoms in fibromyalgia are associated to catechol-O-methyltransferase (COMT) gene Val158Met polymorphism. Xenobiotica 44(10):952–6PubMedCrossRef
628.
Zurück zum Zitat Xiao Y, He W, Russell IJ (2011) Genetic polymorphisms of the beta2-adrenergic receptor relate to guanosine protein-coupled stimulator receptor dysfunction in fibromyalgia syndrome. J Rheumatol 38(6):1095–103PubMedCrossRef Xiao Y, He W, Russell IJ (2011) Genetic polymorphisms of the beta2-adrenergic receptor relate to guanosine protein-coupled stimulator receptor dysfunction in fibromyalgia syndrome. J Rheumatol 38(6):1095–103PubMedCrossRef
629.
Zurück zum Zitat Solak O, Erdogan MO, Yildiz H, Ulasli AM, Yaman F, Terzi ES et al (2014) Assessment of opioid receptor μ1 gene A118G polymorphism and its association with pain intensity in patients with fibromyalgia. Rheumatol Int 34(9):1257–61PubMedCrossRef Solak O, Erdogan MO, Yildiz H, Ulasli AM, Yaman F, Terzi ES et al (2014) Assessment of opioid receptor μ1 gene A118G polymorphism and its association with pain intensity in patients with fibromyalgia. Rheumatol Int 34(9):1257–61PubMedCrossRef
630.
Zurück zum Zitat Kim SK, Kim SH, Nah SS, Lee JH, Hong SJ, Kim HS et al (2013) Association of guanosine triphosphate cyclohydrolase 1 gene polymorphisms with fibromyalgia syndrome in a Korean population. J Rheumatol 40(3):316–22PubMedCrossRef Kim SK, Kim SH, Nah SS, Lee JH, Hong SJ, Kim HS et al (2013) Association of guanosine triphosphate cyclohydrolase 1 gene polymorphisms with fibromyalgia syndrome in a Korean population. J Rheumatol 40(3):316–22PubMedCrossRef
631.
Zurück zum Zitat Lee YH, Choi SJ, Ji JD, Song GG (2012) Candidate gene studies of fibromyalgia: a systematic review and meta-analysis. Rheumatol Int 32(2):417–26PubMedCrossRef Lee YH, Choi SJ, Ji JD, Song GG (2012) Candidate gene studies of fibromyalgia: a systematic review and meta-analysis. Rheumatol Int 32(2):417–26PubMedCrossRef
632.
Zurück zum Zitat Ablin JN, Bar-Shira A, Yaron M, Orr-Urtreger A (2009) Candidate-gene approach in fibromyalgia syndrome: association analysis of the genes encoding substance P receptor, dopamine transporter and α1-antitrypsin. Clin Exp Rheumatol 27:S33–38PubMed Ablin JN, Bar-Shira A, Yaron M, Orr-Urtreger A (2009) Candidate-gene approach in fibromyalgia syndrome: association analysis of the genes encoding substance P receptor, dopamine transporter and α1-antitrypsin. Clin Exp Rheumatol 27:S33–38PubMed
633.
Zurück zum Zitat Alasehirli B, Demiryurek S, Arica E, Gursoy S, Demiryurek AT (2007) No evidence for an association between the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and fibromyalgia syndrome. Rheumatol Int 27:275–280PubMedCrossRef Alasehirli B, Demiryurek S, Arica E, Gursoy S, Demiryurek AT (2007) No evidence for an association between the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and fibromyalgia syndrome. Rheumatol Int 27:275–280PubMedCrossRef
634.
Zurück zum Zitat Bondy B, Spaeth M, Offenbaecher M et al (1999) The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. Neurobiol Dis 6:433–439PubMedCrossRef Bondy B, Spaeth M, Offenbaecher M et al (1999) The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. Neurobiol Dis 6:433–439PubMedCrossRef
635.
Zurück zum Zitat Cohen H, Neumann L, Glazer Y, Ebstein RP, Buskila D (2009) The relationship between a common catechol-O-methyltransferase (COMT) polymorphism val 158 met and fibromyalgia. Clin Exp Rheumatol 27:S51–56PubMed Cohen H, Neumann L, Glazer Y, Ebstein RP, Buskila D (2009) The relationship between a common catechol-O-methyltransferase (COMT) polymorphism val 158 met and fibromyalgia. Clin Exp Rheumatol 27:S51–56PubMed
636.
Zurück zum Zitat Frank B, Niesler B, Bondy B et al (2004) Mutational analysis of serotonin receptor genes: HTR3A and HTR3B in fibromyalgia patients. Clin Rheumatol 23:338–344PubMedCrossRef Frank B, Niesler B, Bondy B et al (2004) Mutational analysis of serotonin receptor genes: HTR3A and HTR3B in fibromyalgia patients. Clin Rheumatol 23:338–344PubMedCrossRef
637.
Zurück zum Zitat Gursoy S (2002) Absence of association of the serotonin transporter gene polymorphism with the mentally healthy subset of fibromyalgia patients. Clin Rheumatol 21:194–197PubMedCrossRef Gursoy S (2002) Absence of association of the serotonin transporter gene polymorphism with the mentally healthy subset of fibromyalgia patients. Clin Rheumatol 21:194–197PubMedCrossRef
638.
Zurück zum Zitat Gürsoy S, Erdal E, Herken H, Madenci E, Alaşehirli B (2001) Association of T102C polymorphism of the 5-HT2A receptor gene with psychiatric status in fibromyalgia syndrome. Rheumatol Int 21:58–61PubMedCrossRef Gürsoy S, Erdal E, Herken H, Madenci E, Alaşehirli B (2001) Association of T102C polymorphism of the 5-HT2A receptor gene with psychiatric status in fibromyalgia syndrome. Rheumatol Int 21:58–61PubMedCrossRef
639.
Zurück zum Zitat Gürsoy S, Erdal E, Herken H, Madenci E, Alaşehirli B, Erdal N (2003) Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int 23:104–107PubMed Gürsoy S, Erdal E, Herken H, Madenci E, Alaşehirli B, Erdal N (2003) Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int 23:104–107PubMed
640.
Zurück zum Zitat Gürsoy S, Erdal E, Sezgin M et al (2008) Which genotype of MAO gene that the patients have are likely to be most susceptible to the symptoms of fibromyalgia? Rheumatol Int 28:307–311PubMedCrossRef Gürsoy S, Erdal E, Sezgin M et al (2008) Which genotype of MAO gene that the patients have are likely to be most susceptible to the symptoms of fibromyalgia? Rheumatol Int 28:307–311PubMedCrossRef
641.
Zurück zum Zitat Offenbaecher M, Bondy B, de Jonge S et al (1999) Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum 42:2482–2488PubMedCrossRef Offenbaecher M, Bondy B, de Jonge S et al (1999) Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum 42:2482–2488PubMedCrossRef
642.
Zurück zum Zitat Potvin S, Larouche A, Normand E et al (2009) DRD3 Ser9Gly polymorphism is related to thermal pain perception and modulation in chronic widespread pain patients and healthy controls. J Pain 10:969–975PubMedCrossRef Potvin S, Larouche A, Normand E et al (2009) DRD3 Ser9Gly polymorphism is related to thermal pain perception and modulation in chronic widespread pain patients and healthy controls. J Pain 10:969–975PubMedCrossRef
643.
Zurück zum Zitat Potvin S, Larouche A, Normand E et al (2010) No relationship between the ins del polymorphism of the serotonin transporter promoter and pain perception in fibromyalgia patients and healthy controls. Eur J Pain 14:742–746PubMedCrossRef Potvin S, Larouche A, Normand E et al (2010) No relationship between the ins del polymorphism of the serotonin transporter promoter and pain perception in fibromyalgia patients and healthy controls. Eur J Pain 14:742–746PubMedCrossRef
644.
Zurück zum Zitat Su SY, Chen JJ, Lai CC, Chen CM, Tsai FJ (2007) The association between fibromyalgia and polymorphism of monoamine oxidase A and interleukin-4. Clin Rheumatol 26:12–16PubMedCrossRef Su SY, Chen JJ, Lai CC, Chen CM, Tsai FJ (2007) The association between fibromyalgia and polymorphism of monoamine oxidase A and interleukin-4. Clin Rheumatol 26:12–16PubMedCrossRef
645.
Zurück zum Zitat Tander B, Gunes S, Boke O et al (2008) Polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase genes: a study on fibromyalgia susceptibility. Rheumatol Int 28:685–691PubMedCrossRef Tander B, Gunes S, Boke O et al (2008) Polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase genes: a study on fibromyalgia susceptibility. Rheumatol Int 28:685–691PubMedCrossRef
646.
Zurück zum Zitat Vargas-Alarcon G, Fragoso JM, Cruz-Robles D et al (2007) Catechol-O-methyltransferase gene haplotypes in Mexican and Spanish patients with fibromyalgia. Arthritis Res Ther 9:R110PubMedCentralPubMedCrossRef Vargas-Alarcon G, Fragoso JM, Cruz-Robles D et al (2007) Catechol-O-methyltransferase gene haplotypes in Mexican and Spanish patients with fibromyalgia. Arthritis Res Ther 9:R110PubMedCentralPubMedCrossRef
647.
Zurück zum Zitat Vargas-Alarcon G, Fragoso JM, Cruz-Robles D et al (2009) Association of adrenergic receptor gene polymorphisms with different fibromyalgia syndrome domains. Arthritis Rheum 60:2169–2173PubMedCrossRef Vargas-Alarcon G, Fragoso JM, Cruz-Robles D et al (2009) Association of adrenergic receptor gene polymorphisms with different fibromyalgia syndrome domains. Arthritis Rheum 60:2169–2173PubMedCrossRef
Metadaten
Titel
Fibromyalgia: A Critical and Comprehensive Review
verfasst von
Andrea T. Borchers
M. Eric Gershwin
Publikationsdatum
01.10.2015
Verlag
Springer US
Erschienen in
Clinical Reviews in Allergy & Immunology / Ausgabe 2/2015
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-015-8509-4

Weitere Artikel der Ausgabe 2/2015

Clinical Reviews in Allergy & Immunology 2/2015 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.